# EDGAR Filing Document

**Accession Number:** 0001801169
**File Stem:** 0001801169-25-000092
**Filing Date:** 2025-11
**Character Count:** 419356
**Document Hash:** 2e2188b72485b5a3f88cb65079078598
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001801169-25-000092.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0001801169-25-000092

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 94

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Opendoor Technologies Inc.
- **CENTRAL INDEX KEY:** 0001801169
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE AGENTS & MANAGERS (FOR OTHERS) [6531]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 301318214
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39253
- **FILM NUMBER:** 251459030

**BUSINESS ADDRESS:**
- **STREET 1:** 410 N. SCOTTSDALE ROAD, SUITE 1000
- **CITY:** TEMPE
- **STATE:** AZ
- **ZIP:** 85288
- **BUSINESS PHONE:** 480-618-6760

**MAIL ADDRESS:**
- **STREET 1:** 410 N. SCOTTSDALE ROAD, SUITE 1000
- **CITY:** TEMPE
- **STATE:** AZ
- **ZIP:** 85288

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Social Capital Hedosophia Holdings Corp. II
- **DATE OF NAME CHANGE:** 20200124

?xml version='1.0' encoding='ASCII'? open-20250930

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ___________ to ____________.** 

**Commission file number 001-39253** 

**Opendoor Technologies Inc.**

(Exact name of registrant as specified in its charter)

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **Delaware** | **30-1318214** |
| (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer Identification No.) |
| **410 N. Scottsdale Road,** | **410 N. Scottsdale Road,** | **Suite 1000** | |
| **Tempe,** | **AZ** | | **85288** |
| (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Zip Code) |

---

**(480) 618-6760** 

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.0001 par value per share | OPEN | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of registrant's common stock outstanding as of October 30, 2025 was approximately 772,845,479.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **<u>[PART I - FINANCIAL INFORMATION](#id3a54f4223484e1994a5847be5a2a243_16)</u>** | **<u>[PART I - FINANCIAL INFORMATION](#id3a54f4223484e1994a5847be5a2a243_16)</u>** | |
| &nbsp;&nbsp;[Item 1.](#id3a54f4223484e1994a5847be5a2a243_19) | [Financial Statements](#id3a54f4223484e1994a5847be5a2a243_19) | [3](#id3a54f4223484e1994a5847be5a2a243_19) |
|  | [Condensed Consolidated Balance Sheets](#id3a54f4223484e1994a5847be5a2a243_22) | [3](#id3a54f4223484e1994a5847be5a2a243_22) |
|  | [Condensed Consolidated Statements of Operations](#id3a54f4223484e1994a5847be5a2a243_25) | [4](#id3a54f4223484e1994a5847be5a2a243_25) |
|  | [Condensed Consolidated Statements of Comprehensive Loss](#id3a54f4223484e1994a5847be5a2a243_28) | [5](#id3a54f4223484e1994a5847be5a2a243_28) |
|  | [Condensed Consolidated Statements of Shareholders' Equity](#id3a54f4223484e1994a5847be5a2a243_31) | [6](#id3a54f4223484e1994a5847be5a2a243_31) |
|  | [Condensed Consolidated Statements of Cash Flows](#id3a54f4223484e1994a5847be5a2a243_34) | [8](#id3a54f4223484e1994a5847be5a2a243_34) |
|  | [Notes to Condensed Consolidated Financial Statements](#id3a54f4223484e1994a5847be5a2a243_37) | [9](#id3a54f4223484e1994a5847be5a2a243_37) |
| &nbsp;&nbsp;[Item 2.](#id3a54f4223484e1994a5847be5a2a243_130) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#id3a54f4223484e1994a5847be5a2a243_130) | [32](#id3a54f4223484e1994a5847be5a2a243_130) |
| &nbsp;&nbsp;[Item 3.](#id3a54f4223484e1994a5847be5a2a243_226) | [Quantitative and Qualitative Disclosures About Market Risk](#id3a54f4223484e1994a5847be5a2a243_226) | [52](#id3a54f4223484e1994a5847be5a2a243_226) |
| &nbsp;&nbsp;[Item 4.](#id3a54f4223484e1994a5847be5a2a243_229) | [Controls and Procedures](#id3a54f4223484e1994a5847be5a2a243_229) | [52](#id3a54f4223484e1994a5847be5a2a243_229) |
| **<u>[PART II - OTHER INFORMATION](#id3a54f4223484e1994a5847be5a2a243_232)</u>** | **<u>[PART II - OTHER INFORMATION](#id3a54f4223484e1994a5847be5a2a243_232)</u>** |  |
| &nbsp;&nbsp;[Item 1.](#id3a54f4223484e1994a5847be5a2a243_235) | [Legal Proceedings](#id3a54f4223484e1994a5847be5a2a243_235) | [54](#id3a54f4223484e1994a5847be5a2a243_235) |
| &nbsp;&nbsp;[Item 1A.](#id3a54f4223484e1994a5847be5a2a243_238) | [Risk Factors](#id3a54f4223484e1994a5847be5a2a243_238) | [54](#id3a54f4223484e1994a5847be5a2a243_238) |
| &nbsp;&nbsp;[Item 2.](#id3a54f4223484e1994a5847be5a2a243_241) | [Unregistered Sales of Equity Securities and Use of Proceeds](#id3a54f4223484e1994a5847be5a2a243_241) | [56](#id3a54f4223484e1994a5847be5a2a243_241) |
| &nbsp;&nbsp;[Item 3.](#id3a54f4223484e1994a5847be5a2a243_244) | [Defaults Upon Senior Securities](#id3a54f4223484e1994a5847be5a2a243_244) | [56](#id3a54f4223484e1994a5847be5a2a243_244) |
| &nbsp;&nbsp;[Item 4.](#id3a54f4223484e1994a5847be5a2a243_247) | [Mine Safety Disclosures](#id3a54f4223484e1994a5847be5a2a243_247) | [56](#id3a54f4223484e1994a5847be5a2a243_247) |
| &nbsp;&nbsp;[Item 5.](#id3a54f4223484e1994a5847be5a2a243_250) | [Other Information](#id3a54f4223484e1994a5847be5a2a243_250) | [56](#id3a54f4223484e1994a5847be5a2a243_250) |
| &nbsp;&nbsp;[Item 6.](#id3a54f4223484e1994a5847be5a2a243_256) | [Exhibits](#id3a54f4223484e1994a5847be5a2a243_256) | [57](#id3a54f4223484e1994a5847be5a2a243_256) |
|  | [Signatures](#id3a54f4223484e1994a5847be5a2a243_259) | [60](#id3a54f4223484e1994a5847be5a2a243_259) |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

As used in this Quarterly Report on Form 10-Q, unless the context requires otherwise, references to "Opendoor," the "Company," "we," "us," and "our," and similar references refer to Opendoor Technologies Inc. and its wholly owned subsidiaries following the Business Combination (as defined herein) and to Opendoor Labs Inc. prior to the Business Combination.

**FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding: current and future health and stability of the real estate housing market and general economy; volatility of mortgage interest rates; changes in resale clearance rates and expectations regarding future behavior of consumers and partners; the health and status of our financial condition and expectations with respect to our debt and equity financing; anticipated future results of operations or financial performance; priorities of the Company to achieve future financial and business goals; impacts to our business from political and regulatory activity, including recent trade policies and potential increased tariffs; the likelihood of offer acceptance among high-quality homes in response to refinements to our spread policy; our ability to continue to effectively navigate the markets in which we operate; anticipated future and ongoing impacts and benefits of acquisitions, partnership channel expansions, product innovations and other business decisions; health of our balance sheet to weather ongoing market transitions and any expectation to quickly re-scale in the future upon market stabilization; our ability to adopt an effective approach to manage economic and industry risk, as well as inventory health, including by improving the quality of homes in our portfolio and supporting faster sell-through; our expectations with respect to the future success of our partnerships and our ability to drive significant growth in sales volumes through such partnerships; the expected repurchase of certain of our outstanding convertible notes; the expected terms of the warrants to be issued pursuant to our warrant dividend distribution; our business strategy and plans, including plans to expand into additional markets; market opportunity and expansion and objectives of management for future operations, including statements regarding the benefits and timing of the roll out of new markets, products, or technology; and the expected diversification of funding sources, are forward-looking statements. When used in this Quarterly Report on Form 10-Q, words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "might," "opportunity," "plan," "possible," "potential," "predict," "project," "should," "strategy," "strive," "target," "vision," "will," or "would," any negative of these words or other similar terms or expressions may identify forward-looking statements. The absence of these words does not mean that a statement is not forward-looking.

These forward-looking statements are based on information available as of the date of this Quarterly Report on Form 10-Q and current expectations, forecasts and assumptions, which involve a number of judgments, risks and uncertainties, including without limitation, risks related to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the current and future health and stability of the economy, financial conditions and residential housing market, including any extended downturns or slowdowns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in general economic and financial conditions (including federal monetary policy, the imposition of tariffs and price or exchange controls, interest rates, inflation, actual or anticipated recession, home price fluctuations, and housing inventory), as well as the probability of such changes occurring, that may impact demand for our products and services, lower our profitability or reduce our access to future financings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our real estate assets and increased competition in the U.S. residential real estate industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ability to operate and grow our core business products, including the ability to obtain sufficient financing and resell purchased homes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• investment of resources to pursue strategies and develop new products and services that may not prove effective or that are not attractive to customers and real estate partners or that do not allow us to compete successfully;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to acquire and resell homes profitably;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to grow market share in our existing markets or any new markets we may enter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to leverage artificial intelligence ("AI") to drive operational efficiency;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage our growth effectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to expeditiously sell and appropriately price our inventory;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage our capital resources and access sources of capital, including debt financing and securitization funding to finance our real estate inventories and other sources of capital to finance operations and growth;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain liquidity and to raise the funds necessary for any cash settlement upon conversion of our outstanding convertible notes or upon repurchasing our outstanding convertible notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any dilutive effect on our common stock upon any settlement of our outstanding convertible notes through the conversion of notes into shares of our common stock;

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain and enhance our products and brand, and to attract customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage, develop and refine our digital platform, including our automated pricing and valuation technology;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to realize expected benefits from our restructuring and cost reduction efforts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to comply with multiple listing service rules and requirements to access and use listing data, and to maintain or establish relationships with listings and data providers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to obtain or maintain licenses and permits to support our current and future business operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• acquisitions, strategic partnerships, joint ventures, capital-raising activities or other corporate transactions or commitments by us or our competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• actual or anticipated changes in technology, products, markets or services by us or our competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our success in retaining or recruiting, or changes required in, our officers, key employees and/or directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of the regulatory environment and potential regulatory instability within our industry and complexities with compliance related to such environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any future impact of pandemics, epidemics, or other public health crises on our ability to operate, demand for our products or services, or general economic conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to maintain our listing on the Nasdaq Global Select Market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in laws or government regulation affecting our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of pending or any future litigation or regulatory actions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the price of our common stock has been and may in the future be volatile; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the other important factors described in the "Risk Factors" section of this Quarterly Report on Form 10-Q and in Part I. Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "Annual Report") and in "Part II – Item 1A. Risk Factors" in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (the "June 2025 Quarterly Report").

Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the effect of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(In millions, except share data)

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | | **September 30,<br>2025** | **December 31, <br>2024** |
| **ASSETS** | | | |
| CURRENT ASSETS: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents |  | $962 | $671 |
| &nbsp;&nbsp;&nbsp;Restricted cash |  | 490 | 92 |
| &nbsp;&nbsp;&nbsp;Marketable securities |  |  | 8 |
| &nbsp;&nbsp;&nbsp;Escrow receivable |  | 9 | 6 |
| &nbsp;&nbsp;&nbsp;Real estate inventory, net |  | 1053 | 2159 |
| &nbsp;&nbsp;&nbsp;Other current assets |  | 73 | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets |  | 2587 | 2997 |
| PROPERTY AND EQUIPMENT – Net |  | 31 | 48 |
| RIGHT OF USE ASSETS |  | 9 | 18 |
| GOODWILL |  | 3 | 3 |
| OTHER ASSETS |  | 70 | 60 |
| TOTAL ASSETS | <sup>(1)</sup> | $2700 | $3126 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |  |
| CURRENT LIABILITIES: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and other accrued liabilities |  | $91 | $92 |
| &nbsp;&nbsp;&nbsp;Non-recourse asset-backed debt – current portion |  | 374 | 432 |
| &nbsp;&nbsp;&nbsp;Convertible senior notes – current portion  |  | 439 |  |
| &nbsp;&nbsp;&nbsp;Interest payable |  | 9 | 3 |
| &nbsp;&nbsp;&nbsp;Lease liabilities – current portion |  | 1 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities |  | 914 | 529 |
| NON-RECOURSE ASSET-BACKED DEBT – Net of current portion |  | 966 | 1492 |
| CONVERTIBLE SENIOR NOTES – Net of current portion |  |  | 378 |
| LEASE LIABILITIES – Net of current portion |  | 7 | 13 |
| OTHER LIABILITIES |  | 2 | 1 |
| Total liabilities | <sup>(2)</sup> | 1889 | 2413 |
| COMMITMENTS AND CONTINGENCIES (See Note 15) |  |  |  |
| SHAREHOLDERS' EQUITY: |  |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value; 3,000,000,000 shares authorized; 771,534,057 and 719,990,121 shares issued, respectively; 771,534,057 and 719,990,121 shares outstanding, respectively |  |  |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital |  | 4740 | 4438 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit |  | (3929) | (3725) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity |  | 811 | 713 |
| &nbsp;&nbsp;&nbsp;TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |  | $2700 | $3126 |

---

________________

<sup>(1)</sup> The Company's consolidated assets at September 30, 2025 and December 31, 2024 include the following assets of certain variable interest entities ("VIEs") that can only be used to settle the liabilities of those VIEs: Restricted cash, $480 and $81; Real estate inventory, net, $1,035 and $2,141; Escrow receivable, $9 and $6; Other current assets, $4 and $8; and Total assets of $1,528 and $2,236, respectively.

<sup>(2)</sup> The Company's consolidated liabilities at September 30, 2025 and December 31, 2024 include the following liabilities for which the VIE creditors generally do not have recourse to Opendoor: Accounts payable and other accrued liabilities, $18 and $21; Current portion of non-recourse asset-backed debt, $374 and $432; Interest payable, $1 and $3; Non-recourse asset-backed debt, net of current portion, $966 and $1,492; and Total liabilities, $1,359 and $1,948, respectively. See "*Note 4. Variable Interest Entities*" for additional information regarding our VIEs.

*See accompanying notes to condensed consolidated financial statements.*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

(In millions, except share amounts which are presented in thousands, and per share amounts)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| REVENUE | $915 | $1377 | $3635 | $4069 |
| COST OF REVENUE | 849 | 1272 | 3342 | 3721 |
| GROSS PROFIT  | 66 | 105 | 293 | 348 |
| OPERATING EXPENSES: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Sales, marketing and operations | 66 | 96 | 250 | 325 |
| &nbsp;&nbsp;&nbsp;General and administrative | 48 | 46 | 109 | 141 |
| &nbsp;&nbsp;&nbsp;Technology and development | 19 | 30 | 61 | 108 |
| &nbsp;&nbsp;&nbsp;Restructuring | 1 |  | 10 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 134 | 172 | 430 | 574 |
| LOSS FROM OPERATIONS | (68) | (67) | (137) | (226) |
| (LOSS) GAIN ON EXTINGUISHMENT OF DEBT | (1) |  | 9 | (1) |
| INTEREST EXPENSE | (34) | (34) | (103) | (101) |
| OTHER INCOME – Net | 14 | 23 | 28 | 50 |
| LOSS BEFORE INCOME TAXES | (89) | (78) | (203) | (278) |
| INCOME TAX EXPENSE | (1) |  | (1) | (1) |
| NET LOSS  | $(90) | $(78) | $(204) | $(279) |
| Net loss per share attributable to common shareholders: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.12) | $(0.11) | $(0.28) | $(0.40) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.12) | $(0.11) | $(0.28) | $(0.40) |
| Weighted-average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 741939 | 705359 | 731722 | 693796 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 741939 | 705359 | 731722 | 693796 |

---

*See accompanying notes to condensed consolidated financial statements.*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

(In millions)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| NET LOSS | $(90) | $(78) | $(204) | $(279) |
| OTHER COMPREHENSIVE INCOME: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Unrealized gain on marketable securities |  |  |  | 1 |
| COMPREHENSIVE LOSS | $(90) | $(78) | $(204) | $(278) |

---

*See accompanying notes to condensed consolidated financial statements.*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

(In millions, except number of shares)

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** |
| | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| BALANCE–June 30, 2025 | 733592980 | $— | $4470 | $(3839) | $— | $631 |
| Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes | 6897890 |  |  |  |  |  |
| Exercise of stock options | 2648969 |  | 4 |  |  | 4 |
| Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes | 641139 |  | 1 |  |  | 1 |
| Issuance of common stock in connection with PIPE offering, net of equity issuance costs | 6165412 |  | 41 |  |  | 41 |
| Issuance of common stock under at-the-market offering, net of equity issuance costs | 21587667 |  | 195 |  |  | 195 |
| Settlement of Capped Calls related to the 2026 Notes |  |  | 1 |  |  | 1 |
| Stock-based compensation |  |  | 28 |  |  | 28 |
| Other comprehensive income |  |  |  |  |  |  |
| Net loss |  |  |  | (90) |  | (90) |
| BALANCE–September 30, 2025 | 771534057 | $— | $4740 | $(3929) | $— | $811 |
|  | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** |
|  | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
|  | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| BALANCE–December 31, 2024 | 719990121 | $— | $4438 | $(3725) | $— | $713 |
| Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes | 19528927 |  | 2 |  |  | 2 |
| Exercise of stock options | 2677452 |  | 4 |  |  | 4 |
| Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes | 1584478 |  | 2 |  |  | 2 |
| Issuance of common stock in connection with PIPE offering, net of equity issuance costs | 6165412 |  | 41 |  |  | 41 |
| Issuance of common stock under at-the-market offering, net of equity issuance costs | 21587667 |  | 195 |  |  | 195 |
| Settlement of Capped Calls related to the 2026 Notes |  |  | 1 |  |  | 1 |
| Stock-based compensation |  |  | 57 |  |  | 57 |
| Other comprehensive income |  |  |  |  |  |  |
| Net loss |  |  |  | (204) |  | (204) |
| BALANCE–September 30, 2025 | 771534057 | $— | $4740 | $(3929) | $— | $811 |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

(In millions, except number of shares)

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** |
| | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| BALANCE–June 30, 2024 | 698843166 | $— | $4379 | $(3534) | $— | $845 |
| Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes | 11194753 |  | 1 |  |  | 1 |
| Exercise of stock options | 169483 |  |  |  |  |  |
| Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes | 1453469 |  | 3 |  |  | 3 |
| Stock-based compensation |  |  | 30 |  |  | 30 |
| Other comprehensive income |  |  |  |  |  |  |
| Net loss |  |  |  | (78) |  | (78) |
| BALANCE–September 30, 2024 | 711660871 | $— | $4413 | $(3612) | $— | $801 |
|  | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** | **Shareholders' Equity** |
|  | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
|  | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Accumulated<br>Deficit** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total**<br>**Shareholders'**<br>**Equity** |
| BALANCE–December 31, 2023 | 677636163 | $— | $4301 | $(3333) | $(1) | $967 |
| Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes | 30590634 |  | 1 |  |  | 1 |
| Exercise of stock options | 363277 |  |  |  |  |  |
| Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes | 3070797 |  | 5 |  |  | 5 |
| Stock-based compensation |  |  | 106 |  |  | 106 |
| Other comprehensive income |  |  |  |  | 1 | 1 |
| Net loss |  |  |  | (279) |  | (279) |
| BALANCE–September 30, 2024 | 711660871 | $— | $4413 | $(3612) | $— | $801 |

---

*See accompanying notes to condensed consolidated financial statements.*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

(In millions)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| CASH FLOWS FROM OPERATING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(204) | $(279) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to cash, cash equivalents, and restricted cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 33 | 37 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of right of use asset | 2 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 54 | 91 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory valuation adjustment | 48 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in fair value of equity securities | 3 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 7 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on extinguishment of debt | (9) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on deconsolidation, net |  | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Escrow receivable | (3) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Real estate inventory | 1054 | (422) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (15) | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other accrued liabilities | 4 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest payable | 6 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities | (1) | (5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 979 | (515) |
| CASH FLOWS FROM INVESTING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of property and equipment | (9) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales, maturities, redemptions and paydowns of marketable securities | 6 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of equity investments  | (6) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash impact of deconsolidation of subsidiaries |  | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) provided by investing activities | (9) | 31 |
| CASH FLOWS FROM FINANCING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible senior notes, net of discount | 75 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement of capped calls related to the convertible senior notes | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options | 4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock for ESPP | 2 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from PIPE offering | 41 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the issuance of common stock under at-the-market offering, net | 198 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from non-recourse asset-backed debt | 684 | 417 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal payments on non-recourse asset-backed debt | (1268) | (424) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of loan origination fees and debt issuance costs | (16) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financing activities  | (2) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (281) | (2) |
| &nbsp;&nbsp;&nbsp;NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | 689 | (486) |
| &nbsp;&nbsp;&nbsp;CASH, CASH EQUIVALENTS, AND RESTRICTED CASH – Beginning of period | 763 | 1540 |
| &nbsp;&nbsp;&nbsp;CASH, CASH EQUIVALENTS, AND RESTRICTED CASH – End of period | $1452 | $1054 |
| &nbsp;&nbsp;&nbsp;SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION – Cash paid during the period for interest | $88 | $93 |
| &nbsp;&nbsp;&nbsp;DISCLOSURES OF NONCASH INVESTING AND FINANCING ACTIVITIES: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense capitalized for internally developed software | $3 | $15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal value of 2026 Notes extinguished in Debt Exchange  | $(246) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principal value of 2030 Notes issued in Debt Exchange  | $246 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment in non-marketable equity securities of deconsolidated entities  | $3 | $39 |
| &nbsp;&nbsp;&nbsp;RECONCILIATION TO CONDENSED CONSOLIDATED BALANCE SHEETS: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $962 | $829 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 490 | 225 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents, and restricted cash | $1452 | $1054 |

---

*See accompanying notes to condensed consolidated financial statements.*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

**1. DESCRIPTION OF BUSINESS AND ACCOUNTING POLICIES**

***Description of Business***

Opendoor Technologies Inc. (the "Company" and "Opendoor") including its consolidated subsidiaries and certain variable interest entities ("VIEs"), is a managed marketplace for residential real estate. By leveraging its centralized digital platform, Opendoor is working towards a future that enables sellers and buyers of residential real estate to experience a simple and certain transaction that is dramatically improved from the traditional process. The Company was incorporated in Delaware on December 30, 2013.

The Company completed a business combination with Social Capital Hedosophia Holdings Corp. II ("SCH"), a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the "Business Combination"). The Business Combination, pursuant to which Opendoor Labs Inc. became a wholly owned subsidiary of SCH and SCH changed its name from "Social Capital Hedosophia Holdings Corp. II" to "Opendoor Technologies Inc.", was completed on December 18, 2020, and was accounted for as a reverse recapitalization, in accordance with GAAP.

***Basis of Presentation and Principles of Consolidation***

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to generally accepted accounting principles in the United States of America ("GAAP"). The condensed consolidated financial statements as of September 30, 2025 and December 31, 2024 and for the three and nine month periods ended September 30, 2025 and 2024 include the accounts of Opendoor, its wholly owned subsidiaries and VIEs where the Company is the primary beneficiary. The accompanying unaudited condensed consolidated financial statements reflect all adjustments which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. All significant intercompany accounts and transactions have been eliminated in the condensed consolidated financial statements herein.

The accompanying interim condensed consolidated financial statements and these related notes should be read in conjunction with the consolidated financial statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "Annual Report") filed on February 27, 2025.

***At-The-Market Equity Offering***

In May 2024, the Company entered into an at-the-market equity offering sales agreement (the "ATM Agreement") with Barclays Capital Inc. and Virtu Americas LLC, as sales agents (the "Agents"), pursuant to which the Company may offer and sell, from time to time, through the Agents, shares of the Company's common stock having an aggregate offering price of up to $200 million. Under the ATM Agreement, the Agents may sell shares by any method deemed to be an "at-the-market offering." During the three and nine months ended September 30, 2025, the Company issued and sold an aggregate of 21,587,667 shares at a weighted average price of $9.26 per share, under the ATM Agreement for total cash proceeds, after commissions, of approximately $198 million, and Net Proceeds, as defined in the ATM Agreement, of approximately $195 million. As of September 30 2025, there are no shares available for issuance under the ATM Agreement.

***Private Investment in Public Equity Offerings***

On September 10, 2025, the Company closed certain private investment in public equity ("PIPE") offerings and entered into purchase agreements with accredited investors that resulted in aggregate gross cash proceeds to the Company of approximately $41 million. See *"Note 13 — Related Parties"* to the condensed consolidated financial statements for details regarding the PIPE offerings.

***Use of Estimates***

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that have a material impact on the amounts reported in the financial statements and accompanying notes. Significant estimates, assumptions and judgments made by management include, among others, share-based awards and

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

inventory valuation adjustment. Management believes that the estimates and judgments upon which management relies are reasonable based upon information available to management at the time that these estimates and judgments are made. To the extent there are material differences between these estimates, assumptions and judgments and actual results, the carrying values of the Company's assets and liabilities and the results of operations will be affected. The health of the residential housing market and interest rate environment have introduced additional uncertainty with respect to judgments, estimates and assumptions, which may materially impact the estimates previously listed, among others.

***Significant Risks and Uncertainties***

The Company operates in a dynamic industry and, accordingly, can be affected by a variety of factors. For example, the Company believes that changes in any of the following factors could have a significant negative effect on the Company in terms of its future financial position, results of operations or cash flows: its rates of revenue growth; its ability to manage inventory; engagement and usage of its products; the effectiveness of its investment of resources to pursue strategies; competition in its market; the stability of the residential real estate market; the impact of interest rate changes on demand for and pricing of its products and on the cost of capital; its ability to leverage artificial intelligence ("AI") to drive operational efficiency; impacts to its business from political and regulatory activity, including recent trade policies, potential increased tariffs; changes in technology, products, markets or services by the Company or its competitors; its ability to maintain or establish relationships with listings and data providers; its ability to obtain or maintain licenses and permits to support its current and future businesses; actual or anticipated changes to its products and services; changes in government regulation affecting its business; the outcomes of legal proceedings; natural disasters and catastrophic events, such as pandemics or epidemics; scaling and adaptation of existing technology and network infrastructure; its management of its growth; its ability to attract and retain qualified employees and key personnel; its ability to successfully integrate and realize the benefits of its past or future strategic acquisitions or investments; the protection of customers' information and other privacy concerns; the protection of its brand and intellectual property; and intellectual property infringement and other claims, among other things.

***Concentrations of Credit Risk***

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, and investments in marketable and non-marketable securities. The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company's investments.

***Summary of Significant Accounting Policies***

The Company's significant accounting policies are discussed in *"Part II – Item 8 – Financial Statements and Supplementary Data – Note 1. Description of Business and Accounting Policies"* in the Annual Report. There have been no changes to these significant accounting policies for the nine-month period ended September 30, 2025, except as noted below.

*Impairment of Long-Lived Assets*

Long-lived assets, such as property and equipment and definite-lived intangible assets, among other long-lived assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss is recognized to the extent the carrying amount of the underlying asset exceeds its fair value. The impairment loss recognized for the periods presented is primarily related to impairment of certain internally developed software projects. The impairment loss recognized during the periods presented is as follows (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Technology and development | $2 | $1 | 5 | 4 |
| Total impairment loss | $2 | $1 | $5 | $4 |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

***Convertible Senior Notes***

The Company accounts for each series of its convertible senior notes wholly as debt. The Company has not identified any material embedded features contained within its notes which would require bifurcation from the debt host. As applicable, any debt discount and debt issuance costs incurred in connection with the issuance of the notes are recorded as a direct deduction from the carrying amount of the notes. These amounts are amortized to interest expense using the effective interest method over the expected term of the notes, or if applicable, to the earliest date the noteholder may exercise a put option. Upon conversion, the carrying amount of the notes, including any unamortized debt issuance costs and unamortized discounts, are reduced by cash paid, with any difference being reflected as a change in equity. No gain or loss will be recognized upon conversion. Upon extinguishment of any portion of the notes, the difference between the repurchase price of the extinguished notes and the respective net carrying amount is recorded as a gain or loss in (Loss) gain on extinguishment of debt in the condensed consolidated statements of operations. See *"Note 5 — Credit Facilities and Long-Term Debt"* for further details on the Company's notes.

***Stock-Based Compensation***

*Market Condition Restricted Stock Units ("RSUs")*

The Company has granted certain employees dual-trigger RSUs with vesting conditions including both an applicable market condition as well as a service condition. As described in the share agreement, the applicable market condition is satisfied upon the Company's achievement of certain share price milestones, while the service condition is satisfied through continued service to the Company.

For market-based RSUs, the Company determines the grant-date fair value utilizing Monte Carlo simulations, which incorporate various assumptions, including expected stock price volatility, contractual term, dividend yield, and stock price at grant date. The Company estimates the volatility of common stock on the date of grant based on the Company's historical stock price volatility. As the Company had no history of dividend payments and had not declared any prospective dividends, a 0% dividend yield was assumed.

For stock-based compensation, each market-based condition is treated as an accounting unit and expense is recognized over the requisite service period with respect to each unit. The Company determines the requisite service period by comparing the derived service period to achieve the market-based condition and the explicit service-based period, if any, using the longer of the two service periods as the requisite service period.

***Recently Issued Accounting Standards***

*<u>Recently Adopted Accounting Standards</u>*

For the nine months ended September 30, 2025, the Company did not adopt any material new accounting standards.

*<u>Recently Issued Accounting Standards Not Yet Adopted</u>*

In October 2023, the FASB issued ASU 2023-06 which is intended to clarify or improve disclosure and presentation requirements of a variety of topics. It will allow users to more easily compare entities subject to the U.S. Securities and Exchange Commission's (*"*SEC") existing disclosures with those entities that were not previously subject to the requirements and align the requirements in the FASB accounting standard codification with the SEC's regulations. The effective date for each amendment will be the date on which the SEC's removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the applicable disclosure requirement by June 30, 2027, the amendment will not be effective for any entity. Early adoption is prohibited. The Company is currently assessing the impact on the Company's disclosures.

In December 2023, the FASB issued ASU 2023-09, which expands income tax disclosure requirements to include additional information related to the rate reconciliation of effective tax rates to statutory rates as well as additional disaggregation of taxes paid. This guidance is effective for fiscal years beginning after December 15, 2024, and early adoption is permitted. The Company is currently assessing the impact on the Company's disclosures.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

In November 2024, the FASB issued ASU 2024-03, which is intended to improve the disclosures about a public business entity's expenses and provide detailed information about the types of expenses in commonly presented expense captions. The new guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, and early adoption is permitted. The Company is currently assessing the impact on the Company's condensed consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles – Goodwill and Other – Internal-Use Software, to modernize the outdated guidance for accounting for software costs by aligning the accounting with how software is developed today. The effective date for the standard is for fiscal years beginning after December 15, 2027 and interim periods within those fiscal years. Early adoption is permitted. The amendments in ASU 2025-06 should be applied either prospectively, retrospectively, or utilizing a modified transition approach. The Company is currently assessing the impact on the Company's condensed consolidated financial statements and disclosures.

In September 2025, the FASB issued an accounting standards update, ASU 2025-07. This update clarifies the application of derivative accounting to certain contracts and refines the guidance for share-based noncash consideration received from customers. Specifically, ASU 2025-07 introduces a scope exception for contracts that are not exchange-traded and whose underlying is tied to operations or activities specific to one party. It also clarifies that share-based noncash consideration from a customer should initially be accounted for under Topic 606 until the right to receive or retain such consideration becomes unconditional, at which point financial instruments guidance may apply. The effective date for the standard is for fiscal years beginning after December 15, 2026 and interim periods within those fiscal years. Early adoption is permitted. The amendments in ASU 2025-07 should be applied either prospectively or by utilizing a modified retrospective approach. The Company is currently assessing the impact on the Company's condensed consolidated financial statements and disclosures.

**2. REAL ESTATE INVENTORY**

The following table presents the components of inventory, net of applicable inventory valuation adjustments of $32 million and $26 million, as of September 30, 2025 and December 31, 2024, respectively (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| Work in progress | $122 | $577 |
| Finished goods: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Listed for sale | 657 | 1302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Under contract for sale | 274 | 280 |
| Total real estate inventory | $1053 | $2159 |

---

As of September 30, 2025, the Company was in contract to purchase 526 homes for an aggregate purchase price of $164 million.

During the three and nine months ended September 30, 2025, the Company recorded valuation adjustments for real estate inventory of $15 million and $48 million, respectively, in Cost of revenue in the condensed consolidated statements of operations. During the three and nine months ended September 30, 2024, the Company recorded valuation adjustments for real estate inventory of $10 million and $51 million, respectively, in Cost of revenue in the condensed consolidated statements of operations.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

**3. CASH, CASH EQUIVALENTS, AND INVESTMENTS**

The amortized cost, gross unrealized gains and losses, and fair value of cash, cash equivalents, and marketable securities as of September 30, 2025 and December 31, 2024, were as follows (in millions):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Cost**<br>**Basis** | **Unrealized**<br>**Gains** | **Unrealized**<br>**Losses** | **Fair Value** | **Cash and Cash**<br>**Equivalents** | **Marketable**<br>**Securities** |
| Cash | $54 | $— | $— | $54 | $54 | $— |
| Money market funds | 908 |  |  | 908 | 908 |  |
| Total | $962 | $— | $— | $962 | $962 | $— |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Cost**<br>**Basis** | **Unrealized**<br>**Gains** | **Unrealized**<br>**Losses** | **Fair Value** | **Cash and Cash**<br>**Equivalents** | **Marketable**<br>**Securities** |
| Cash | $60 | $— | $— | $60 | $60 | $— |
| Money market funds | 611 |  |  | 611 | 611 |  |
| Equity securities | 8 |  |  | 8 |  | 8 |
| Total | $679 | $— | $— | $679 | $671 | $8 |

---

The Company had no marketable equity securities as of September 30, 2025. During the three and nine months ended September 30, 2024, the Company recognized $3 million and $7 million of net unrealized losses in the condensed consolidated statements of operations related to marketable equity securities held as of September 30, 2024.

A summary of non-marketable equity securities and equity method investment balances as of September 30, 2025 and December 31, 2024 were as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| Equity method investments | $20 | $20 |
| Non-marketable equity securities | 48 | 39 |
| Total | $68 | $59 |

---

No unrealized losses were recognized during both the three and nine months ended September 30, 2025 and September 30, 2024 in the condensed consolidated statements of operations related to non-marketable equity securities held as of September 30, 2025 and September 30, 2024, respectively.

**4. VARIABLE INTEREST ENTITIES**

The Company utilizes VIEs in the normal course of business to support the Company's financing needs. The Company determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with the VIE and reconsiders that conclusion on an on-going basis.

The Company established certain special purpose entities ("SPEs") for the purpose of financing the Company's purchase and renovation of real estate inventory through the issuance of asset-backed debt. The Company is the primary beneficiary of the various VIEs within these financing structures and consolidates these VIEs. The Company is determined to be the primary beneficiary based on its power to direct the activities that most significantly impact the economic outcomes of the SPEs through its role in designing the SPEs and managing the real estate inventory they purchase and sell. The Company has a potentially significant variable interest in the entities based upon the equity interest the Company holds in the VIEs.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

The following table summarizes the assets and liabilities related to the VIEs consolidated by the Company as of September 30, 2025 and December 31, 2024 (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| **<u>Assets</u>** | | |
| Restricted cash | $480 | $81 |
| Real estate inventory, net | 1035 | 2141 |
| Other<sup>(1)</sup> | 13 | 14 |
| Total assets | $1528 | $2236 |
| **<u>Liabilities</u>** |  |  |
| Non-recourse asset-backed debt | $1340 | $1924 |
| Other<sup>(2)</sup> | 19 | 24 |
| Total liabilities | $1359 | $1948 |

---

________________

<sup>(1)</sup> Includes escrow receivable and other current assets.

<sup>(2)</sup> Includes accounts payable and other accrued liabilities and interest payable.

The creditors of the VIEs generally do not have recourse to the Company's general credit solely by virtue of being creditors of the VIEs. However, certain of the financial covenants included in the inventory financing facilities to which the VIEs are party are calculated by reference to Opendoor Labs Inc. and its consolidated subsidiaries' assets and liabilities. As a result, under certain circumstances, this may limit the Company's flexibility to transfer assets from Opendoor subsidiaries to the Parent Company. See *"Note 5 — Credit Facilities and Long-Term Debt"* for further discussion of the recourse obligations with respect to the VIEs.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

**5. CREDIT FACILITIES AND LONG-TERM DEBT**

The following tables summarize certain details related to the Company's non-recourse asset-backed debt as of September 30, 2025 and December 31, 2024 (in millions, except interest rates):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Outstanding Amount** | **Outstanding Amount** | | | |
|<br>**September 30, 2025** |<br>**Borrowing**<br>**Capacity** | **Current** | **Non-Current** |<br>**Weighted**<br>**Average**<br>**Interest Rate** |<br>**End of Revolving / Withdrawal Period** |<br>**Final Maturity**<br>**Date** |
| Non-Recourse Asset-backed Debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset-backed Senior Revolving Credit Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-2 | $1000 | $— | $— | —% | June 25, 2027 | June 25, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-3 | 1000 | 6 |  | 7.28% | September 29, 2026 | September 29, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-1 | 300 |  |  | 7.24% | February 18, 2027 | February 18, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-2 | 300 |  |  | 7.15% | October 2, 2026 | October 1, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-3 | 100 |  |  | 7.28% | April 5, 2027 | April 3, 2028 |
| &nbsp;&nbsp;Asset-backed Senior Term Debt Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S1 | 400 | 100 |  | 5.88% | February 24, 2026 | August 24, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S2 | 268 | 268 |  | 3.57% | September 10, 2025 | March 10, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S3 | 1000 |  | 625 | 3.75% | January 31, 2027 | July 31, 2027 |
| Total | $4368 | $374 | $625 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  |  | (4) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value |  | $374 | $621 |  |  |  |
| &nbsp;&nbsp;Asset-backed Mezzanine Term Debt Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2020-M1 | 3000 |  | 200 | 12.00% | February 25, 2028 | February 25, 2029 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2022-M1 | 250 |  | 150 | 12.24% | January 31, 2027 | November 1, 2027 |
| Total | $3250 | $— | $350 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  |  | (5) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value |  |  | $345 |  |  |  |
| Total Non-Recourse Asset-backed Debt | $7618 | $374 | $966 |  |  |  |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **Outstanding Amount** | **Outstanding Amount** | |
|<br>**December 31, 2024** | **Current** | **Non-Current** |<br>**Weighted**<br>**Average**<br>**Interest Rate** |
| Non-Recourse Asset-backed Debt: |  |  |  |
| &nbsp;&nbsp;Asset-backed Senior Revolving Credit Facilities |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-2 | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-3 | 182 |  | 8.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-1 |  |  | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-2 |  |  | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-3 |  |  | 8.13% |
| &nbsp;&nbsp;Asset-backed Senior Term Debt Facilities |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S1 |  | 100 | 3.48% |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S2 |  | 300 | 3.31% |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S3 |  | 750 | 3.75% |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2022-S1 | 250 |  | 4.07% |
| Total | $432 | $1150 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  | (7) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value | $432 | $1143 |  |
| &nbsp;&nbsp;Asset-backed Mezzanine Term Debt Facilities |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2020-M1 | $— | $200 | 10.00% |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2022-M1 | $— | $150 | 10.00% |
| Total | $— | $350 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value |  | $349 |  |
| Total Non-Recourse Asset-backed Debt | $432 | $1492 |  |

---

***Non-Recourse Asset-backed Debt***

The Company utilizes inventory financing facilities consisting of asset-backed senior debt facilities and asset-backed mezzanine term debt facilities to provide financing for the Company's real estate inventory purchases and renovation. These inventory financing facilities are typically secured by some combination of restricted cash, equity in real estate owning subsidiaries and related holding companies, and, for senior facilities, the real estate inventory financed by the relevant facility and/or beneficial interests in such inventory.

Each of the borrowers under the inventory financing facilities is a consolidated subsidiary of Opendoor and a separate legal entity. Neither the assets nor credit of any such borrower subsidiaries are generally available to satisfy the debts and other obligations of any other Opendoor entities. The inventory financing facilities are non-recourse to the Company and are non-recourse to Opendoor subsidiaries not party to the relevant facilities, except for limited guarantees provided by an Opendoor subsidiary for certain obligations involving "bad acts" by an Opendoor entity and certain other limited circumstances.

As of September 30, 2025, the Company had total borrowing capacity with respect to its non-recourse asset-backed debt of $7.6 billion. Borrowing capacity amounts under non-recourse asset-backed debt as reflected in the table above are in some cases not fully committed and any borrowings above the committed amounts are subject to the applicable lender's discretion. Any amounts repaid for senior term and mezzanine term debt facilities reduce total borrowing capacity as repaid amounts are not available to be reborrowed. As of September 30, 2025, the Company had committed borrowing capacity with respect to the Company's non-recourse asset-backed debt of $1.8 billion; this committed borrowing capacity is comprised of $400 million for senior revolving credit facilities, $993 million for senior term debt facilities, and $450 million for mezzanine term debt facilities.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

*Asset-backed Senior Revolving Credit Facilities*

The Company classifies the senior revolving credit facilities as current liabilities on the Company's condensed consolidated balance sheets as amounts drawn to acquire and renovate homes are required to be repaid as the related real estate inventory is sold, which the Company expects to occur within 12 months.

The senior revolving credit facilities are typically structured with an initial revolving period of up to 24 months, as may be amended and extended from time to time, during which time amounts can be borrowed, repaid and borrowed again. The borrowing capacity is generally available until the end of the applicable revolving period as reflected in the table above. Outstanding amounts drawn under each senior revolving credit facility are required to be repaid on the facility maturity date or earlier if accelerated due to an event of default or other mandatory repayment event. The final maturity dates and revolving period end dates reflected in the table above are inclusive of any extensions that are at the sole discretion of the Company. These facilities may also have extensions subject to lender discretion that are not reflected in the table above.

Borrowings under the senior revolving credit facilities accrue interest at various floating rates based on a secured overnight financing rate ("SOFR"), plus a margin that varies by facility. The Company may also pay fees on certain unused portions of committed borrowing capacity. The Company's senior revolving credit facility arrangements typically include upfront fees that may be paid at execution of the applicable agreements or be earned at execution and payable over time. These facilities are generally fully prepayable at any time without penalty other than customary breakage costs.

The senior revolving credit facilities have aggregated borrowing bases, which increase or decrease based on the cost and value of the properties financed under a given facility and the time that those properties are in the Company's possession. When the Company resells a home, the proceeds are used to reduce the outstanding balance under the related senior revolving credit facility. The borrowing base for a given facility may be reduced as properties age beyond certain thresholds or the performance of the properties financed under that facility declines, and any borrowing base deficiencies may be satisfied through contributions of additional properties or partial repayment of the facility.

*Asset-backed Senior Term Debt Facilities*

The Company classifies its senior term debt facilities as current or non-current liabilities on the Company's condensed consolidated balance sheets based on the applicable final maturity date.

The senior term debt facilities are typically structured with an initial withdrawal period up to 60 months, as may be amended and extended from time to time, during which the outstanding principal amounts are generally not required to be repaid when homes financed through those facilities are sold and instead are intended to remain outstanding until final maturity for each facility. Outstanding amounts drawn under each senior term debt facility are required to be repaid on the facility maturity date or earlier if accelerated due to an event of default or other mandatory repayment event. The final maturity dates and withdrawal period end dates reflected in the table above are inclusive of any extensions that are at the sole discretion of the Company. These facilities may also have extensions subject to lender discretion that are not reflected in the table above.

Borrowings under the senior term debt facilities accrue interest at a fixed rate. The Company's senior term debt facilities may include upfront issuance costs that are capitalized as part of the facilities' respective carrying values. These facilities are fully prepayable at any time but may be subject to certain customary prepayment penalties.

The senior term debt facilities have aggregated property borrowing bases, which increase or decrease based on the cost and value of the properties financed under a given facility, the time those properties are in the Company's possession and the amount of cash collateral pledged by the relevant borrowers. The borrowing base for a given facility may be reduced as properties age or collateral performance declines beyond certain thresholds, and any borrowing base deficiencies may be satisfied through contributions of additional properties, cash or through partial repayment of the facility.

*Asset-backed Mezzanine Term Debt Facilities*

The Company classifies its mezzanine term debt facilities as current or non-current liabilities on the Company's condensed consolidated balance sheets based on the applicable final maturity date. These facilities are structurally and contractually subordinated to the related asset-backed senior debt facilities.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

The mezzanine term debt facilities have been structured with an initial withdrawal period of up to 42 months, as may be amended and extended from time to time, during which the outstanding principal amounts are generally not required to be repaid when homes financed through those facilities are sold and instead are intended to remain outstanding until final maturity. Outstanding amounts drawn under the mezzanine term debt facilities are required to be repaid on the facility maturity date or earlier if accelerated due to an event of default or other mandatory repayment event. The final maturity date and withdrawal period end date reflected in the table above are inclusive of any extensions that are at the sole discretion of the Company. These facilities may also have extensions subject to lender discretion that are not reflected in the table above.

Borrowings under a given mezzanine term debt facility accrue interest at a fixed rate. The Company's mezzanine term debt facilities include upfront issuance costs that are capitalized as part of the facilities' respective carrying values. These facilities are fully prepayable at any time but may be subject to certain prepayment penalties.

The mezzanine term debt facilities have aggregated property borrowing bases, which increase or decrease based on the cost and value of the properties financed under a given facility and time in the Company's possession of those properties and the amount of cash collateral pledged by the relevant borrowers. The borrowing base for a given facility may be reduced as properties age or collateral performance declines beyond certain thresholds, and any borrowing base deficiencies may be satisfied through contributions of additional properties, cash or through partial repayment of the facility.

*Covenants*

The Company's inventory financing facilities include customary representations and warranties, covenants and events of default. Financed properties are subject to customary eligibility criteria and concentration limits.

The terms of these inventory financing facilities and related financing documents require an Opendoor subsidiary to comply with customary financial covenants, such as maintaining certain levels of liquidity, tangible net worth or leverage (ratio of debt to tangible net worth). Certain of these financial covenants are calculated by reference to Opendoor Labs Inc. and its consolidated subsidiaries' assets and liabilities. As a result, under certain circumstances, this may limit the Company's flexibility to transfer assets from Opendoor subsidiaries to the Parent Company. At September 30, 2025 and December 31, 2024, $200 million and $250 million, respectively, of the Company's net assets were restricted as they reflect minimum net asset requirements at Opendoor Labs Inc. As of September 30, 2025, the Company was in compliance with all financial covenants and no event of default had occurred.

***Convertible Senior Notes*** 

In August 2021, the Company issued 0.25% senior convertible notes due 2026 (the "2026 Notes") and in May 2025, the Company issued 7.00% senior convertible notes due 2030 (the "2030 Notes"; collectively with the 2026 Notes, "Convertible Senior Notes"). The following tables summarize certain details related to the Convertible Senior Notes (in millions, except interest rates):

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2025** | **Remaining Aggregate Principal Amount** | **Unamortized Debt Discount and Issuance Costs** | **Net Carrying Amount** |
| 2026 Notes | $135 | $— | $135 |
| 2030 Notes | 325 | (21) | 304 |
| Total Convertible Senior Notes | $460 | $(21) | $439 |

---

---

| | | | |
|:---|:---|:---|:---|
| **December 31, 2024** | **Remaining Aggregate Principal Amount** | **Unamortized Debt Discount and Issuance Costs** | **Net Carrying Amount** |
| 2026 Notes | $381 | $(3) | $378 |
| Total Convertible Senior Notes | $381 | $(3) | $378 |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **September 30, 2025** | **Maturity Date** | **Stated Cash Interest Rate** | **Effective Interest Rate** | **Semi-Annual Interest Payment Dates** | **Conversion Rate** | **Conversion Price** |
| 2026 Notes | August 15, 2026 | 0.25% | 0.78% | February 15; August 15 | 51.9926 | $19.23 |
| 2030 Notes | May 15, 2030 | 7.00% | 9.47% | May 15; November 15 | 637.105 | $1.57 |

---

*2026 Notes*

The 2026 Notes are convertible at the option of the holders of the 2026 Notes before February 15, 2026 only upon the occurrence of certain events. In addition, the holders of the 2026 Notes will have the right to require the Company to repurchase all or part of their 2026 Notes if certain corporate events occur that constitute a fundamental change. Beginning on August 20, 2024, the Company has the option to redeem the 2026 Notes, in whole or in part, upon meeting certain conditions related to the price of the Company's common stock. The redemption price will be paid in cash equal to 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest, if any. Beginning on February 15, 2026 and until the close of business on the second scheduled trading day immediately preceding the maturity date, the 2026 Notes are convertible at any time at the election of each noteholder. The conversion rate and conversion price are subject to customary adjustments under certain circumstances. In addition, if certain corporate events that constitute a make-whole fundamental change occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time. Upon conversion, the Company may satisfy its obligation by paying cash for the outstanding principal balance, and, a combination of cash and the Company's common stock, at the Company's election, for the remaining amount, if any, based on the applicable conversion rate. Refer to *2030 Notes* section below for information regarding the extinguishment of certain 2026 Notes.

*2030 Notes*

In May 2025, the Company entered into privately negotiated transactions with certain holders of the 2026 Notes and new investors, pursuant to which the Company issued $325 million aggregate principal amount of 2030 Notes consisting of (i) $246 million aggregate principal amount of 2030 Notes issued in exchange for $246 million principal amount of 2026 Notes (the "Debt Exchange") and (ii) $79 million aggregate principal amount of 2030 Notes issued for cash. Such transactions resulted in gross cash proceeds of $75 million, excluding certain fees and other offering expenses, and represent an issue price of 95%. The Company accounted for the Debt Exchange of the 2026 Notes as a debt extinguishment and recorded $10 million of gain on debt extinguishment, included within the Company's condensed consolidated statements of operations. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The 2030 Notes are convertible at the option of the holders of the 2030 Notes before November 15, 2029 only upon the occurrence of certain events. In addition, the holders of the 2030 Notes will have the right to require the Company to repurchase all or part of their 2030 Notes (i) if certain corporate events occur that constitute a fundamental change or (ii) for a one-time optional repurchase on May 15, 2028. Beginning on May 22, 2028, the Company has the option to redeem the 2030 Notes, in whole or in part, upon meeting certain conditions related to the price of the Company's common stock. The redemption or repurchase price will be paid in cash equal to 100% of the principal amount of the 2030 Notes to be redeemed or repurchased, plus accrued and unpaid interest, if any. Beginning on November 15, 2029 and until the close of business on the second scheduled trading day immediately preceding the maturity date, the 2030 Notes are convertible at any time at the election of each noteholder. The conversion rate and conversion price are subject to customary adjustments under certain circumstances. In addition, if certain corporate events that constitute a make-whole fundamental change occur, then the conversion rate will, under certain circumstances, be increased for a specified period of time. Upon conversion, the Company may satisfy its obligation by paying cash for the outstanding principal balance, and, a combination of cash and the Company's common stock, at the Company's election, for the remaining amount, if any, based on the applicable conversion rate.

The 2030 Notes become convertible during any calendar quarter if, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company's common stock exceeds 130% of the conversion price for at least 20 trading days. This condition was met during the third quarter of 2025. Accordingly, the 2030 Notes are convertible at the option of the noteholders from October 1, 2025 through December 31, 2025 and are classified as a current liability in the condensed consolidated balance sheet as of September 30, 2025.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

The following table summarizes the interest expense related to the Convertible Senior Notes (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Contractual interest | $6 | $1 | $9 | $1 |
| Amortization of debt discount and issuance costs | 2 |  | 4 | 1 |
| Total Convertible Senior Notes interest expense | $8 | $1 | $13 | $2 |

---

*Capped Calls*

In August 2021, in connection with the issuance of the 2026 Notes, the Company purchased capped calls (the "Capped Calls") from certain financial institutions at a cost of $119 million. The Capped Calls covered, subject to customary adjustments, the number of shares of the Company's common stock underlying the 2026 Notes. By entering into the Capped Calls, the Company expected to reduce the potential dilution to its common stock (or, in the event a conversion of the 2026 Notes was settled in cash, to reduce its cash payment obligation) in the event that at the time of conversion of the 2026 Notes its common stock price exceeded the conversion price. The Capped Calls had an initial strike price of $19.23 per share and an initial cap price of $29.59 per share or a cap price premium of 100%.

In December 2024, the Company settled 75% of the Capped Calls. In August 2025, the Company settled the remaining outstanding Capped Calls and received cash of $1 million from certain counterparties, which was recognized as an increase in additional paid-in-capital in the third quarter of 2025.

**6. FAIR VALUE DISCLOSURES**

The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures.

Following is a discussion of the fair value hierarchy and the valuation methodologies used for assets and liabilities recorded at fair value on a recurring and nonrecurring basis and for estimating fair value for financial instruments not recorded at fair value.

***Fair Value Hierarchy***

Fair value measurements of assets and liabilities are categorized based on the following hierarchy:

***Level 1 —*** Fair value determined based on quoted prices in active markets for identical assets or liabilities.

***Level 2 —*** Fair value determined using significant observable inputs, such as quoted prices for similar assets or liabilities or quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs that are derived principally from or corroborated by observable market data, by correlation or other means.

***Level 3 —*** Fair value determined using significant unobservable inputs, such as pricing models, discounted cash flows, or similar techniques.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

***Estimation of Fair Value***

The following table summarizes the fair value measurement methodologies, including significant inputs and assumptions, and classification of the Company's assets and liabilities recorded at fair value on a recurring basis.

---

| | | |
|:---|:---|:---|
| **Asset/Liability Class** | **Valuation Methodology, Inputs and**<br>**Assumptions** | **Classification** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Marketable securities** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities | Price is quoted given the securities are traded on an exchange. | Level 1 recurring fair value measurement. |

---

***Assets and Liabilities Recorded at Fair Value on a Recurring Basis***

As of September 30, 2025, the Company did not have any assets or liabilities measured at fair value on a recurring basis. The following table presents the levels of the fair value hierarchy for the Company's assets measured at fair value on a recurring basis as of December 31, 2024 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **December 31, 2024** | **Balance at Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| Marketable securities: |  |  |  |  |
| &nbsp;&nbsp;Equity securities | $8 | $8 | $— | $— |
| Total assets | $8 | $8 | $— | $— |

---

***Fair Value of Financial Instruments***

The following presents the carrying value, estimated fair value and the levels of the fair value hierarchy for the Company's financial instruments other than assets and liabilities measured at fair value on a recurring basis (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Carrying**<br>**Value** | **Fair Value** | **Level 1** | **Level 2** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $962 | $962 | $962 | $— |
| &nbsp;&nbsp;Restricted cash | 490 | 490 | 490 |  |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Non-recourse asset-backed debt – current portion | $374 | $370 | $— | $370 |
| &nbsp;&nbsp;Convertible senior notes – current portion  | 439 | 1819 |  | 1819 |
| &nbsp;&nbsp;Non-recourse asset-backed debt – net of current portion | 966 | 957 |  | 957 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Carrying**<br>**Value** | **Fair Value** | **Level 1** | **Level 2** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $671 | $671 | $671 | $— |
| &nbsp;&nbsp;Restricted cash | 92 | 92 | 92 |  |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Non-recourse asset-backed debt – current portion | $432 | $431 | $— | $431 |
| &nbsp;&nbsp;Non-recourse asset-backed debt – net of current portion | 1492 | 1443 |  | 1443 |
| &nbsp;&nbsp;Convertible senior notes – net of current portion | 378 | 336 |  | 336 |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

**7. PROPERTY AND EQUIPMENT**

Property and equipment as of September 30, 2025 and December 31, 2024, consisted of the following (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| Internally developed software | $107 | $106 |
| Computers | 4 | 9 |
| Security systems | 3 | 4 |
| Office equipment | 2 | 2 |
| Furniture and fixtures | 1 | 1 |
| Software implementation costs | 1 | 1 |
| Total | 118 | 123 |
| Accumulated depreciation and amortization | (87) | (75) |
| Property and equipment – net | $31 | $48 |

---

Depreciation and amortization expense of $8 million and $24 million was recorded for the three and nine months ended September 30, 2025, respectively. Depreciation and amortization expense of $7 million and $25 million was recorded for the three and nine months ended September 30, 2024, respectively.

**8. GOODWILL AND INTANGIBLE ASSETS**

For the nine months ended September 30, 2025 and the year ended December 31, 2024, there were no additions to goodwill. No impairment of goodwill was identified for the three and nine months ended September 30, 2025 and 2024.

As of September 30, 2025 and December 31, 2024, the Company had no remaining intangible assets subject to amortization. Amortization expense for intangible assets was $1 million and $4 million for the three and nine months ended September 30, 2024, respectively.

**9. SHARE-BASED AWARDS**

***Stock options and RSUs***

Option awards are generally granted with an exercise price equal to the fair value of the Company's common stock at the date of grant.

A summary of the stock option activity for the nine months ended September 30, 2025, is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number of**<br>**Options**<br>**(in thousands)** | **Weighted-**<br>**Average**<br>**Exercise**<br>**Price** | **Weighted-**<br>**Average**<br>**Remaining**<br>**Contractual**<br>**Term (in years)** | **Aggregate**<br>**Intrinsic**<br>**Value**<br>**(in millions)** |
| Balance-December 31, 2024 | 7233 | $2.51 | 2.4 | $2 |
| Exercised | (2677) | 2.18 |  |  |
| Expired | (534) | 2.53 |  |  |
| Balance-September 30, 2025 | 4022 | $2.73 | 2.1 | $21 |
| Exercisable-September 30, 2025 | 4022 | $2.73 | 2.1 | $21 |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

A summary of the RSU activity for the nine months ended September 30, 2025, is as follows:

---

| | | |
|:---|:---|:---|
| | **Number of**<br>**RSUs**<br>**(in thousands)** | **Weighted-**<br>**Average**<br>**Grant-Date**<br>**Fair Value** |
| Unvested and outstanding-December 31, 2024 | 45247 | $2.77 |
| Granted | 34613 | 1.98 |
| Vested | (19688) | 2.85 |
| Forfeited | (23731) | 2.16 |
| Unvested and outstanding-September 30, 2025 | 36441 | $2.37 |

---

A summary of the activity for market condition RSUs for the nine months ended September 30, 2025, is as follows:

---

| | | |
|:---|:---|:---|
| | **Number of**<br>**RSUs**<br>**(in thousands)** | **Weighted-**<br>**Average**<br>**Grant-Date**<br>**Fair Value** |
| Unvested and outstanding-December 31, 2024 |  | $— |
| Granted | 81773 | 8.88 |
| Unvested and outstanding-September 30, 2025 | 81773 | $8.88 |

---

***Stock-based compensation expense***

Stock-based compensation expense is allocated based on the cost center to which the award holder belongs. The following table summarizes total stock-based compensation expense by function as presented in the condensed consolidated statements of operations for the three and nine months ended September 30, 2025 and 2024 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| General and administrative | $23 | $16 | $41 | $49 |
| Sales, marketing and operations | 2 | 2 | 6 | 11 |
| Technology and development | 2 | 7 | 7 | 31 |
| Total stock-based compensation expense | $27 | $25 | $54 | $91 |

---

During the three and nine months ended September 30, 2025, the Company issued market condition RSUs to certain employees. The grant-date fair value for the awards is $726 million, which will be recognized over a requisite service period ranging from one year to five years. The Company recognized $14 million of compensation expense during the three and nine months ended September 30, 2025 related to the market condition awards included in General and administrative on the condensed consolidated statements of operations. As of September 30, 2025, there was $712 million of unamortized stock-based compensation costs related to unvested market condition RSUs. The unamortized compensation costs are expected to be recognized over a weighted-average period of approximately 2.9 years.

As of September 30, 2025, there was $74 million of unamortized stock-based compensation costs related to unvested RSUs. The unamortized compensation costs are expected to be recognized over a weighted-average period of approximately 1.7 years.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

**10. WARRANTS**

***Marketing Warrants***

On July 28, 2022, the Company entered into a warrant agreement with Zillow, Inc. ("Zillow") in connection with a partnership arrangement that allows for Zillow to purchase up to 6 million shares of common stock that will vest in tranches (each, a "Tranche") upon Zillow providing resale marketing services to the Company. As of September 30, 2025, one Tranche of 300,000 shares of common stock underlying the warrant has vested, with an exercise price of $15 per share, and none have been exercised.

**11. INCOME TAXES** 

The Company's tax provision and the resulting effective tax rate for interim periods is determined based upon its estimated annual effective tax rate adjusted for the effect of discrete items arising in that quarter.

The Company's provision for income taxes, which consisted of state taxes in the United States and foreign income taxes in Canada and India was nominal and $1 million for the three and nine months ended September 30, 2025, respectively, with an effective tax rate of (0.11)% and (0.25)%, respectively. The Company's provision for income taxes was nominal and $1 million for the three and nine months ended September 30, 2024, respectively, with an effective tax rate of (0.38)% and (0.39)%, respectively. The effective tax rate differs from the U.S. statutory tax rate primarily due to the recording of a full valuation allowance against the net deferred tax assets.

The Company evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets by jurisdiction. Based on the Company's history of operating losses, including a three-year cumulative loss position, the Company believes that based on the weight of available evidence, it is more likely than not that all of the deferred tax assets in the U.S. will not be realized and recorded a full valuation allowance of its federal and state net deferred tax assets as of September 30, 2025 and December 31, 2024.

In December 2021, the Organization for Economic Co-operation and Development Inclusive Framework on Base Erosion Profit Shifting released Model Global Anti-Base Erosion rules ("Model Rules") under Pillar Two. The Model Rules set forth the "common approach" for a Global Minimum Tax at 15 percent for multinational enterprises with a turnover of more than 750 million Euros. Certain aspects of Pillar Two were effective January 1, 2024 and other aspects were effective January 1, 2025. Various countries have adopted legislation and other countries are in the process of introducing legislation to implement Pillar Two. The Company does not expect Pillar Two to have a significant impact on its consolidated financial statements during fiscal year 2025.

On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was enacted into law. The Act includes significant changes to the U.S. tax code, including restoration of immediate recognition of domestic research and development expenditures and reinstatement of 100% bonus depreciation for qualifying property. As of September 30, 2025, the Company is evaluating the impact of the Act on its condensed consolidated financial statements, including the effects on its deferred tax assets and liabilities and expects the results of such evaluations to be reflected in its Annual Report on Form 10-K for the calendar year ended December 31, 2025.

**12. NET LOSS PER SHARE** 

Basic net loss per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. During the periods when there is a net loss, potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. No dividends, including preferred dividends, were declared, paid, or accumulated for the three and nine months ended September 30, 2025 or 2024.

The Company uses the two-class method to calculate net loss per share and applies the more dilutive of the two-class method, treasury stock method or if-converted method to calculate diluted net loss per share. Undistributed earnings for each period are allocated to participating securities, based on the contractual participation rights of the security to share in the current

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

earnings as if all current period earnings had been distributed. As there is no contractual obligation for participating securities to share in losses, the Company's basic net loss per share is computed by dividing the net loss attributable to common shareholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.

The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common shareholders for the three and nine months ended September 30, 2025 and 2024 (in millions, except share amounts which are presented in thousands, and per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Basic and diluted net loss per share:** |  |  |  |  |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;Net loss  | $(90) | $(78) | $(204) | $(279) |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;Weighted average shares outstanding – basic and diluted | 741939 | 705359 | 731722 | 693796 |
| Basic and diluted net loss per share | $(0.12) | $(0.11) | $(0.28) | $(0.40) |

---

The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Common Stock Warrants | 300 |  | 300 |  |
| RSUs | 36441 | 45844 | 36441 | 45844 |
| Market Condition RSUs | 81773 |  | 81773 |  |
| Options | 4022 | 7359 | 4022 | 7359 |
| Employee Stock Purchase Plan | 899 | 2508 | 899 | 2508 |
| Convertible Senior Notes | 127470 |  | 96876 |  |
| Total anti-dilutive securities | 250905 | 55711 | 220311 | 55711 |

---

**13. RELATED PARTIES**

On September 10, 2025, the Board of Directors appointed Keith Rabois, Managing Director at Khosla Ventures and the Company's co-founder as a Class I director of the Company and Eric Wu, the Company's co-founder and former Chief Executive Officer and Chairman of the Board, as a Class III director of the Company, effective immediately. Concurrently with the election of directors, the Company entered into stock purchase agreements with Khosla Ventures Opportunity III, LP, Eric Wu, and a certain other purchaser. Pursuant to the terms of these respective purchase agreements, Khosla Ventures Opportunity III, LP purchased 5,263,158 shares of the Company's common stock, par value of $0.0001 per share (the "Common Stock") for an aggregate investment of $35 million in a PIPE offering, Eric Wu agreed to purchase 751,879 shares of Common Stock for an aggregate investment of $5 million in a PIPE offering, and a certain other purchaser agreed to purchase 150,375 shares of Common Stock for an aggregate investment of $1 million in a PIPE offering.

In connection with the PIPE offerings, the Company issued an aggregate of 6,165,412 shares of Common Stock for aggregate gross cash proceeds of approximately $41 million. The shares were issued in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, and were not registered under the Securities Act of 1933.

As of September 30, 2025, the retained interest in Mainstay Labs Inc. ("Mainstay"), a formerly consolidated subsidiary of the Company, that was deconsolidated on July 31, 2024 (the "Deconsolidation"), was $48 million, which is presented in Other assets in the condensed consolidated balance sheets. The investment is recognized as a non-marketable equity security

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

investment under ASC 321, Investment - Equity Securities, and is measured at fair value on a non-recurring basis, with the fair value initially determined as of the transaction date. In connection with the Deconsolidation, the Company entered into a contractual agreement to provide Mainstay with certain transition administrative services for a limited period of time ("Transition Services") and to fulfill certain funding obligations to be paid in the form of Mainstay Series A Preferred Stock at the original Series A Preferred Stock issuance price. In September 2025, the Company received $9 million of Series A Preferred Stock as consideration for the Transition Services and related funding requirements. The Company will continue to fund bonuses for certain Mainstay employees, other than Mainstay Management, through November 2025. Amounts paid during the three and nine months ended September 30, 2025 were $2 million and $5 million, respectively. As of September 30, 2025, there have been no indicators of impairment or other observable price changes. As a result of the Company's continued investment in Mainstay, transactions between the Company and Mainstay subsequent to the Deconsolidation are considered to be related-party transactions. Prior to the Deconsolidation, transactions between Mainstay and Opendoor were eliminated upon consolidation.

Subsequent to the Deconsolidation, the Company has no compensation arrangements with the management of Mainstay who are responsible for directing the activities that most significantly impact the economics of Mainstay ("Mainstay Management"). As of the Deconsolidation, outstanding Opendoor RSUs held by Mainstay employees, other than Mainstay Management, were modified so that the service-based vesting requirement will be satisfied as long as the Mainstay employee continues to provide services to Mainstay ("Post Deconsolidation RSUs"). During the three and nine months ended September 30, 2025, 72,631 and 742,851 shares of common stock, respectively were issued to Mainstay employees for the settlement of RSUs, net of shares withheld for participant taxes. As of September 30, 2025, 74,039 RSUs remained unvested and outstanding.

In April 2025, the Company entered into an agreement with Mainstay to create Mainstay National Title LLC, which provides title and escrow services to institutional customers. The Company has a 25% interest in and provides certain services to Mainstay National Title LLC. The initial investment is recognized as an equity method investment under ASC 323, Investments – Equity Method and Joint Ventures. Equity method investments are presented in Other assets on the condensed consolidated balance sheets. During the three and nine months ended September 30, 2025, the Company recognized revenue of $3 million and $7 million, respectively presented within the condensed consolidated statement of operations related to services provided to Mainstay National Title LLC.

There have been no other material changes to the related party transactions disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024. For a full description of those arrangements, see "*Part II – Item 8. Financial Statements and Supplementary Date – Note 17. Related Parties*" of our Annual Report on Form 10-K.

**14. SEGMENT INFORMATION** 

The Company is managed as a single operating and reportable segment on a consolidated basis, reflecting how the Company's Chief Operating Decision Maker ("CODM") allocates resources and evaluates the Company's financial information. The operating segment is the Company's residential real estate product and service offerings. The Company determined that the Chief Executive Officer is the CODM, given their responsibility for making resource allocation decisions, assessing performance, making strategic operational decisions and managing the organization at a consolidated level.

As the Company is managed as a single operating and reportable segment, the measure of segment profit or loss is consolidated net loss. The CODM utilizes the financial information below in assessing the segment's performance and allocating resources. The measure of segment assets is reported on the Company's condensed consolidated balance sheets as total assets.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

The table below highlights the Company's reportable segment's expenses and net loss for the three and nine months ended September 30, 2025 and 2024 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Revenue | $915 | $1377 | $3635 | $4069 |
| Less: |  |  |  |  |
| Cost of revenue | (849) | (1272) | (3342) | (3721) |
| Direct selling costs<sup>(1)</sup> | (28) | (32) | (100) | (109) |
| Holding costs<sup>(2)</sup> | (16) | (15) | (56) | (44) |
| Advertising and other marketing expense<sup>(3)</sup> | (7) | (15) | (38) | (66) |
| Operations<sup>(4)</sup> | (12) | (18) | (43) | (57) |
| Fixed operating expense<sup>(5)</sup> | (37) | (52) | (107) | (166) |
| Stock-based compensation | (13) | (25) | (40) | (91) |
| Stock-based compensation for market condition RSUs | (14) |  | (14) |  |
| Interest expense | (34) | (34) | (103) | (101) |
| Interest income | 12 | 12 | 26 | 42 |
| Other<sup>(6)</sup> | (7) | (4) | (22) | (35) |
| Net loss | $(90) | $(78) | $(204) | $(279) |

---

________________

<sup>(1)</sup> Represents selling costs incurred related to homes sold in the relevant period. This primarily includes broker commissions, external title and escrow-related fees and transfer taxes and are included in Sales, marketing and operations.

<sup>(2)</sup> Represents holding costs incurred both in the period presented and in prior periods on homes sold in the period presented ("Resale Cohort Holding Costs"). Holding costs include mainly property taxes, insurance, utilities, homeowners association dues, cleaning and maintenance costs. Holding costs are included in Sales, marketing and operations in the period in which they are incurred ("GAAP Holding Costs").

<sup>(3)</sup> Advertising expenses are included in Sales, marketing and operations. Other marketing expenses include non-advertising marketing expenses such as acquisition leads and referrals and public relations services and are included in Sales, marketing and operations.

<sup>(4)</sup> Represents operating expenses that are generally related to the volume of homes transacted during the period and tend to be variable in nature. Primarily includes workforce expenses in support of sales, and real estate inventory operations.

<sup>(5)</sup> Represents operating expenses that are not directly correlated with home transaction volumes. These expenses generally include costs related to salaries and benefits for our leadership, finance, technology, human resources, legal, marketing and administrative personnel, as well as third-party professional services fees, rent expense and third-party software.

<sup>(6)</sup> Other segment income (expenses) are primarily made up of depreciation and amortization, gain on deconsolidation, net, restructuring, and amortization of stock-based compensation capitalized to internally developed software. This also includes the elimination of holding costs incurred in prior periods on homes sold in the periods presented, and includes holding costs incurred in the current period on homes remaining in inventory at period end.

**15. COMMITMENTS AND CONTINGENCIES** 

***Lease Commitments***

In May 2025, the Company amended its Tempe, Arizona office lease to terminate the Company's obligation with respect to a portion of the leased premises ("Partial Lease Termination"). The Partial Lease Termination resulted in a decrease of undiscounted, future lease payments of $10 million. The Company recognized a loss of $1 million, as a result of the reduction of right-of-use assets by $8 million and lease liabilities by $7 million, and an additional $2 million in other associated costs, both of which are recognized within Restructuring on the condensed consolidated statements of operations. See *"Note 16 —* 

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

*Restructuring"* for further discussion. There were no other material lease modifications for the nine months ended September 30, 2025.

***Legal Matters***

From time to time, the Company may be subject to potential liability relating to the ownership and operations of the Company's properties. Accruals are recorded when the outcome is probable and can be reasonably estimated.

There are various claims and lawsuits arising in the normal course of business pending against the Company, some of which seek damages and other relief which, if granted, may require future cash expenditures. In addition, from time to time the Company receives inquiries and audit requests from various government agencies and fully cooperates with these requests. The Company does not believe that it is reasonably possible that the resolution of these matters would result in any liability that would materially affect the Company's condensed consolidated results of operations or financial condition except as noted below.

On October 7, 2022 and November 22, 2022, purported securities class action lawsuits were filed in the United States District Court for the District of Arizona, captioned *Alich v. Opendoor Technologies Inc., et al.* (Case No. 2:22-cv-01717-JFM) ("Alich") and *Oakland County Voluntary Employee's Beneficiary Association, et al. v. Opendoor Technologies Inc., et al.* (Case No. 2:22-cv-01987-GMS) ("Oakland County"), respectively. The lawsuits were consolidated into a single action, captioned *In re Opendoor Technologies Inc. Securities Litigation* (Case No. 2:22-CV-01717-MTL). The consolidated amended complaint names as defendants the Company, SCH, certain of the Company's current and former officers and directors and the underwriters of a securities offering the Company made in February 2021. The complaint alleges that the Company and certain officers violated Section 10(b) of the Exchange Act and SEC Rule 10b-5, and that the Company, SCH, certain officers and directors and the underwriters violated Section 11 of the Securities Act, in each case by making materially false or misleading statements related to the effectiveness of the Company's pricing algorithm. The plaintiffs also allege that certain defendants violated Section 20(a) of the Exchange Act and Section 15 of the Securities Act, respectively, which provide for control person liability. The complaint asserts claims on behalf of all persons and entities that purchased, or otherwise acquired, Company common stock between December 21, 2020 and November 3, 2022 or pursuant to offering documents issued in connection with our business combination with SCH and the secondary public offering conducted by the Company in February 2021. The plaintiffs seek class certification, an award of unspecified compensatory damages, an award of interest and reasonable costs and expenses, including attorneys' fees and expert fees, and other and further relief as the court may deem just and proper. The defendants filed motions to dismiss on June 30, 2023, which the court granted on February 27, 2024 without prejudice. On May 14, 2024, the court granted plaintiffs' motion for reconsideration of certain portions of the court's order dismissing the complaint. The court's orders on the motion to dismiss and motion for reconsideration dismissed all Exchange Act claims and Securities Act claims except for a portion of plaintiffs' claims brought under Section 11 and Section 15 of the Securities Act. Defendants filed answers to the complaint on July 12, 2024. The plaintiffs and the defendant participated in a mediation in February 2025. On March 26, 2025, the Company reached an agreement in principle with the plaintiffs to resolve all claims against all defendants in the consolidated action on a class-wide basis for an amount within the limits of insurance coverage. On June 13, 2025, the Company executed a Stipulation and Agreement of Settlement memorializing the terms and conditions of the settlement. The same day, the plaintiffs filed a motion with the court for preliminary approval of the settlement. On October 21, 2025, the court granted the preliminary approval motion and scheduled a final settlement approval hearing for January 6, 2026. The Company has recorded a liability reflecting the proposed settlement amount and a corresponding asset reflecting estimated insurance recoveries. If the proposed settlement is not consummated or approved by the Court, the Company intends to vigorously defend itself in the matter.

On March 1, 2023 and March 15, 2023, shareholder derivative lawsuits were filed in the United States District Court for the District of Arizona, captioned *Carlson v. Rice, et al.* (Case No. 2:23-cv-00367-GMS) and *Van Dorn v. Wu, et al.* (Case No. 2:23-cv-00455-DMF), respectively, which were subsequently consolidated into a single action, captioned *Carlson v. Rice* (Case No. 2:23-CV-00367-GMS). Plaintiffs voluntarily dismissed the matter on June 22, 2023, and thereafter re-filed complaints in the Court of Chancery of the State of Delaware, captioned *Carlson v. Rice, et al.* (Case No. 2023-0642) and *Van Dorn v. Rice, et al.* (Case No. 2023-0643). The cases have been consolidated into a single action, captioned Opendoor Technologies Inc. Stockholder Derivative Litigation (Case No. 2023-0642). The consolidated derivative action has been stayed pending further developments in *In re Opendoor Technologies Inc. Securities Litigation*.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

On June 29, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of Delaware, captioned *Juul v. Wu, et al.* (Case No. 1:23-cv-00705-UNA). The complaints in each matter are based on the same facts and circumstances as *In re Opendoor Technologies Inc. Securities Litigation* and name certain officers and directors of the Company as defendants. The defendants are alleged to have violated Section 10(b) of the Exchange Act and SEC Rule 10b-5 and breached fiduciary duties. The plaintiffs seek to maintain the derivative actions on behalf of the Company, an award of unspecified compensatory damages, an order directing the Company to reform its corporate governance and internal procedures, restitutionary relief, an award of interest and expenses, including attorneys' fees and expert fees, and other and further relief as the court may deem just and proper. This derivative action has been stayed pending further developments in *In re Opendoor Technologies Inc. Securities Litigation*.

On October 13, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of Delaware, captioned *Woods, et al. v. Bain, et al*. (Case No. 1:23-cv-01158-UNA). The complaint is based on facts and circumstances related to *In re Opendoor Technologies Inc. Securities Litigation*. The plaintiffs have brought claims against certain current and former directors and officers of the Company for breach of fiduciary duty, contribution under Sections 10(b) and 21D of the Exchange Act, SEC Rule 10b-5, violations of Section 14(a) of the Exchange Act, and SEC Rule 14a-9 promulgated thereunder. The plaintiffs seek to maintain the derivative action on behalf of the Company, an award of unspecified compensatory damages, an order directing one of the defendants to disgorge monies allegedly obtained from certain personal sales of Company stock, equitable relief, an award of interest and expenses, including attorneys' fees and expert fees, and other and further relief as the court may deem just and proper. This derivative action has been stayed pending further developments in *In re Opendoor Technologies Inc. Securities Litigation*.

On October 18, 2023, a shareholder derivative lawsuit was filed in the United States District Court for the District of Arizona, captioned *Gera v. Palihapitiya, et al*. (Case No. 2:23-cv-02164-SMB). The complaint is based on facts and circumstances related to *In re Opendoor Technologies Inc. Securities Litigation*, and names as defendants certain current and former officers and directors of the Company and SCH Sponsor II LLC. The complaint alleges that the defendants violated Section 14(a) of the Exchange Act, and SEC Rule 14a-9 promulgated thereunder. The plaintiff seeks to maintain the derivative action on behalf of the Company, an award of unspecified compensatory damages, an order directing the Company to reform certain corporate governance and internal procedures, restitution, an award of cost and expenses, including attorneys' fees and expert fees, and other and further relief as the court may deem just and proper. The defendants filed motions to dismiss on February 8, 2024, which were granted without prejudice on August 14, 2024, and the plaintiff filed an amended complaint on September 12, 2024. On October 28, 2024, the defendants filed motions to dismiss the complaint, which are pending before the court. This derivative action has been stayed pending further developments with respect to the settlement of the case.

A global mediation of all pending shareholder derivative lawsuits based on the same facts and circumstances as *In re Opendoor Technologies Inc. Securities Litigation* was held on February 7, 2025. The parties agreed in principle that Opendoor would adopt certain corporate governance reforms as part of a potential global resolution of the shareholder derivative lawsuits and in exchange for a full release of claims. On June 27, 2025, the Company executed a Stipulation of Settlement memorializing the terms and conditions of the settlement. The same day, the plaintiff in the *Gera* action filed a motion with the court for preliminary approval of the settlement. On September 11, 2025, the court issued an order granting preliminary approval of the settlement. The Company has recorded a liability reflecting the proposed settlement amount and a corresponding asset reflecting estimated insurance recoveries. The Company expects that the payment of any court-approved attorneys' fees and costs would be funded by proceeds from applicable insurance policies. If the settlement is not consummated or approved by the relevant courts, the Company and its officers and directors intend to vigorously defend themselves in the litigation.

**16. RESTRUCTURING**

Restructuring costs for ongoing employee benefit arrangements, inclusive of statutory requirements, are recognized in accordance with ASC 712, Compensation - Non-retirement Post-employment Benefits when it becomes probable that an obligation has been incurred and the amount can be reasonably estimated. If applicable, the Company recognizes restructuring costs over the terminated employees' remaining service period. The liabilities for restructuring costs are recognized in Accounts payable and other accrued liabilities on the condensed consolidated balance sheets.

In 2024, the Company began a series of cost-reduction and organizational streamlining efforts ("Transformation Initiatives") aimed at supporting its strategic focus on long-term growth and operational efficiency. Restructuring costs

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

primarily include expenses associated with workforce reductions, such as severance and other termination-related benefits to affected employees, and lease terminations.

During the nine months ended September 30, 2025, the Company incurred restructuring costs in connection with the Transformation Initiatives including workforce reductions affecting approximately 125 employees. These actions resulted in $6 million of expenses from post-employment benefits and other cost reduction efforts. In addition to the workforce reduction, the Company incurred $4 million of costs related to the early termination of two leases. Payments for restructuring costs incurred during the nine months ended September 30, 2025 were substantially completed by the third quarter of 2025.

The following table presents the activity of the restructuring liability as of September 30, 2025 (in millions):

---

| | |
|:---|:---|
| | **September 30,<br>2025** |
| Balance-December 31, 2024 | $7 |
| Additions charged to expense | 10 |
| Costs paid or otherwise settled<sup>(1)</sup> | (16) |
| Balance- September 30, 2025 | $1 |

---

________________

<sup>(1)</sup> Inclusive of $1 million in non-cash activity associated with lease termination costs.

**17. SUBSEQUENT EVENTS**

***Convertible Notes***

On November 6, 2025, simultaneous with the filing of these condensed consolidated financial statements with the SEC, the Company entered into share purchase agreements with a limited number of purchasers, pursuant to which the Company is offering shares of its common stock in a registered direct offering to such purchasers. Concurrently with the pricing of such offering, the Company entered into separate privately negotiated agreements with certain holders of the 2030 Notes, pursuant to which the Company agreed to repurchase approximately $264 million aggregate principal amount of the 2030 Notes for an aggregate repurchase price of approximately $1.2 billion, which the Company will repurchase using the net proceeds from the registered direct offering. On a net basis, the Company does not expect to receive any proceeds from these transactions. The conversion value of the 2030 Notes to be repurchased is calculated based on the closing price of the Company's common stock on November 6, 2025. Following the expected repurchase of the 2030 Notes, there will be approximately $61 million aggregate principal outstanding for the 2030 Notes. The Company is not aware of any holders of the remaining outstanding 2030 Notes that have elected to convert their notes through the date of this filing.

***Warrant Dividend Distribution***

On November 6, 2025, simultaneous with the filing of these condensed consolidated financial statements with the SEC, we declared a warrant dividend distribution to the holders of record of the Company's common stock as of the close of business on November 18, 2025, (the "Record Date") in the form of warrants to purchase shares of the Company's common stock (the "Warrants"). Each registered holder of common stock on the Record Date will receive three (3) series of Warrants—Series K, Series A, and Series Z—one (1) Warrant of each series for every thirty (30) shares of common stock held, rounded down to the nearest whole number. Additionally, in lieu of an adjustment to the conversion rate, holders of the Company's 2030 Notes as of the Record Date will also receive, at the same time and on the same terms as holders of common stock, Warrants, without having to convert such holder's 2030 Notes, as if such holder held a number of shares of common stock, equal to the product of (i) the conversion rate applicable to the 2030 Notes in effect on the Record Date and (ii) the aggregate principal amount (expressed in thousands) of 2030 Notes held by such holder on the Record Date. The Warrants are expected to have an exercise price of $9.00 per Series K Warrant, $13.00 per Series A Warrant and $17.00 per Series Z Warrant and a one year term, which may be accelerated for a particular series of Warrants if the price of the Company's common stock, as measured under the terms of the warrant agreement for the Warrants, exceeds the applicable early expiration trigger price for such series of Warrants. The early expiration trigger price for a series of Warrants is expected to be initially equal to 120% of the exercise price of such series of Warrants, subject to adjustment in accordance with the warrant agreement. The Warrants are expected to

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u>

**OPENDOOR TECHNOLOGIES INC.**

**Notes to Condensed Consolidated Financial Statements**

(Tabular amounts in millions, except share and per share amounts, ratios, or as noted)

(Unaudited)

be initially exercisable only by paying the exercise price in cash, subject to the Company's ability to change the exercise method to net exercise as provided in the warrant agreement.

\*\*\*\*\*\*\*

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.** 

*The following discussion and analysis provides information that our management believes is relevant to an assessment and understanding of our condensed consolidated results of operations and financial condition. The discussion should be read together with the historical condensed consolidated financial statements and related notes that appear in this Quarterly Report on Form 10-Q.*

*This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under "Forward-Looking Statements," "Risk Factors," or in other parts of this Quarterly Report on Form 10-Q, and in "Part I - Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "Annual Report"), and in "Part II – Item 1A. Risk Factors," in our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (the "June 2025 Quarterly Report").*

**Overview**

Opendoor's mission is to power life's progress, one move at a time. Residential real estate is a trillion-dollar industry underpinned by a process that is complicated, time-consuming, stressful, and offline. Our data-driven pricing models and integrated local operations are modernizing residential real estate by providing a simple, certain, and largely digital way to buy and sell homes. Since our founding, we have completed over 291,000 transactions across the United States, making us one of the largest buyers and sellers of homes in the United States.

**Financial Highlights and Operating Metrics**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | |
| **(in millions, except percentages, homes purchased, homes sold, number of markets, and homes in inventory)** | **2025** | **2024** |<br>**Change** | **2025** | **2024** |<br>**Change** |
| Revenue | $915 | $1377 | $(462) | $3635 | $4069 | $(434) |
| Gross profit | $66 | $105 | $(39) | $293 | $348 | $(55) |
| Gross margin | 7.2% | 7.6% |  | 8.1% | 8.6% |  |
| Net loss | $(90) | $(78) | $(12) | $(204) | $(279) | $75 |
| Homes sold | 2568 | 3615 | (1047) | 9813 | 10771 | (958) |
| Homes purchased | 1169 | 3504 | (2335) | 6535 | 11733 | (5198) |
| Homes in inventory (at period end) | 3139 | 6288 | (3149) | 3139 | 6288 | (3149) |
| Inventory (at period end) | $1053 | $2145 | $(1092) | $1053 | $2145 | $(1092) |
| Percentage of homes "on the market" for greater than 120 days (at period end) | 51% | 23% |  | 51% | 23% |  |
| **Non-GAAP Financial Highlights** <sup>(1)</sup> |  |  |  |  |  |  |
| Contribution Profit | $20 | $52 | $(32) | $143 | $204 | $(61) |
| Contribution Margin | 2.2% | 3.8% |  | 3.9% | 5.0% |  |
| Adjusted EBITDA | $(33) | $(38) | $5 | $(40) | $(93) | $53 |
| Adjusted EBITDA Margin | (3.6)% | (2.8)% |  | (1.1)% | (2.3)% |  |
| Adjusted Net Loss | $(61) | $(70) | $9 | $(133) | $(181) | $48 |

---

________________

<sup>(1)</sup> See "—*Non-GAAP Financial Measures*" for further details and a reconciliation of such non-GAAP measures to their nearest comparable GAAP measures.

**Current Housing Environment**

In the third quarter of 2025, U.S. housing market activity remained subdued amid elevated mortgage rates and persistent affordability constraints. Seasonally adjusted annualized existing-home sales hovered around 4 million units, roughly 20 percent below the pre-pandemic decade average of about 5 million. Home prices were largely stable year-over-year, supported

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

by tight inventory, even as transaction volumes and days-on-market reflected continued buyer hesitancy. New listings fell below 2024 levels, while total active inventory remained above 2024 levels; however, both measures were still below historical norms, limiting overall market liquidity. Clearance rates stayed muted at roughly 20 percent below prior-year levels while delistings edged higher through the quarter, underscoring the ongoing disconnect between seller expectations and buyer affordability.

In response to this challenging environment, we remain committed to a flexible and data-driven approach to managing our business, dynamically adjusting our pricing strategies to balance growth, margin, and risk. In the third quarter of 2025 we continued to have elevated spread levels in response to this uncertainty and expanded our agent-led distribution channel and capital-light product initiatives. Beginning in the fourth quarter of 2025, we refined our blanket high spread policy to adopt a more tailored approach, offering stronger offers for higher-quality homes with greater expected resale velocity while maintaining higher spreads for lower-quality homes with elevated risk and slower resale clearance expectations. We believe these refinements will increase the likelihood of offer acceptance among higher-quality homes, improve the overall quality mix of homes in our portfolio, and support faster sell-through. In addition, we dynamically adjust list prices to calibrate to market sell-through rates and drive resale clearance. We closely monitor macroeconomic developments and remain agile in our decision-making, enabling us to respond effectively to shifts in interest rates and broader market conditions.

**Factors Affecting our Business Performance**

***Market Penetration in Existing Markets***

Residential real estate is one of the largest consumer markets in the United States, of which less than 1% of the estimated $1.7 trillion of home value transacted annually is conducted online. Given the fact that we operate in a highly fragmented industry and offer a differentiated value proposition to the traditional offline selling process, we believe there is significant opportunity to expand our share in our existing markets. By providing a consistent, high-quality and differentiated experience to our customers, we hope to continue to drive positive word-of-mouth awareness and trust in our platform.

We have expanded our reach through our agent-led distribution channel, which enables us to connect home sellers with trusted local agents at the beginning of their journey. These agents present one or more selling solutions, including cash offers and listings, helping customers navigate their options with expert guidance. By integrating agents into our platform experience, we're able to offer more personalized, high-touch support to customers while broadening the scope, geography, and flexibility of services we provide.

Partnership channels with homebuilders, agents, and online real estate platforms are an important source of leads for our business. We have relationships with two of the largest online real estate platforms, Zillow and Redfin, which together reach millions of unique monthly visitors and allow home sellers to request an offer directly from Opendoor. In addition to driving incremental acquisitions, we expect these partnerships can build our brand awareness and serve as additional avenues for sellers to learn about the benefits of our flagship cash offer.

A continued source of opportunity is re-engagement with our base of registered sellers, meaning sellers that have received an offer from Opendoor but have not yet sold their home. In the last ten years, we have sent millions of offers and, while not everyone is ready to act when they request an offer, we treat everyone as a potential future seller. We perpetually iterate on our re-engagement strategies and believe that our registered customer base will continue to be an important source of home acquisition volumes.

***Geographic Footprint***

We continually evaluate opportunities to expand our market footprint. At the start of 2025, our products were available in 50 markets across select U.S. states. By the end of the third quarter of 2025, Opendoor expanded its reach to serve customers nationwide through one or more of its product offerings, including cash offers and partner agent listing services.

***Adjacent Services***

We believe home sellers and buyers value simplicity and certainty. To that end, we are building an online, integrated suite of home services, which currently includes title insurance, escrow services and real estate brokerage services.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

Our success with title insurance and escrow services helps validate our view that customers prefer an online, integrated experience. We will continue to evaluate new ways to improve our end-to-end solution and expect to invest in additional adjacent products and services over time, including through potential strategic transactions, growth opportunities or partnerships, with the expectation that these adjacent services will continue to improve our unit economics.

***Unit Economics***

We view Contribution Margin as a key measure of unit economic performance. Contribution Margin is a non-GAAP financial measure. See "—*Non-GAAP Financial Measures*" for further details and a reconciliation of Contribution Margin to gross margin. Our long-term financial performance depends, in part, on continuing to maintain and expand unit margins through the following initiatives:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Optimization and enhancements of our pricing engine;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Platform efficiency improvements through greater use of generative AI, automation and self-service;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incremental attach of services, which supplement the core transaction margin profile

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Continuation of our agent-led distribution channel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Leveraging our platform to develop additional offerings, which we expect can increase overall conversion and unlock more capital-light margin.

***Inventory Management***

Effectively managing our overall inventory position and balancing growth, margin, and risk are critical to our financial performance. Since our inception, we have prioritized investment in our pricing capabilities across our home acquisition processes and our forecasting and resale systems, and expect to continue to do so. As part of our overall risk management framework, we consider both individual market and aggregate portfolio exposures. We typically seek to maximize the resale margin performance of our inventory in the context of managing overall risk and inventory health through monitoring sell-through rates, holding periods, and portfolio aging, and we will adjust down listed prices on our inventory when appropriate to stay in-line with market sell-through rates and drive resale clearance. We also adjust the spreads embedded in our offers to respond to current market conditions, both at a macro and local level. (Spreads are defined as total discount to our home valuation at time of offer less the Opendoor service fee.)

Real estate inventory is reviewed for valuation adjustments on a quarterly basis. If the carrying amount for a given home is not expected to be recovered, an inventory valuation adjustment is recorded to cost of revenue and the home's carrying value is adjusted to its net realizable value. Inventory valuation adjustments are not offset by any expected gains and are not reversed or adjusted should the expected net realizable value subsequently increase. We recorded inventory valuation adjustments of $15 million and $48 million during the three and nine months ended September 30, 2025, respectively, and $10 million and $51 million during three and nine months ended September 30, 2024, respectively. See "*Part II – Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – Real Estate Inventory*" in our Annual Report on Form 10-K for the year ended December 31, 2024.

As one key measure of inventory management performance, we evaluate our portfolio metrics relative to the broader market (as observed on the multiple listing services ("MLS")). One such metric is our percentage of homes "on the market" for greater than 120 days as measured from initial listing date. As of September 30, 2025, such homes represented 51% of our portfolio, compared to 23% for the broader market when filtered for the types of homes we are able to underwrite and acquire based on characteristics such as market, price range, home type, home location, year built and lot size (which we refer to as our "buybox"). This metric fluctuates based on seasonal factors, market dynamics, and our resale strategies.

Beginning in February, we began raising spreads and intentionally slowed our home acquisition pace in response to our risk management objectives and broader macroeconomic uncertainty. When newly acquired homes represent a smaller proportion of our overall inventory, average days on market for our portfolio generally increases.

Further, broader market delistings continued to rise, with the delisting rate at quarter end substantially higher than the previous 10-year average. When more sellers in the broader market choose to delist rather than wait for a sale, it can artificially lower the average days on market for the overall market.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

***Inventory Financing***

Our business model is working capital intensive and inventory financing is a key enabler of our growth. We primarily rely on our access to non-recourse asset-backed debt, which consists of asset-backed senior debt facilities and asset-backed mezzanine term debt facilities, to finance our home acquisitions. See "—*Liquidity and Capital Resources — Debt and Financing Arrangements.*"

***Seasonality***

The residential real estate market is seasonal, with greater demand and home price appreciation from home buyers in the spring and summer, and typically weaker demand and lower home price appreciation in late fall and winter. In general, we expect our financial results and working capital requirements to reflect seasonal variations over time. However, other factors, including growth, market expansion and changes in macroeconomic conditions, such as inflation and interest rate fluctuations, have obscured the impact of seasonality in our historical financials and may continue to do so.

**Non-GAAP Financial Measures**

In addition to our results of operations below, we report certain financial measures that are not required by, or presented in accordance with, U.S. generally accepted accounting principles ("GAAP").

These measures have limitations as analytical tools when assessing our operating performance and should not be considered in isolation or as a substitute for GAAP measures, including gross profit and net loss. We may calculate or present our non-GAAP financial measures differently than other companies who report measures with similar titles and, as a result, the non-GAAP financial measures we report may not be comparable with those of companies in our industry or in other industries.

***Adjusted Gross Profit and Contribution Profit***

To provide investors with additional information regarding our margins and return on inventory acquired, we have included Adjusted Gross Profit and Contribution Profit, which are non-GAAP financial measures. We believe that Adjusted Gross Profit and Contribution Profit are useful financial measures for investors as they are supplemental measures used by management in evaluating unit level economics and our operating performance. Each of these measures is intended to present the economics related to homes sold during a given period. We do so by including revenue generated from homes sold (and adjacent services) in the period and only the expenses that are directly attributable to such home sales, even if such expenses were recognized in prior periods, and excluding expenses related to homes that remain in inventory as of the end of the period. Contribution Profit provides investors a measure to assess Opendoor's ability to generate returns on homes sold during a reporting period after considering home purchase costs, renovation and repair costs, holding costs and selling costs.

Adjusted Gross Profit and Contribution Profit are supplemental measures of our operating performance and have limitations as analytical tools. For example, these measures include costs that were recorded in prior periods under GAAP and exclude, in connection with homes held in inventory at the end of the period, costs required to be recorded under GAAP in the same period. Accordingly, these measures should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. We include a reconciliation of these measures to the most directly comparable GAAP financial measure, which is gross profit.

*Adjusted Gross Profit / Margin*

We calculate Adjusted Gross Profit as gross profit under GAAP adjusted for (1) inventory valuation adjustment in the current period, and (2) inventory valuation adjustment in prior periods. Inventory valuation adjustment in the current period is calculated by adding back the inventory valuation adjustments recorded during the period on homes that remain in inventory at period end. Inventory valuation adjustment in prior periods is calculated by subtracting the inventory valuation adjustments recorded in prior periods on homes sold in the current period. Adjusted Gross Margin is Adjusted Gross Profit as a percentage of revenue.

We view this metric as an important measure of business performance as it captures gross margin performance isolated to homes sold in a given period and provides comparability across reporting periods. Adjusted Gross Profit helps management assess home pricing, service fees and renovation performance for a specific resale cohort.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

*Contribution Profit / Margin*

We calculate Contribution Profit as Adjusted Gross Profit, minus certain costs incurred on homes sold during the current period including: (1) holding costs incurred in the current period, (2) holding costs incurred in prior periods, and (3) direct selling costs. Contribution Margin is Contribution Profit as a percentage of revenue.

We view this metric as an important measure of business performance as it captures the unit level performance isolated to homes sold in a given period and provides comparability across reporting periods. Contribution Profit helps management assess inflows and outflows directly associated with a specific resale cohort.

The following table presents a reconciliation of our Adjusted Gross Profit and Contribution Profit to our gross profit, which is the most directly comparable GAAP measure, for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| **(in millions, except percentages)** | **2025** | **2024** | **2025** | **2024** |
| **Revenue (GAAP)** | $**915** | $**1377** | $**3635** | $**4069** |
| **Gross profit (GAAP)** | $**66** | $**105** | $**293** | $**348** |
| *Gross Margin* | 7.2% | 7.6% | 8.1% | 8.6% |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory valuation adjustment – Current Period<sup>(1)(2)</sup> | 15 | 10 | 29 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory valuation adjustment – Prior Periods<sup>(1)(3)</sup> | (17) | (16) | (23) | (24) |
| **Adjusted Gross Profit** | $**64** | $**99** | $**299** | $**357** |
| *Adjusted Gross Margin* | 7.0% | 7.2% | 8.2% | 8.8% |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct selling costs<sup>(4)</sup> | (28) | (32) | (100) | (109) |
| &nbsp;&nbsp;&nbsp;&nbsp;Holding costs on sales – Current Period<sup>(5)(6)</sup> | (4) | (6) | (33) | (30) |
| &nbsp;&nbsp;&nbsp;&nbsp;Holding costs on sales – Prior Periods<sup>(5)(7)</sup> | (12) | (9) | (23) | (14) |
| **Contribution Profit** | $**20** | $**52** | $**143** | $**204** |
| *Contribution Margin* | 2.2% | 3.8% | 3.9% | 5.0% |

---

________________

<sup>(1)</sup> Inventory valuation adjustment includes adjustments to record real estate inventory at the lower of its carrying amount or its net realizable value.

<sup>(2)</sup> Inventory valuation adjustment — Current Period is the inventory valuation adjustments recorded during the period presented associated with homes that remain in inventory at period end.

<sup>(3)</sup> Inventory valuation adjustment — Prior Periods is the inventory valuation adjustments recorded in prior periods associated with homes that sold in the period presented.

<sup>(4)</sup> Represents selling costs incurred related to homes sold in the relevant period. This primarily includes broker commissions, external title and escrow-related fees and transfer taxes. Selling costs are included in Sales, marketing and operations on the Condensed Consolidated Statements of Operations.

<sup>(5)</sup> Holding costs include mainly property taxes, insurance, utilities, homeowners association dues, cleaning and maintenance costs. Holding costs are included in Sales, marketing, and operations on the Condensed Consolidated Statements of Operations.

<sup>(6)</sup> Represents holding costs incurred in the period presented on homes sold in the period presented.

<sup>(7)</sup> Represents holding costs incurred in prior periods on homes sold in the period presented.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

***Adjusted Net Loss and Adjusted EBITDA***

We also present Adjusted Net Loss and Adjusted EBITDA, which are non-GAAP financial measures that management uses to assess our underlying financial performance. These measures are also commonly used by investors and analysts to compare the underlying performance of companies in our industry. We believe these measures provide investors with meaningful period over period comparisons of our underlying performance, adjusted for certain charges that are non-cash, not directly related to our revenue-generating operations, not aligned to related revenue, or not reflective of ongoing operating results that vary in frequency and amount.

Adjusted Net Loss and Adjusted EBITDA are supplemental measures of our operating performance and have important limitations. For example, these measures exclude the impact of certain costs required to be recorded under GAAP. These measures also include inventory valuation adjustments that were recorded in prior periods under GAAP and exclude, in connection with homes held in inventory at the end of the period, inventory valuation adjustments required to be recorded under GAAP in the same period. These measures could differ substantially from similarly titled measures presented by other companies in our industry or companies in other industries. Accordingly, these measures should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. We include a reconciliation of these measures to the most directly comparable GAAP financial measure, which is net loss.

*Adjusted Net Loss*

We calculate Adjusted Net Loss as GAAP net loss adjusted to exclude non-cash expenses of stock-based compensation, equity securities fair value adjustment, intangibles amortization expense, and the amortization of stock-based compensation capitalized to internally developed software ("IDSW"). It excludes expenses that are not directly related to our revenue-generating operations such as restructuring. It also excludes loss (gain) on extinguishment of debt as these expenses or gains were incurred as a result of decisions made by management to terminate or partially extinguish portions of our outstanding credit facilities or convertible senior notes early; these expenses are not reflective of ongoing operating results and vary in frequency and amount. Adjusted Net Loss also aligns the timing of inventory valuation adjustments recorded under GAAP to the period in which the related revenue is recorded in order to improve the comparability of this measure to our non-GAAP financial measures of unit economics, as described above. Our calculation of Adjusted Net Loss does not currently include the tax effects of the non-GAAP adjustments because our taxes and such tax effects have not been material to date.

*Adjusted EBITDA / Margin*

We calculated Adjusted EBITDA as Adjusted Net Loss adjusted for depreciation and amortization, property financing and other interest expense, interest income, and income tax expense. Adjusted EBITDA is a supplemental performance measure that our management uses to assess our operating performance and the operating leverage in our business. Adjusted EBITDA Margin is Adjusted EBITDA as a percentage of revenue.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

The following table presents a reconciliation of our Adjusted Net Loss and Adjusted EBITDA to our net loss, which is the most directly comparable GAAP measure, for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| **(in millions, except percentages)** | **2025** | **2024** | **2025** | **2024** |
| **Revenue (GAAP)** | $**915** | $**1377** | $**3635** | $**4069** |
| **Net loss (GAAP)** | $**(90)** | $**(78)** | $**(204)** | $**(279)** |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 13 | 25 | 40 | 91 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation for market condition RSUs | 14 |  | 14 |  |
| &nbsp;&nbsp;&nbsp;Equity securities fair value adjustment<sup>(1)</sup> |  | 3 | 3 | 7 |
| &nbsp;&nbsp;&nbsp;Intangibles amortization expense<sup>(2)</sup> |  | 1 |  | 4 |
| &nbsp;&nbsp;&nbsp;Amortization of stock-based compensation capitalized to IDSW<sup>(3)</sup> | 4 |  | 11 |  |
| &nbsp;&nbsp;&nbsp;Inventory valuation adjustment – Current Period<sup>(4)(5)</sup> | 15 | 10 | 29 | 33 |
| &nbsp;&nbsp;&nbsp;Inventory valuation adjustment – Prior Periods<sup>(4)(6)</sup> | (17) | (16) | (23) | (24) |
| &nbsp;&nbsp;&nbsp;Restructuring<sup>(7)</sup> | 1 |  | 10 |  |
| &nbsp;&nbsp;&nbsp;Loss (gain) on extinguishment of debt | 1 |  | (9) | 1 |
| &nbsp;&nbsp;&nbsp;Other<sup>(8)</sup> | (2) | (15) | (4) | (14) |
| **Adjusted Net Loss** | $**(61)** | $**(70)** | $**(133)** | $**(181)** |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization, excluding amortization of intangibles | 5 | 10 | 15 | 28 |
| &nbsp;&nbsp;&nbsp;Property financing<sup>(9)</sup> | 23 | 30 | 81 | 88 |
| &nbsp;&nbsp;&nbsp;Other interest expense<sup>(10)</sup> | 11 | 4 | 22 | 13 |
| &nbsp;&nbsp;&nbsp;Interest income<sup>(11)</sup> | (12) | (12) | (26) | (42) |
| &nbsp;&nbsp;&nbsp;Income tax expense | 1 |  | 1 | 1 |
| **Adjusted EBITDA** | $**(33)** | $**(38)** | $**(40)** | $**(93)** |
| *Adjusted EBITDA Margin* | (3.6)% | (2.8)% | (1.1)% | (2.3)% |

---

________________

<sup>(1)</sup> Represents the gains and losses on certain financial instruments, which are marked to fair value at the end of each period.

<sup>(2)</sup> Represents amortization of acquisition-related intangible assets. The acquired intangible assets had useful lives ranging from 1 to 5 years and amortization was incurred until the intangible assets were fully amortized in 2024.

<sup>(3)</sup> Beginning in the quarter ended March 31, 2025, the Company revised the presentation of the amortization of stock-based compensation capitalized to IDSW to more appropriately present the full impact of all stock-based compensation expenses. This expense was previously included in "Depreciation and amortization, excluding amortization of intangibles." Had this presentation been applied for the three and nine months ended September 30, 2024, Adjusted Net Loss would have improved by $3 million and $10 million, respectively, with no impact to Adjusted EBITDA.

<sup>(4)</sup> Inventory valuation adjustment includes adjustments to record real estate inventory at the lower of its carrying amount or its net realizable value.

<sup>(5)</sup> Inventory valuation adjustment — Current Period is the inventory valuation adjustments recorded during the period presented associated with homes that remain in inventory at period end.

<sup>(6)</sup> Inventory valuation adjustment — Prior Periods is the inventory valuation adjustments recorded in prior periods associated with homes that sold in the period presented.

<sup>(7)</sup> Restructuring costs consist primarily of severance and employee termination benefits and bonuses incurred in connection with the elimination of employees' roles, consulting fees, and expenses related to the termination of certain leases incurred during the restructuring process.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

<sup>(8)</sup> Primarily includes gain on deconsolidation, net and related party services income.

<sup>(9)</sup> Includes interest expense on our non-recourse asset-backed debt facilities.

<sup>(10)</sup> Includes amortization of debt issuance costs and loan origination fees, amortization of debt discounts, commitment fees, unused fees, other interest related costs on our asset-backed debt facilities, and interest expense related to the convertible senior notes outstanding.

<sup>(11)</sup> Consists mainly of interest earned on cash, cash equivalents, restricted cash and marketable securities.

**Components of Our Results of Operations**

***Revenue***

We generate the majority of our revenue from the sale of homes that we previously acquired from homeowners. In addition, we generate revenue from additional services we provide to both home sellers and buyers, which consists primarily of title insurance and escrow services and brokerage services.

Home sales revenue from selling residential real estate is recognized when title to and possession of the property has transferred to the buyer and we have no continuing involvement with the property, which is generally the close of escrow. The amount of revenue recognized for each home sale is equal to the sale price of the home net of any concessions.

***Cost of Revenue***

Cost of revenue includes the property purchase price, acquisition costs, and direct costs to renovate or repair the home. These costs are accumulated in real estate inventory during the property holding period and charged to cost of revenue under the specific identification method when the property is sold. Real estate inventory is reviewed for valuation adjustments at least quarterly. If the carrying amount for a given home is not expected to be recovered, an inventory valuation adjustment is recorded to cost of revenue and the home's carrying value is adjusted to its net realizable value. Additionally, for our revenue other than home sales revenue, cost of revenue consists of any costs incurred in delivering the service, including associated headcount expenses such as salaries, benefits, and stock-based compensation.

***Operating Expenses***

*Sales, Marketing and Operations Expense*

Sales, marketing and operations expense consists primarily of broker commissions (paid to the home buyers' real estate agents and third-party listing agents, if applicable), resale closing costs, holding costs related to real estate inventory including utilities, property taxes and maintenance, and expenses associated with product marketing, promotions and brand-building. Sales, marketing and operations expense also includes any headcount expenses in support of sales, marketing, and real estate operations such as salaries, benefits and stock-based compensation.

*General and Administrative Expense*

General and administrative expense consists primarily of headcount expenses, including salaries, benefits and stock-based compensation for our executive, finance, human resources, legal and administrative personnel, third-party professional services fees and rent expense.

*Technology and Development Expense*

Technology and development expense consists primarily of headcount expenses, including salaries, benefits and stock-based compensation for employees in the design, development, testing, maintenance and operation of our websites, tools, applications, and mobile apps that support our products. Technology and development expense also includes amortization of capitalized software development costs and third-party software and hosting costs.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

*Restructuring Expense*

Restructuring expense consists primarily of severance and other termination benefits for employees whose roles have been eliminated, consulting fees, and expenses related to the termination of certain leases incurred during the restructuring process. See "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 16. Restructuring"* for additional information regarding restructuring expenses.

***Loss (gain) on Extinguishment of Debt***

Loss (gain) on extinguishment of debt consists primarily of gains or losses recognized in conjunction with the termination or partial debt extinguishment of debt facilities and convertible senior notes and the derecognition of associated unamortized deferred costs.

***Interest Expense***

Interest expense consists primarily of interest paid or payable and the amortization of debt discounts and debt issuance costs. Interest expense varies period over period, primarily due to fluctuations in our inventory volumes and changes in the floating benchmark interest rates ("Benchmark Rates"), based on the secured overnight financing rate ("SOFR"), plus an applicable margin, which impact the interest incurred on our senior revolving credit facilities (see "— *Liquidity and Capital Resources — Debt and Financing Arrangements*").

We expect our overall interest expense to increase as inventory increases. Subject to market conditions and cost of capital trade-offs, we will evaluate opportunities to expand our sources of financing over time, which may allow us to diversify our mix of financing sources to include more cost-effective financing relative to our higher cost mezzanine term debt facilities.

***Other Income — Net***

Other income *—* net consists primarily of interest income on our Cash and Restricted cash balances and from our investment in money market funds, time deposits, and debt securities as well as changes in fair value of, and dividend income from, our investment in equity securities and gains from deconsolidation.

***Income Tax Expense***

We record income taxes using the asset and liability method. Under this method, deferred income tax assets and liabilities are recorded based on the estimated future tax effects of differences between the financial statement and income tax basis of existing assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to apply to taxable income for the years in which differences are expected to reverse. We recognize the effect on deferred income taxes of a change in tax rates in income in the period that includes the enactment date.

We record a valuation allowance to reduce our deferred tax assets and liabilities to the net amount that we believe is more likely than not to be realized. We consider all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing tax planning strategies in assessing the need for a valuation allowance.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

**Results of Operations**

The following table sets forth our results of operations for each of the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Change in** |
| **(in thousands, except percentages)** | **2025** | **2024** | $**%** |
| Revenue | $915 | $1377 | (34)% |
| Cost of revenue | 849 | 1272 | (33)% |
| Gross profit | 66 | 105 | (37)% |
| Operating expenses: |  |  |  |
| Sales, marketing and operations | 66 | 96 | (31)% |
| General and administrative | 48 | 46 | 4% |
| Technology and development | 19 | 30 | (37)% |
| Restructuring | 1 |  | N/M |
| Total operating expenses | 134 | 172 | (22)% |
| Loss from operations | (68) | (67) | 1% |
| Loss on extinguishment of debt | (1) |  | N/M |
| Interest expense | (34) | (34) | —% |
| Other income-net | 14 | 23 | (39)% |
| Loss before income taxes | (89) | (78) | 14% |
| Income tax expense | (1) |  | N/M |
| Net loss | $(90) | $(78) | 15% |

---

N/M - Not meaningful.

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Change in** |
| **(in thousands, except percentages)** | **2025** | **2024** | $**%** |
| Revenue | $3635 | $4069 | (11)% |
| Cost of revenue | 3342 | 3721 | (10)% |
| Gross profit | 293 | 348 | (16)% |
| Operating expenses: |  |  |  |
| Sales, marketing and operations | 250 | 325 | (23)% |
| General and administrative | 109 | 141 | (23)% |
| Technology and development | 61 | 108 | (44)% |
| Restructuring | 10 |  | N/M |
| Total operating expenses | 430 | 574 | (25)% |
| Loss from operations | (137) | (226) | (39)% |
| Gain (loss) on extinguishment of debt | 9 | (1) | N/M |
| Interest expense | (103) | (101) | 2% |
| Other income-net | 28 | 50 | (44)% |
| Loss before income taxes | (203) | (278) | (27)% |
| Income tax expense | (1) | (1) | —% |
| Net loss | $(204) | $(279) | (27)% |

---

N/M - Not meaningful.

*Revenue*

Revenue decreased by $462 million, or 34%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease in revenue was primarily attributable to lower sales volumes in the third quarter of 2025. We sold 2,568 homes during the three months ended September 30, 2025, compared to 3,615 homes during the three months ended September 30, 2024, representing a decrease of 29%. Revenue per home sold decreased 6% between the same periods.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

Revenue decreased by $434 million, or 11%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease in revenue was primarily attributable to lower sales volumes in the first nine months of 2025. We sold 9,813 homes during the nine months ended September 30, 2025, compared to 10,771 homes during the nine months ended September 30, 2024, representing a decrease of 9%. Revenue per home sold decreased 2% between the same periods.

*Cost of Revenue and Gross Profit* 

Cost of revenue decreased by $423 million, or 33%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease in cost of revenue was primarily attributable to lower sales volumes and a 6% decrease in cost of revenue per home.

Cost of revenue decreased by $379 million, or 10%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease in cost of revenue was primarily attributable to lower sales volumes.

Gross profit decreased from $105 million to $66 million and gross margin decreased from 7.6% to 7.2% for the three months ended September 30, 2024 and September 30, 2025, respectively. For the same periods, Adjusted Gross Margin decreased from 7.2% to 7.0% and Contribution Margin decreased from 3.8% to 2.2%. The decrease in gross margin, Adjusted Gross Margin, and Contribution Margin is driven by a higher mix of older inventory in the resale cohort. As a reminder, Adjusted Gross Margin and Contribution Margin include inventory valuation adjustments recorded in prior periods on homes sold in the current period and exclude inventory valuation adjustments on homes remaining in inventory at the end of the period, which can create significant differences between these metrics and Gross margin. Adjusted Gross Margin and Contribution Margin are non-GAAP financial measures. See "— *Non-GAAP Financial Measures*" for further details and a reconciliation of such non-GAAP measures to their nearest comparable GAAP measures.

Gross profit decreased from $348 million to $293 million and gross margin decreased from 8.6% to 8.1% for the nine months ended September 30, 2024 and September 30, 2025, respectively. For the same periods, Adjusted Gross Margin decreased from 8.8% to 8.2% and Contribution Margin decreased from 5.0% to 3.9%. The decrease in gross margin, Adjusted Gross Margin, and Contribution Margin is driven by a higher mix of older inventory in the resale cohort. Adjusted Gross Margin and Contribution Margin are non-GAAP financial measures. See "— *Non-GAAP Financial Measures*" for further details and a reconciliation of such non-GAAP measures to their nearest comparable GAAP measures.

*Operating Expenses*

*Sales, Marketing and Operations*. Sales, marketing and operations decreased by $30 million, or 31%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease was primarily attributable to an $8 million decrease in advertising expense, which decreased from $15 million for the three months ended September 30, 2024 to $7 million for the three months ended September 30, 2025, an $8 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts, a $7 million decrease in property holding costs due to decreased homes in inventory, and a $4 million decrease in resale broker commissions, consistent with a decrease in revenue.

Sales, marketing and operations decreased by $75 million, or 23%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily attributable to a $30 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts, a $25 million decrease in advertising expense, which decreased from $63 million for the nine months ended September 30, 2024 to $38 million for the nine months ended September 30, 2025, and a $9 million decrease in resale broker commissions, consistent with a decrease in revenue.

*General and Administrative*. General and administrative increased by $2 million, or 4%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The increase was primarily attributable to a $14 million increase in market-condition restricted stock units granted to executives, partially offset by a $12 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

General and administrative decreased by $32 million, or 23%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily attributable to a $39 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts, and a $3 million decrease in rent expense. These cost reductions were partially offset by a $14 million increase in market-condition restricted stock units granted to executives.

*Technology and Development*. Technology and development decreased by $11 million, or 37%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease was primarily attributable to a $16 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts. These cost reductions were partially offset by a $8 million decrease in capitalization and amortization of IDSW expenses.

Technology and development decreased by $47 million, or 44%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily attributable to a $67 million decrease in headcount expenses, including salaries, benefits, and stock-based compensation expenses due to lower headcount consistent with ongoing cost-reduction and organizational streamlining efforts. These cost reductions were partially offset by a $26 million decrease in capitalization and amortization of IDSW expenses.

*Restructuring*. Restructuring increased by $1 million for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.

Restructuring increased by $10 million, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. Restructuring expense for the nine months ended September 30, 2025 was attributable to the Company's workforce reductions, related consulting fees, and expenses associated with lease terminations incurred during the period.

*Gain (loss) on Extinguishment of Debt*

Loss on extinguishment of debt decreased by $1 million, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.

Gain (loss) on extinguishment of debt increased by $10 million, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The gain on extinguishment of debt during the nine months ended September 30, 2025 was primarily attributable to the Company's partial extinguishment of its 2026 Notes.

*Interest Expense*

Interest expense changed by a nominal amount for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.

Interest expense increased by $2 million, or 2%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024.

*Other Income — Net*

Other income *—* net decreased by $9 million, or 39%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease was primarily attributable to a $14 million gain related to the deconsolidation of Mainstay on July 31, 2024, partially offset by a $3 million net loss on marketable equity securities recognized during the three months ended September 30, 2024, with no corresponding activity recognized during the three months ended September 30, 2025.

Other income *—* net decreased by $22 million, or 44%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily attributable to a $15 million decrease in interest income due to a reduction in the average cash, cash equivalents and restricted cash balances and a $14 million gain related to the deconsolidation of Mainstay on July 31, 2024 and recognized during the nine months ended September 30, 2024, with no

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

corresponding activity recognized during the nine months ended September 30, 2025. The decrease in Other income was partially offset by a $4 million decrease in net loss on marketable equity securities.

*Income Tax Expense*

Income tax expense changed by a nominal amount for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024.

**Liquidity and Capital Resources**

*Overview*

Our principal sources of liquidity have historically consisted of cash generated from our operations and from financing activities. As of September 30, 2025, we had cash and cash equivalents of $962 million and restricted cash of $490 million. The increase in our cash, cash equivalents and marketable securities balance of $283 million as compared to December 31, 2024 resulted primarily from approximately $198 million of total cash proceeds, after commissions, from the issuance of common stock under the at-the-market equity offering sales agreement (the "ATM Agreement"), as well as $75 million of net proceeds from the issuance of convertible senior notes, $41 million of proceeds from certain PIPE offerings and capital released as a result of a decrease in real estate inventory partially offset by operating losses. The increase in our restricted cash balance of $398 million as compared to December 31, 2024 was primarily a result of capital released as a result of a decrease in real estate inventory partially offset by $584 million net principal payments on non-recourse asset-backed debt.

As of September 30, 2025, the Company had total outstanding balances on our asset-backed debt of $1.3 billion and aggregate principal outstanding from convertible senior notes of $460 million. In addition, we had undrawn borrowing capacity of $6.3 billion under our non-recourse asset-backed debt facilities (as described further below), of which $494 million was committed.

As market conditions warrant, we may, from time to time, repurchase our outstanding debt securities in the open market, in privately negotiated transactions, by tender offer, by exchange transaction or otherwise. Such repurchases, if any, will be upon such terms and at such prices as we may determine, and will depend on prevailing market conditions, our liquidity and other factors and may be commenced or suspended at any time. The amounts involved and total consideration paid may be material.

In May 2025, the Company entered into privately negotiated transactions with certain holders of the 0.25% senior convertible notes due in 2026 (the "2026 Notes") and new investors, pursuant to which the Company issued $325 million aggregate principal amount of 7.00% senior convertible notes due 2030 (the "2030 Notes"; collectively with the 2026 Notes, "Convertible Senior Notes") consisting of (i) $246 million aggregate principal amount of 2030 Notes issued in exchange for $246 million principal amount of 2026 Notes and (ii) $79 million aggregate principal amount of 2030 Notes issued for cash. Such transactions resulted in gross cash proceeds of $75 million, excluding certain fees and other offering expenses, and represent an issue price of 95%. During the third quarter of 2025, the remaining 2026 Notes became due within 12 months of the balance sheet date. Accordingly, the entire principal balance of the 2026 Notes ($135 million) has been classified as a current liability in the condensed consolidated balance sheet as of September 30, 2025.

The 2030 Notes become convertible during any calendar quarter if, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company's common stock exceeds 130% of the conversion price for at least 20 trading days. This condition was met during the third quarter of 2025. Accordingly, the 2030 Notes are convertible at the option of the noteholders from October 1, 2025 through December 31, 2025 and, consequently, the entire principal balance of the 2030 Notes ($325 million) has been classified as a current liability in the condensed consolidated balance sheet as of September 30, 2025.

In May 2024, the Company entered into the ATM Agreement with Barclays Capital Inc. and Virtu Americas LLC, as sales agents (the "Agents"), pursuant to which the Company may offer and sell, from time to time, through the Agents, shares of the Company's common stock having an aggregate offering price of up to $200 million. Under the ATM Agreement, the Agents may sell shares by any method deemed to be an "at-the-market offering." During the three and nine months ended September 30, 2025, the Company issued and sold an aggregate of 21,587,667 shares at a weighted average price of $9.26 per share, under the ATM Agreement for total cash proceeds, after commissions, of approximately $198 million.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

On September 10, 2025, the Company closed certain private investment in public equity ("PIPE") offerings and entered into purchase agreements with accredited investors that resulted in aggregate gross cash proceeds to the Company of approximately $41 million. See "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 13 — Related Parties"* for details regarding the PIPE offerings.

We have incurred losses from inception through September 30, 2025, with the exception of net income during the three months ended March 31, 2022 and three months ended June 30, 2023, and we expect to incur additional losses in the future. Our ability to service our debt and fund working capital, business operations and capital expenditures will depend on our ability to generate cash from operating activities, which is subject to our future operating success, and ability to obtain inventory acquisition financing on reasonable terms, which is subject to factors beyond our control, including potential economic recession, rising interest rates, inflation and general economic, political and financial market conditions.

Our working capital requirements may increase should our inventory balance increase. We believe our cash and cash equivalents, together with cash we expect to generate from future operations and borrowings, will be sufficient to meet our working capital and capital expenditure requirements for a period of at least 12 months from the date of this Quarterly Report on Form 10-Q.

*Debt and Financing Arrangements*

Our financing activities include: short-term borrowings under our asset-backed senior revolving credit facilities; the issuance of long-term asset-backed senior term debt, asset-backed mezzanine term debt, and convertible debt; and new issuances of equity. Historically, we have required access to external financing resources in order to fund growth, expansion into new markets and strategic initiatives and we expect this to continue in the future. Our access to capital markets can be impacted by factors outside our control, including economic conditions.

We primarily use non-recourse asset-backed debt, consisting of asset-backed senior debt facilities and asset-backed mezzanine term debt facilities, to provide financing for our real estate inventory purchases and renovations. Our business is capital intensive and maintaining adequate liquidity and capital resources is needed as we continue to scale and accumulate additional inventory. We intend to actively manage our relationships with multiple financial institutions and seek to optimize duration, flexibility, efficiency and cost of funds, but there can be no assurance that we will be able to obtain sufficient capital for our business or to do so on acceptable financial and other terms.

Our asset-backed facilities are each collateralized by a specified pool of assets, consisting of real estate inventory, restricted cash and equity interests in certain consolidated subsidiaries of Opendoor that directly or indirectly own our real estate inventory. The terms of our inventory financing facilities require an Opendoor subsidiary to comply with customary financial covenants, such as maintaining certain levels of liquidity, tangible net worth or leverage (ratio of debt to tangible net worth). As of September 30, 2025, the Company was in compliance with all financial covenants.

Our property financing subsidiaries' assets and credit generally are not available to satisfy the debts and other obligations of any other Opendoor entities. Our asset-backed debt is non-recourse to Opendoor and our subsidiaries that are not party to the relevant financing arrangements, except for limited guarantees provided by an Opendoor subsidiary for certain obligations in situations involving "bad acts" by an Opendoor entity and certain other limited circumstances.

Our asset-backed senior debt facilities generally provide for advance rates of 75% to 90% against our cost basis in the underlying properties upon acquisition. Our mezzanine term facilities may finance up to 95% to 100% of our cost basis in the underlying properties upon acquisition. The maximum initial advance rates vary by facility and generally decrease on a fixed timeline that varies by facility based on the length of time a given property has been financed and other facility-specific adjustments, including adjustments based on collateral performance.

We would be required to keep amounts in restricted cash accounts to collateralize our asset-backed term debt facilities if the property borrowing base is insufficient to satisfy the borrowing base requirements or if the value of the assets of a certain Opendoor subsidiary declines below certain levels. If these events occur, we may utilize other available credit facilities for our cash needs, potentially at higher interest rates. The amounts required to be kept in restricted cash accounts may fluctuate due to seasonality, timing of property acquisitions and resales, and the outstanding loan balances under our asset-backed term debt facilities.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

The following table summarizes certain details related to our non-recourse asset-backed debt as of September 30, 2025 (in millions, except interest rates):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Outstanding Amount** | **Outstanding Amount** | | | |
|<br>**September 30, 2025** |<br>**Borrowing**<br>**Capacity** | **Current** | **Non-Current** |<br>**Weighted**<br>**Average**<br>**Interest Rate** |<br>**End of Revolving / Withdrawal Period** |<br>**Final Maturity**<br>**Date** |
| Non-Recourse Asset-backed Debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset-backed Senior Revolving Credit Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-2 | $1000 | $— | $— | —% | June 25, 2027 | June 25, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2018-3 | 1000 | 6 |  | 7.28% | September 29, 2026 | September 29, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-1 | 300 |  |  | 7.24% | February 18, 2027 | February 18, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-2 | 300 |  |  | 7.15% | October 2, 2026 | October 1, 2027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revolving Facility 2019-3 | 100 |  |  | 7.28% | April 5, 2027 | April 3, 2028 |
| &nbsp;&nbsp;Asset-backed Senior Term Debt Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S1 | 400 | 100 |  | 5.88% | February 24, 2026 | August 24, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S2 | 268 | 268 |  | 3.57% | September 10, 2025 | March 10, 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2021-S3 | 1000 |  | 625 | 3.75% | January 31, 2027 | July 31, 2027 |
| Total | $4368 | $374 | $625 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  |  | (4) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value |  | $374 | $621 |  |  |  |
| &nbsp;&nbsp;Asset-backed Mezzanine Term Debt Facilities |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2020-M1 | 3000 |  | 200 | 12.00% | February 25, 2028 | February 25, 2029 |
| &nbsp;&nbsp;&nbsp;&nbsp;Term Debt Facility 2022-M1 | 250 |  | 150 | 12.24% | January 31, 2027 | November 1, 2027 |
| Total | $3250 | $— | $350 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance Costs |  |  | (5) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Carrying Value |  |  | $345 |  |  |  |
| Total Non-Recourse Asset-backed Debt | $7618 | $374 | $966 |  |  |  |

---

*Asset-backed Senior Revolving Credit Facilities*

We classify the senior revolving credit facilities as current liabilities on our condensed consolidated balance sheets. In some cases, the borrowing capacity amounts under the asset-backed senior revolving credit facilities as reflected in the table are not fully committed and any borrowings above the committed amounts are subject to the applicable lender's discretion. As of September 30, 2025, we had committed borrowing capacity with respect to asset-backed senior revolving credit facilities of $400 million.

The revolving period end dates and final maturity dates reflected in the table above are inclusive of any extensions that are at the sole discretion of the Company. Certain of our asset-backed senior revolving credit facilities may also have additional extension options that are subject to lender approval that are not reflected in the table above.

*Asset-backed Senior Term Debt Facilities*

We classify our senior term debt facilities as current or non-current liabilities in our condensed consolidated balance sheets based on the applicable final maturity date. The carrying value of the non-current liabilities is reduced by issuance costs of $4 million. In some cases, the borrowing capacity amounts under the asset-backed senior term debt facilities as reflected in the table are not fully committed and any borrowings above the committed amounts are subject to the applicable lender's discretion. As of September 30, 2025, we had committed borrowing capacity with respect to asset-backed senior term debt facilities of $1.0 billion.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

The withdrawal period end dates and final maturity dates reflected in the table above are inclusive of any extensions that are at the sole discretion of the Company. Certain of our asset-backed senior term debt facilities may also have additional extension options that are subject to lender approval that are not reflected in the table above.

*Asset-backed Mezzanine Term Debt Facilities*

In addition to the asset-backed senior revolving credit facilities and asset-backed senior term debt facilities, we have issued asset-backed mezzanine term debt facilities which are subordinated to the related senior facilities. The borrowing capacity amounts under the asset-backed mezzanine term debt facilities as reflected in the table are not fully committed and any borrowing above the committed amounts are subject to the applicable lender's discretion. As of September 30, 2025, we had committed borrowing capacity with respect to asset-backed mezzanine term debt facilities of $450 million.

*Convertible Senior Notes*

In August 2021, we issued the 2026 Notes and in May 2025, we issued the 2030 Notes. The table below summarizes certain details related to our Convertible Senior Notes (in millions), as of September 30, 2025, which includes certain repurchases:

---

| | | | |
|:---|:---|:---|:---|
| **September 30, 2025** | **Remaining Aggregate Principal Amount** | **Unamortized Debt Discount and Issuance Costs** | **Net Carrying Amount** |
| 2026 Notes | $135 | $— | $135 |
| 2030 Notes | 325 | (21) | 304 |
| Total Convertible Senior Notes | $460 | $(21) | $439 |

---

See "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 5. Credit Facilities and Long-Term Debt*" for additional information regarding our debt and financing arrangements.

*Special Purpose Entities*

The Company has established certain special purpose entities ("SPEs") for the purpose of financing the Company's purchase and renovation of real estate inventory through the issuance of asset-backed debt. The Company is the primary beneficiary of the various variable interest entities ("VIE") within these financing structures and consolidates these VIEs. See "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 4. Variable Interest Entities*" for additional information regarding our VIEs.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

The following table summarizes the assets and liabilities related to the VIEs consolidated by the Company as well as the assets, liabilities and equity related to Opendoor Technologies Inc. (Parent Company Only) ("Parent Company") and subsidiaries that are not VIEs, as of September 30, 2025 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **VIE** | **Non-VIE** | **Total** |
| CURRENT ASSETS: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents |  | $— | $962 | $962 |
| &nbsp;&nbsp;&nbsp;Restricted cash |  | 480 | 10 | 490 |
| &nbsp;&nbsp;&nbsp;Escrow receivable |  | 9 |  | 9 |
| &nbsp;&nbsp;&nbsp;Real estate inventory |  | 1066 | 19 | 1085 |
| &nbsp;&nbsp;&nbsp;Inventory valuation adjustment |  | (31) | (1) | (32) |
| &nbsp;&nbsp;&nbsp;Real estate inventory, net |  | 1035 | 18 | 1053 |
| &nbsp;&nbsp;&nbsp;Other current assets |  | 4 | 69 | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets |  | 1528 | 1059 | 2587 |
| OTHER ASSETS | <sup>(1)</sup> |  | 113 | 113 |
| TOTAL ASSETS |  | $1528 | $1172 | $2700 |
| CURRENT LIABILITIES: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Current asset-backed senior revolving credit |  | $6 | $— | $6 |
| &nbsp;&nbsp;&nbsp;Current asset-backed senior term debt |  | 368 |  | 368 |
| &nbsp;&nbsp;&nbsp;Convertible senior notes – current portion |  |  | 439 | 439 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | <sup>(2)</sup> | 19 | 82 | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities |  | 393 | 521 | 914 |
| Non-current asset-backed mezzanine term debt |  | 345 |  | 345 |
| Non-current asset-backed senior term debt |  | 621 |  | 621 |
| LEASE LIABILITIES – Net of current portion |  |  | 7 | 7 |
| OTHER LIABILITIES |  |  | 2 | 2 |
| TOTAL LIABILITIES |  | $1359 | $530 | $1889 |
| SHAREHOLDERS' EQUITY: |  | $169 | $642 | $811 |

---

________________

<sup>(1)</sup> The Company's consolidated Other Assets include the following assets as shown in the Condensed Consolidated Balance Sheets: Property and Equipment - Net, $31 million; Right of Use Assets, $9 million; Goodwill, $3 million; and Other Assets, $70 million.

<sup>(2)</sup> The Company's consolidated Other Current Liabilities include the following liabilities as shown in the Condensed Consolidated Balance Sheets: Accounts Payable and Other Accrued Liabilities, $91 million; Interest Payable, $9 million; and Lease Liabilities *–* Current, $1 million.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

***Cash Flows***

The following table summarizes our cash flows for the periods presented:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| **(in millions)** | **2025** | **2024** |
| Net cash provided by (used in) operating activities | $979 | $(515) |
| Net cash (used in) provided by investing activities | $(9) | $31 |
| Net cash used in financing activities | $(281) | $(2) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $689 | $(486) |

---

***Net Cash Provided by (Used in) Operating Activities***

Net cash provided by (used in) operating activities was $979 million and $(515) million for the nine months ended September 30, 2025 and 2024, respectively. For the nine months ended September 30, 2025, cash provided by operating activities was primarily driven by the $1.1 billion decrease in real estate inventory, partially offset by our net loss, net of non-cash items, of $66 million. For the nine months ended September 30, 2024, cash used in operating activities was primarily driven by a $422 million increase in real estate inventory and our net loss, net of non-cash items, of $98 million.

***Net Cash (Used in) Provided by Investing Activities***

Net cash (used in) provided by investing activities was $(9) million and $31 million for the nine months ended September 30, 2025 and 2024, respectively. For the nine months ended September 30, 2025, cash used in investing activities consisted of a $9 million increase in property and equipment principally related to IDSW capitalization, as well as, a $6 million increase in equity investments, partially offset by a decrease in marketable securities of $6 million. For the nine months ended September 30, 2024, cash provided by investing activities primarily consisted of a decrease in marketable securities of $55 million, partially offset by an $22 million increase in property and equipment principally related to IDSW capitalization.

***Net Cash Used in Financing Activities***

Net cash used in financing activities was $281 million and $2 million for the nine months ended September 30, 2025 and 2024, respectively. For the nine months ended September 30, 2025, cash used in financing activities was primarily attributable to $584 million net principal payments on non-recourse asset-backed debt, partially offset by approximately $198 million of total cash proceeds , after commissions, from the issuance of common stock under the at-the-market offering agreement, as well as $75 million of proceeds from the issuance of convertible senior notes, net of discount, and $41 million of proceeds from certain PIPE offerings. For the nine months ended September 30, 2024, cash used in financing activities was primarily attributable to $7 million net principal payments on non-recourse asset-backed debt.

**Contractual Obligations and Commitments**

There have been no material changes outside the ordinary course of business in our commitments under contractual obligations as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024, except for the

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

categories of contractual obligations discussed above with respect to the Convertible Senior Notes and otherwise included in the table below, which have been updated to reflect our contractual obligations as of September 30, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** |
| **(in millions)** | **Total** | **Less than**<br>**1 year** | **1 – 3 years** | **4 – 5 years** | **More than**<br>**5 years** |
| Senior revolving credit facilities<sup>(1)</sup> | $6 | $6 | $— | $— | $— |
| Senior and mezzanine term debt facilities<sup>(2)</sup> | 1520 | 445 | 865 | 210 |  |
| Convertible senior notes<sup>(3)</sup> | 484 | 484 |  |  |  |
| Operating lease<sup>(4)</sup> | 11 | 1 | 4 | 4 | 2 |
| Purchase commitments<sup>(5)</sup> | 164 | 164 |  |  |  |
| Total | $2185 | $1100 | $869 | $214 | $2 |

---

______________

<sup>(1)</sup> Represents the principal amounts outstanding as of September 30, 2025. Includes estimated interest payments, calculated using the variable rate in existence at period end over an assumed holding period of 90 days. Borrowings under the senior revolving credit facilities are payable as the related inventory is sold. The payment is expected to be within one year of September 30, 2025.

<sup>(2)</sup> Represents the principal amounts outstanding as of September 30, 2025 and estimated interest payments assuming the principal balances remain outstanding until maturity. The final maturity dates of the senior and mezzanine term debt facilities vary, as discussed above.

<sup>(3)</sup> Represents the principal amounts outstanding for the 2026 Notes as of September 30, 2025 and interest payments assuming the principal balances remain outstanding until maturity. Includes the principal amounts outstanding for the 2030 Notes as of September 30, 2025 and interest payments assuming the notes matures within one year. The 2030 Notes have an original maturity date of May 15, 2030 and noteholders have the option to convert through December 31, 2025. Assuming there are no conversions, total future cash outflows would be as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** | **Payment Due by Year** |
| **(in millions)** | **Total** | **Less than**<br>**1 year** | **1 – 3 years** | **4 – 5 years** | **More than**<br>**5 years** |
| Convertible senior notes | $576 | $159 | $46 | $371 | $— |

---

<sup>(4)</sup> Represents future payments for long-term operating leases that have commenced, or have been executed but not yet commenced, as of September 30, 2025. In May 2025, the Company amended its Tempe, Arizona office lease to terminate the Company's obligations with respect to a portion of the leased premises, which resulted in a decrease of undiscounted, future lease payments of $10 million.

<sup>(5)</sup> As of September 30, 2025, we were under contract to purchase 526 homes for an aggregate purchase price of $164 million.

**Critical Accounting Policies and Estimates**

Discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities, revenue, and expenses at the date of the financial statements. Generally, we base our estimates on historical experience and on various other assumptions in accordance with GAAP that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

We consider an accounting judgment, estimate or assumption to be critical when (1) the estimate or assumption is complex in nature or requires a high degree of judgment and (2) the use of different judgments, estimates and assumptions could have a material impact on the condensed consolidated financial statements. Based on this definition, critical accounting policies and estimates are discussed in "*Part II – Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates*" in the Annual Report on Form 10-K for the year ended December 31, 2024. There have been no significant changes to these critical accounting estimates during the first nine months of 2025. In addition, we have other key accounting policies and estimates that are described in "*Part I – Item 1. Financial* 

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

(Tabular amounts in millions, except share and per share data and ratios, or as noted)

*Statements – Notes to Condensed Consolidated Financial Statements – Note 1. Description of Business and Accounting Policies*" in this Quarterly Report on Form 10-Q.

**Recent Accounting Pronouncements**

For information on recent accounting standards, see "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 1. Description of Business and Accounting Policies"*.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

We are exposed to market risks in the ordinary course of our business. These risks primarily consist of fluctuations in interest rates and exposure to inflationary pressures.

***Interest Rate Risk***

We are subject to market risk by way of changes in interest rates on borrowings under our inventory financing facilities. As of September 30, 2025, we had total outstanding balances on our asset-backed debt of $1.3 billion, 100% of which was based on a fixed rate with an average duration of 1.7 years. Total property financing interest expense for the nine months ended September 30, 2025 was $81 million, of which $68 million was fixed and $13 million was floating. Accordingly, fluctuations in market interest rates may increase or decrease our interest expense. We may use interest rate cap derivatives, interest rate swaps or other interest rate hedging instruments to economically hedge and manage interest rate risk with respect to our variable floating rate debt. Many of our floating rate debt facilities also have benchmark rate floors. See "*Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 5. Credit Facilities and Long-Term Debt*" for additional information regarding our inventory financing facilities and fixed and floating interest rates. Assuming no change in the outstanding borrowings on our credit facilities, we estimate that a one percentage point increase in applicable benchmark rates would not have resulted in an impact on our annual interest expense as of September 30, 2025.

***Inflation Risk***

We believe the inflation experienced in recent years has impacted the cost of goods and services that we consume, such as labor and materials costs for home repairs. Moreover, the current U.S. presidential administration has implemented tariffs on imports from a number of countries, and has proposed or announced tariffs on goods from numerous additional countries and other trade policies intended to restrict imports, which may further increase the cost and the scarcity of materials used for home repairs. We endeavor to offset these impacts in our business by appropriately considering them in our pricing and operational models. However, if our costs were to become subject to significant incremental inflationary pressure, we may not be able to fully offset such higher costs by adjusting our operational model or our pricing methodology. Our inability to do so could harm our business, results of operations and financial condition.

In response to persistent inflationary pressures in the U.S., the Federal Reserve implemented a number of increases to the federal funds rate in 2022 and 2023. Despite the Federal Reserve's rate reductions in 2024 and 2025, the federal funds rate remains elevated compared to recent historical levels. Higher interest rates contribute to increased mortgage rates, which reduce home affordability and can lead to lower transaction volumes, extended holding periods, and increased holding and financing costs for our owned inventory. See "*Part I – Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations – Current Housing Environment*" for a further discussion of the impact of the elevated federal funds rate on our business.

**Item 4. Controls and Procedures.**

**Inherent Limitations on Effectiveness of Controls**

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

**Evaluation of Disclosure Controls and Procedures**

Our management, with the participation of our Chief Executive Officer and Interim Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on the evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that our disclosure controls and procedures are effective at the reasonable assurance level as of September 30, 2025.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended September 30, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**PART II – OTHER INFORMATION**

**Item 1. Legal Proceedings.**

The information required by this Item 1 is incorporated herein by reference to the discussion in *Part I – Item 1. Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 15. Commitments and Contingencies – Legal Matters*.

In addition to the legal matters referenced above, we are currently and have in the past been subject to legal proceedings and regulatory actions in the ordinary course of business. We do not anticipate that the ultimate liability, if any, arising out of any such matters will have a material effect on our financial condition, results of operations or cash flows. In the future, we may be subject to further legal proceedings and regulatory actions in the ordinary course of business and we cannot predict whether any such proceeding or matter will have a material effect on our financial condition, results of operations or cash flows.

**Item 1A. Risk Factors.**

In the course of conducting our business operations, we are exposed to a variety of risks. You should carefully consider the risks described below, the risks described in "Part I – Item 1A. Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "Annual Report"), and in "Part II – Item 1A. Risk Factors," in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 (the "June 2025 Quarterly Report,"), as well as the other information in this Quarterly Report on Form 10-Q, including our financial statements and related notes and "Item 2. Management's Discussion and Analysis of Financial Condition and Result of Operations," before deciding whether to invest in our common stock. Any of the risk factors we described in "Part I – Item 1A. Risk Factors," in our Annual Report or in subsequent periodic reports, have affected or could materially and adversely affect our business, financial condition, results of operations, and prospects. The market price of shares of our common stock could decline, possibly significantly or permanently, if one or more of these risks and uncertainties occurs. Certain statements in "Risk Factors" are forward-looking statements. See "Forward-Looking Statements."

There have been no material changes to our risk factors since the Annual Report and our June 2025 Quarterly Report, other than the following:

**We utilize a significant amount of debt and financing arrangements in the operation of our business. Our cash flows and operating results could be adversely affected by required payments of debt or related interest and other risks of our debt financing.**

As of September 30, 2025, we had approximately $1.3 billion of non-recourse asset-backed loans. Our leverage could have meaningful consequences to us, including increasing our vulnerability to economic downturns, limiting our ability to withstand competitive pressures, or reducing our flexibility to respond to changing business and economic conditions. We are also subject to general risks associated with debt financing, including (1) our cash flow may not be sufficient to satisfy required payments of principal and interest; (2) we may not be able to refinance our existing indebtedness or refinancing terms may be less favorable to us than the terms of our existing debt; (3) debt service obligations or facility prepayments could reduce funds available for capital investment and general corporate purposes; (4) the conversion of our outstanding convertible notes and their corresponding settlement in whole or in part in cash could adversely affect our liquidity; and (5) any default on our indebtedness could result in acceleration of the indebtedness and foreclosure on the homes collateralizing that indebtedness, with our attendant loss of any prospective income and equity value from such property. Any of these risks could place strains on our cash flows, reduce our ability to grow, and adversely affect our results of operations.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**We may not have the ability to raise the funds necessary for cash settlement upon conversion of the Convertible Senior Notes (as defined below) or to repurchase the Convertible Senior Notes for cash following a fundamental change or, in respect of the 2030 Notes, to repurchase the 2030 Notes if the holders of the 2030 Notes require so on May 15, 2028, and our future debt may contain limitations on our ability to pay cash upon conversion of the Convertible Senior Notes or to repurchase the Convertible Senior Notes.**

Holders of our 0.25% convertible senior notes due 2026 (the "2026 Notes") or our 7.00% convertible senior notes due 2030 (the "2030 Notes" and together with the 2026 Notes, the "Convertible Senior Notes") have the right to convert their Convertible Senior Notes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• during any calendar quarter, if the last reported sale price of our common stock exceeds 130% of the conversion price for each of at least twenty business days (whether or not consecutive) during the thirty consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• during the five consecutive business day period after any 10 consecutive trading day period if the trading price per $1,000 principal amount of the applicable Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate of the notes on each such trading day;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• upon the occurrence of specified corporate events; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• if we call any or all of the Convertible Senior Notes for redemption, at any time prior to the close of business on the scheduled trading day prior to the redemption date.

If one or more holders elect to convert their Convertible Senior Notes, such conversions of the Convertible Senior Notes will be settled in cash up to at least the principal amount being converted. During the quarter ended September 30, 2025, the last reported sale price of our common stock exceeded 130% of the conversion price of our 2030 Notes for the requisite period described above. As a result, the holders of our 2030 Notes are entitled to convert such 2030 Notes pursuant to the terms of the indenture governing the 2030 Notes at their option at any time during the quarter ending December 31, 2025. If the holders of our 2030 Notes elect to convert their 2030 Notes and we elect to satisfy our conversion obligation by fully or partially settling through the payment of cash, our liquidity may be adversely affected. If the holders of our 2030 Notes elect to convert their notes and we elect to partially satisfy our conversion obligation by delivering shares of our common stock, there may be a substantial dilutive effect on our common stock. Even if holders do not elect to convert their 2030 Notes, we are required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 2030 Notes as a current rather than long-term liability, which has had and may continue to result in a material reduction of our net working capital.

In addition, subject to limited exceptions, holders of the Convertible Senior Notes have the right to require us to repurchase their 2026 Notes or 2030 Notes, respectively, upon the occurrence of a fundamental change at a cash repurchase price generally equal to 100% of the principal amount of the applicable Convertible Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. Further, holders of the 2030 Notes have the right to require us to repurchase all or part of their 2030 Notes on May 15, 2028 at a cash repurchase price equal to 100% of the principal amount of their 2030 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date.

However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of Convertible Senior Notes surrendered therefor or pay the cash amounts due upon conversion. In addition, our ability to repurchase the Convertible Senior Notes or to pay cash upon conversions of the Convertible Senior Notes may be limited by applicable law, by regulatory authorities or by agreements governing our future indebtedness. Our failure to repurchase the Convertible Senior Notes at a time when such repurchase is required by the indenture governing the Convertible Senior Notes or to pay the cash amounts due upon future conversions of the Convertible Senior Notes as required by such indenture would constitute a default under such indenture. A default under the indenture governing the Convertible Senior Notes or the fundamental change itself may also lead to a default under agreements governing our existing or future indebtedness, which may result in such existing or future indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under such existing or future indebtedness and repurchase the Convertible Senior Notes or make cash payments upon conversions thereof.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

***Unregistered Sales of Equity Securities***

Other than as disclosed in our Current Report on Form 8-K dated September 11, 2025, none.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not applicable.

**Item 5. Other Information.**

(a) &nbsp;&nbsp;&nbsp;&nbsp;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 31, 2025, Sydney Schaub notified the Company's Chief Executive Officer of her resignation as the Company's Chief Legal Officer, effective as of November 7, 2025. Following her resignation, the Company expects that Ms. Schaub will remain as an advisor through November 21, 2025.

On November 5, 2025, the Company appointed Giang Nguyen (LeGrice), age 44, as Chief Operating Officer of the Company. Ms. LeGrice joined the Company as Senior Vice President, Operations, in October, and she previously served as Vice-President, Operations at Shopify Inc., an all-in-one commerce platform for businesses, from May 2021 to October 2025 and as its Head of Operations from December 2020 to April 2021. Ms. LeGrice holds a Bachelor of Commerce in Actuarial Mathematics & Finance from the University of Manitoba in Canada.

(b) &nbsp;&nbsp;&nbsp;&nbsp;None.

(c) &nbsp;&nbsp;&nbsp;&nbsp;Securities Trading Arrangements of Directors and Executive Officers

*Rule 10b5-1 Trading Plans*

The following table describes contracts, instructions or written plans for the sale or purchase of our securities that were intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement" by our directors or executive officers during the three-month period ended September 30, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | **Trading Arrangement** | **Trading Arrangement** | | |
| |<br>**Action** |<br>**Date** | **Rule 10b5-1** <sup>(1)</sup> | **Non-Rule 10b5-1** <sup>(2)</sup> |<br>**Maximum Shares to be Sold** |<br>**Expiration Date** |
| Shrisha Radhakrishna (President) | Adopt | 8/5/2025 | X |  | 1402500<sup>(3)</sup> | 10/31/2026 |
| Selim Freiha (Former Chief Financial Officer) | Adopt | 8/5/2025 | X |  | 2252093<sup>(4)</sup> | 10/31/2026 |
| Shrisha Radhakrishna (President) | Terminate | 8/15/2025 | X |  | 1402500<sup>(3)</sup> | 10/31/2026 |
| Sydney Schaub (Chief Legal Officer) | Terminate | 8/22/2025 | X |  | 1194668<sup>(5)</sup> | 12/15/2025 |
| Selim Freiha (Former Chief Financial Officer) | Terminate | 8/25/2025 | X |  | 2252093<sup>(4)</sup> | 10/31/2026 |

---

______________

<sup>(1)</sup> Intended to satisfy the affirmative defense of Rule 10b5-1(c)

<sup>(2)</sup> Not intended to satisfy the affirmative defense of Rule 10b5-1(c)

<sup>(3)</sup> At the time of adoption, the maximum number of shares that could be sold was unknown. The Rule 10b5-1 trading arrangement contemplated, as of the adoption date, the sale of up to 1,402,500 shares of common stock subject to RSUs previously granted to Mr. Radhakrishna that will vest at various dates between November 15, 2025 and October 15, 2026.

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

The aggregate number of Mr. Radhakrishna's RSU shares that will be available for sale under the Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such RSU awards.

<sup>(4)</sup> At the time of adoption, the maximum number of shares that could be sold was unknown. The Rule 10b5-1 trading arrangement contemplated, as of the adoption date, the sale of up to 2,252,093 shares of common stock subject to RSUs previously granted to Mr. Freiha that were scheduled to vest or vested at various dates between November 15, 2025 and October 15, 2026, prior to Mr. Freiha's resignation from his position as Chief Financial Officer effective September 19, 2025. The aggregate number of Mr. Freiha's RSU shares that will be available for sale under the Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such RSU awards.

<sup>(5)</sup> At the time of adoption, the maximum number of shares that could be sold was unknown. The Rule 10b5-1 trading arrangement contemplated, as of the adoption date, the sale of up to 393,260 shares of common stock; however, 373,382 of such shares may be sold pursuant to a prior Rule 10b5-1 trading arrangement that will expire prior to the commencement of sales under the plan adopted on September 3, 2024. The Rule 10b5-1 trading arrangement also contemplated, as of the adoption date, the sale of up to 801,408 shares of common stock subject to RSUs previously granted to Ms. Schaub that will vest or vested at various dates between September 15, 2024 and October 15, 2025, as well as an unknown number of shares to be purchased in the future pursuant to the Company's Employee Stock Purchase Plan. The aggregate number of Ms. Schaub's RSU shares that will be available for sale under the Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such RSU awards.

*Rule 10b5-1 Sell to Cover Instruction Letter*

On August 5, 2025, Mr. Radhakrishna and Mr. Freiha each entered into a 10b5-1 Instruction Letter (the "Instructions") with respect to all RSUs granted or to be granted to each of them under the Company's equity plans or any successor plans, in order to instruct the broker(s) chosen by the Company to sell shares of common stock in order to satisfy any tax withholding obligations that arise in connection with the vesting and settlement of such RSU awards. The Instructions are intended to satisfy the affirmative defense of Rule 10b5-1(c). The aggregate number of shares to be sold under the Instructions is not determinable and there is no set expiration date for the Instructions.

On September 12, 2025, Ms. Schaub canceled the 10b5-1 Instruction Letter she had previously entered into on August 13, 2024 (the "2024 Instructions"). The 2024 Instructions covered all RSUs granted or to be granted to Ms. Schaub under the Company's equity plans or any successor plans, in order to instruct the broker(s) chosen by the Company to sell shares of common stock in order to satisfy any tax withholding obligations that arose in connection with the vesting and settlement of such RSU awards. The 2024 Instructions were intended to satisfy the affirmative defense of Rule 10b5-1(c). The aggregate number of shares to be sold under the 2024 Instructions is not determinable and there was no set expiration date for the 2024 Instructions.

On September 12, 2025, Ms. Schaub entered into a 10b5-1 Instruction Letter (the "2025 Instructions") with respect to all RSUs granted or to be granted to her under the Company's equity plans or any successor plans, in order to instruct the broker(s) chosen by the Company to sell shares of common stock, beginning January 1, 2026, in order to satisfy any tax withholding obligations that arise in connection with the vesting and settlement of such RSU awards. The 2025 Instructions are intended to satisfy the affirmative defense of Rule 10b5-1(c). The aggregate number of shares to be sold under the 2025 Instructions is not determinable and there is no set expiration date for the 2025 Instructions.

**Item 6. Exhibits.**

The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Exhibit**<br>**No.** | **Description** | **Form** | **File No.** | **Exhibit** | **Filing Date** | **Filed Herewith** |
| 2.1 | <u>[Agreement and Plan of Merger, dated as of September 15, 2020, by and among Social Capital Hedosophia Corp. II, Hestia Merger Sub Inc. and Opendoor Labs Inc.](https://www.sec.gov/Archives/edgar/data/1801169/000110465920105791/tm2030935d1_ex2-1.htm)</u> | 8-K | 001-39253 | 2.1 | 09/17/2020 |  |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| 3.1 | <u>[Certificate of Incorporation of Opendoor Technologies Inc.](https://www.sec.gov/Archives/edgar/data/1801169/000110465920137517/tm2038661d2_ex3-1.htm)</u> | 8-K | 001-39253 | 3.1 | 12/18/2020 |  |
| 3.2 | <u>[Amended and Restated Bylaws of Opendoor Technologies Inc.](https://www.sec.gov/Archives/edgar/data/1801169/000119312523013575/d386352dex31.htm)</u> | 8-K | 001-39253 | 3.1 | 01/24/2023 |  |
| 4.1 | <u>[Specimen Common Stock Certificate of Opendoor Technologies Inc.](https://www.sec.gov/Archives/edgar/data/1801169/000110465920122215/tm2030455d5_ex4-5.htm)</u> | S-4/A | 333-249302 | 4.5 | 11/06/2020 |  |
| 4.2 | <u>[Warrant Agreement, dated July 28, 2022, between Opendoor Technologies Inc. and Zillow, Inc.](https://www.sec.gov/Archives/edgar/data/1801169/000180116922000079/exhibit992opendoor-warrant.htm)</u> | 8-K | 001-39253 | 99.2 | 08/05/2022 |  |
| 10.1 | <u>[O](exhibit101opendoorofferlet.htm)[ffer Letter Agreement, dated as of September 10, 2024, by and between Opendoor Labs Inc. and Shrisha Radhakrishna](exhibit101opendoorofferlet.htm)</u> |  |  |  |  | \* |
| 10.2 | <u>[Amendment of](exhibit102opendooramendedo.htm)[Offer Letter Agreement, dated as of](exhibit102opendooramendedo.htm)[August 26,](exhibit102opendooramendedo.htm)[202](exhibit102opendooramendedo.htm)[5](exhibit102opendooramendedo.htm)[, by and between Opendoor Labs Inc. and Shrisha Radhakrishna](exhibit102opendooramendedo.htm)</u> |  |  |  |  | \* |
| 10.3 | <u>[O](exhibit103opendoor-ceooffe.htm)[ffer Letter Agreement, dated as of September 10, 2025, by and between Opendoor Labs Inc. and Kaz Nejatian](exhibit103opendoor-ceooffe.htm)</u> |  |  |  |  | \* |
| 10.4 | <u>[R](exhibit103opendoor-ceooffe.htm)[estricted Stock Unit Grant Notice and Restricted Stock Unit Agreement by and between Opendoor Technologies Inc. and Kaz Nejatian (included as Exhibit A to Exhibit 10.3)](exhibit103opendoor-ceooffe.htm)</u> |  |  |  |  | \* |
| 10.5 | <u>[P](https://www.sec.gov/Archives/edgar/data/1801169/000114036125034856/ef20055523_ex4-4.htm)[erformance Restricted Stock Unit Grant](https://www.sec.gov/Archives/edgar/data/1801169/000114036125034856/ef20055523_ex4-4.htm)[Notice and Performance Restricted Stock Unit Agreement (First Sign-On PSU Award) by and between Opendoor Technologies Inc. and Kaz Nejatian (Exhibit B to Exhibit 10.3)](https://www.sec.gov/Archives/edgar/data/1801169/000114036125034856/ef20055523_ex4-4.htm)</u> | S-8 | 333-290224 | 4.4 | 09/12/2025 |  |
| 10.6 | <u>[Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement (Second Sign-On PSU Award) by and between Opendoor Technologies Inc. and Kaz Nejatian (Exhibit C to Exhibit 10.3)](https://www.sec.gov/Archives/edgar/data/1801169/000114036125034856/ef20055523_ex4-5.htm)</u> | S-8 | 333-290224 | 4.5 | 09/12/2025 |  |
| 10.7 | <u>[O](exhibit107opendoorofferlet.htm)[ffer Letter Agreement, dated as of September 18, 2025, by and between Opendoor](exhibit107opendoorofferlet.htm)[Labs Inc.](exhibit107opendoorofferlet.htm)[and Christy Schwartz](exhibit107opendoorofferlet.htm)</u> |  |  |  |  | \* |
| 10.8 | <u>[A](exhibit108open_advisoryagr.htm)[dvisory Agreement](exhibit108open_advisoryagr.htm)[, dated as of August 15, 2025,](exhibit108open_advisoryagr.htm)[by and between Opendoor Technologies Inc. and Carrie Wheeler](exhibit108open_advisoryagr.htm)</u> |  |  |  |  | \* |
| 31.1 | <u>[Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](q32025exhibit311.htm)</u> |  |  |  |  | \* |
| 31.2 | <u>[Certification of](q32025exhibit312.htm)[Interim](q32025exhibit312.htm)[Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](q32025exhibit312.htm)</u> |  |  |  |  | \* |
| 32.1 | <u>[Certification of Chief Executive Officer and](q32025exhibit321.htm)[Interim](q32025exhibit321.htm)[Chief](q32025exhibit321.htm)[Financial](q32025exhibit321.htm)[Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](q32025exhibit321.htm)</u> |  |  |  |  | \*\* |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document |  |  |  |  | \* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |  |  | \* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  |  | \* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  |  | \* |

---

------

<u>[**TABLE OF CONTENTS**](#id3a54f4223484e1994a5847be5a2a243_7)</u> 

**OPENDOOR TECHNOLOGIES INC.**

---

| | | |
|:---|:---|:---|
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | \* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | \* |
| 104 | Cover Page Interactive Data File (as formatted as Inline XBRL and contained in Exhibit 101) | \* |

---

________________

\*&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith.

\*\*&nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith.

#&nbsp;&nbsp;&nbsp;&nbsp;Indicates management contract or compensatory plan.

------

**OPENDOOR TECHNOLOGIES INC.**

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **OPENDOOR TECHNOLOGIES INC.** | **OPENDOOR TECHNOLOGIES INC.** | **OPENDOOR TECHNOLOGIES INC.** |
| Date: | November 06, 2025 | By: | /s/ Kaz Nejatian | /s/ Kaz Nejatian |
|  |  |  | Name: | Kaz Nejatian |
|  |  |  | Title: | *Chief Executive Officer* |
|  |  |  |  | *(Principal Executive Officer)* |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| Date: | November 06, 2025 | By: | /s/ Christy Schwartz | /s/ Christy Schwartz |
|  |  |  | Name: | Christy Schwartz |
|  |  |  | Title: | *Interim Chief Financial Officer* |
|  |  |  |  | *(Principal Financial and Accounting Officer)* |

---

## Exhibit 10.1

**Exhibit 10.1**

**OPENDOOR LABS INC.**

410 N Scottsdale Rd Ste 1600

Tempe, AZ, 85288

VIA EMAIL

September 10, 2024

Shrisha Radhakrishna

[\*\*\*]

Re: &nbsp;&nbsp;&nbsp;&nbsp;Employment Offer

Dear Shrisha:

Opendoor Labs Inc., a Delaware corporation (the "<u>Company</u>"), is pleased to offer you employment as the Company's Chief Technology and Product Officer, on the terms described in this letter agreement (this "<u>Agreement</u>"). Your employment shall commence no later than November 16, 2024 (such actual date of your commencement of employment shall be referred to herein as the "<u>Start Date</u>").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.<u>Employment</u>.** As Chief Technology and Product Officer, you will be responsible for performing such duties as are customarily associated with such position, and such other responsibilities consistent with your title, including product development, as may be assigned to you by Carrie Wheeler, Chief Executive Officer, to whom you will report. You will be employed on a full-time basis. During the term of your employment with the Company, you will devote your best efforts and substantially all of your business time and attention to the business of the Company, except for approved vacation periods and reasonable periods of illness or other incapacities permitted by the Company's general employment policies. You will be based in the San Francisco Bay Area, you will work in person from our San Francisco, California office three days per week or otherwise in accordance with in accordance with the Company's standard policies with respect to in-office expectations for senior employees, and you will travel as reasonably required in connection with your duties when deemed necessary or requested by the Company from time to time. This is an exempt position.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.<u>Salary</u>.** You will be paid a base salary at the annual rate of $500,000, to be paid in accordance with the Company's regular payroll practices. As an exempt salaried employee, you will be required to work the Company's normal business hours, and such additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation. The Company may change your base salary from time to time with reasonable advance notice, subject to the terms and conditions set forth herein.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.<u>Annual Bonus</u>.** In addition to your base salary, you will be eligible to earn, for each fiscal year of the Company ending during the term of your employment with the Company, an annual cash bonus, as approved from time to time by the Board of Directors or Compensation Committee of Opendoor Technologies Inc. ("<u>Parent</u>"). Your target annual bonus opportunity will be 50% of your base salary actually paid for the year to which such annual bonus relates. Your actual annual bonus will be determined on the basis of such criteria established by the Board of Directors or Compensation Committee of Parent in accordance with the terms and conditions of any bonus plan adopted from time to time. Except as otherwise provided in the Severance Plan (as defined below), you must be employed by the Company on the date of payment of such annual bonus in order to be eligible to receive such annual bonus. You hereby acknowledge and agree that nothing contained herein confers upon you any right to an annual bonus in any year, and that whether the Company pays you an annual bonus and the amount of any such annual bonus will be determined by the Company in its sole discretion. Notwithstanding the foregoing, your annual bonus for 2024 will be guaranteed in an aggregate amount equal to $500,000 (your "<u>Sign-on Payment</u>"), to be paid (less taxes, deductions, and withholdings) in two equal installments of $250,000 each, with the first installment payable on the date that is 30 days after your Start Date and with the second installment payable on the date that is six months after your Start Date. If you resign your employment with the Company without Good Reason (as defined below), or the Company terminates your employment for Cause (as defined below), at any time prior to the first anniversary of your Start Date, you shall repay, within 60 days of your last day of employment with the Company, any amount of the Sign-on Payment paid to you prior to the termination of your employment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.<u>Benefits</u>.** You will be eligible to participate in all of the employee benefit plans or programs the Company generally makes available to similarly situated employees, pursuant to the terms and conditions of such plans. You will be eligible for Company-paid holidays and paid time off in accordance with the Company's policies. The Company may, from time to time, change these benefits in its discretion, provided that you shall be treated no less favorably than similarly situated employees. Additional information regarding these benefits is available for your review upon request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.<u>Equity</u>.** Subject to the approval of the Board of Directors or Compensation Committee of Parent, as soon as practicable following the Start Date, you will be granted 4,250,000 restricted stock units ("<u>RSUs</u>" and such grant, the "<u>RSU Grant</u>"). Each RSU will represent the right to receive one share of the common stock of Parent. The RSU Grant will vest on the following schedule, subject to your continuous service on each such date, except as set forth herein: 1,416,667 RSUs will vest on the 15th day of the calendar month in which the first anniversary of the Start Date falls, and the remaining 2,833,333 RSUs will vest in equal installments on a quarterly basis over the two years thereafter. The RSU Grant will be subject to the provisions of Parent's current equity incentive plan or inducement award plan, as applicable (the "<u>Plan</u>") and our standard form of RSU award agreement, which will govern and control in all respects, except as otherwise set forth herein. You will be eligible to receive refresh grant(s) at the discretion of the Board of Directors or Compensation Committee of Parent. The RSUs will be eligible for accelerated vesting as provided in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.<u>At-Will Employment; Severance</u>.** Employment with the Company is for no specific period of time. Your employment with the Company is "at will," meaning that either you or the Company

------

may terminate your employment at any time and for any reason, with or without Cause (as defined in the Severance Plan) and with or without advance notice. Any contrary representations which may have been made to you are superseded by this offer. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company's personnel policies and procedures, may change from time to time, the "at will" nature of your employment may only be changed in an express written agreement signed by you and the Chief Executive Officer of the Company.

Notwithstanding the foregoing, you may be entitled to severance upon certain qualifying terminations of employment, as outlined in the Opendoor Technologies Inc. Executive Severance Plan (the "<u>Severance Plan</u>").<sup>1</sup> By signing this Agreement and the Participation Agreement with respect to your participation in the Severance Plan, attached hereto as Attachment 1 (the "<u>Participation Agreement</u>"), you acknowledge your designation as a Tier 2 Executive (as defined in the Severance Plan) in the Severance Plan and your understanding that you agree to all the terms and conditions of the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.<u>Expenses</u>.** You will be entitled to reimbursement for all ordinary and reasonable out-of-pocket business expenses which are reasonably incurred by you in furtherance of the Company's business, with appropriate documentation and in accordance with the Company's standard policies. Any reimbursement of expenses or in-kind benefits payable under this Agreement shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid on or before the last day of your taxable year following the taxable year in which you incurred the expenses. The amount of expenses reimbursed or in-kind benefits payable in one year shall not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of yours, and your right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.<u>Compliance with Confidentiality Information Agreement and Company Policies</u>.** In connection with your employment with the Company, you will receive and have access to Company confidential information and trade secrets. Accordingly, as a condition to your commencement of employment with the Company, you will be required to execute the Employee Confidential Information and Inventions Assignment Agreement ("<u>Confidentiality Agreement</u>") attached hereto as <u>Attachment 2</u>, which contains restrictive covenants and prohibits unauthorized use or disclosure of the Company's confidential information and trade secrets, among other obligations. In addition, you are required to abide by the Company's policies and procedures (including but not limited to the Company's employee handbook), as adopted or modified from time to time within the Company's discretion, and acknowledge in writing that you have read and will comply with such policies and procedures (and provide additional such acknowledgements as such policies and procedures may be modified from time to time). The Company may modify, revoke, suspend or terminate any of the policies and/or procedures at any time, with or without notice.

<sup>1</sup> A copy of the Severance Plan can be reviewed at <u>[https://www.sec.gov/Archives/edgar/data/1801169/000180116924000085/a101opendoortechnologiesin.htm](https://www.sec.gov/Archives/edgar/data/1801169/000180116924000085/a101opendoortechnologiesin.htm)</u> and is available upon request.

------

&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement or the Confidentiality Agreement shall prevent you from (i) communicating directly with, cooperating with, or providing information to, or receiving financial awards from, any federal, state or local government agency, including without limitation the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations Board, without notifying or seeking permission from the Company, (ii) exercising any rights you may have under Section 7 of the U.S. National Labor Relations Act, such as the right to engage in concerted activity, including collective action or discussion concerning wages or working conditions, or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination based on a protected characteristic or any other conduct that Employee has reason to believe is unlawful. In addition, you acknowledge receipt of the following notice of immunity rights under the U.S. Defend Trade Secrets Act, which states: "(1) An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (2) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal, and (B) does not disclose a trade secret, except pursuant to court order."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.<u>Protection of Third-Party Information</u>.** By signing this Agreement, you are representing that you have full authority to accept this position and perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty to or duties for the Company. You specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company on and after the Start Date. You agree not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of your former employers. You also represent that you are not in unauthorized possession of any materials containing a third party's confidential and proprietary information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.<u>Outside Activities</u>.** During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) 1% of any class of securities of any enterprise (but without participating in the activities of such enterprise) and you may passively invest in hedge funds, mutual funds, private equity funds and similar funds. Nothing in this Agreement shall prohibit or restrict you from managing your personal investments in companies that are not competitive with the Company or engaging in civic, charitable, religious or political activities, sitting on a non-profit, professional, or industry boards, or conducting personal speaking or educational engagements, in each case provided such endeavors do not

------

materially interfere with your obligations under this Agreement. In addition, in the event that you wish to undertake any business activity outside the scope of your employment by the Company, which activity you believe entails no conflict with the Company's activities, you agree to inform the Company of your intentions prior to the initiation of such outside business activity, and you furthermore agree to abide by the Company's decision as to whether or not there is no conflict. If, in the Company's sole determination, a conflict exists or is likely to develop, you agree not to undertake such outside business activity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.<u>Miscellaneous</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)**<u>Background Check and Proof of Right to Work</u>.** This offer is contingent upon a satisfactory reference check and satisfactory proof of your right to work in the United States. If the Company informs you that you are required to complete a background check or drug test, this offer is contingent upon satisfactory clearance of such background check and/or drug test. You agree to assist as needed and to complete any documentation at the Company's request to meet these conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)**<u>Governing Law</u>.** The validity, interpretation, construction and performance of this Agreement, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of State of California, without giving effect to principles of conflicts of law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)**<u>Entire Agreement</u>.** You acknowledge and agree that as of your execution of this Agreement, your sole entitlement to any compensation or benefits from the Company will be as set forth in this Agreement. This Agreement, together with the Confidentiality Agreement, the Indemnification Agreement (as defined below) and the documents governing any equity awards granted to you, sets forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, understandings and agreements, whether oral or written, between you and the Company relating to the subject matter hereof. No amendment or modification to this Agreement shall be effective unless it is in writing and signed by an authorized officer of the Company and by you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)**<u>Counterparts</u>.** This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement. Facsimile and electronic image signatures (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) will be deemed an original and valid signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)**<u>Successors and Assigns</u>.** This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns, except that you may not assign any of your duties hereunder and you may not assign any of your rights hereunder, without the written consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)**<u>Severability</u>.** If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement

------

and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)**<u>Waiver</u>.** Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)**<u>Electronic Delivery</u>.** The Company may, in its sole discretion, decide to deliver any documents or notices related to this Agreement, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's Certificate of Incorporation or Bylaws by email or any other electronic means. You hereby consent to: (i) conduct business electronically; (ii) receive such documents and notices by such electronic delivery; and (iii) sign documents electronically and agree to participate through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)**<u>Arbitration</u>.** You agree that any and all disputes relating to or regarding your employment, including disputes regarding compensation and any and all other conflicts, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16 ("<u>FAA</u>"), or if inapplicable, the California Arbitration Act, to the fullest extent permitted by law, by final and binding arbitration. You further agree that such disputes shall be resolved on an individual basis only, and not on a class, collective or representative basis on behalf of other employees ("<u>Class Waiver</u>"), to the extent permitted by applicable law. Any claim that all or part of the Class Waiver is invalid, unenforceable, unconscionable, void or voidable may be determined only by a court. In no case may class, collective or representative claims proceed in arbitration. Notwithstanding the foregoing, this paragraph shall not apply to an action or claim brought in court that cannot be subject to mandatory arbitration as a matter of law, including without limitation, claims alleging sexual harassment or a nonconsensual sexual action or sexual contact, to the extent any such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law is not preempted by the FAA or otherwise invalid (the "<u>Excluded Claims</u>"). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You and the Company agree to bring any dispute in arbitration before a single neutral arbitrator with JAMS, Inc. or its successor ("<u>JAMS</u>"), in San Francisco, California or in the county of your residence if it is not in the San Francisco Bay Area at the time of the commencement of an arbitration proceeding, pursuant to the JAMS Employment Rules & Procedures (which can currently be reviewed at <u>http://www.jamsadr.com/rules-employment-arbitration/</u> and will be provided to you upon request). You on the one hand, and the Company on the other, waive any rights to a jury trial or a bench trial in connection with the resolution of any dispute under this Agreement or your employment (although both parties may seek interim emergency relief from a court to prevent irreparable harm pending the conclusion of any arbitration). The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator's essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that you or the Company would be entitled to seek in a court of law. You and the Company shall equally share all JAMS' arbitration fees, or such fees shall be paid in

------

such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company's agreement to arbitrate; provided, however, if you reside in California, the Company shall pay all JAMS' arbitration fees in excess of the amount of court fees that would be required of you if the dispute were filed in Superior Court. To the extent JAMS does not collect or you otherwise do not pay to JAMS an equal share of all JAMS' arbitration fees for any reason, and the Company pays JAMS your share, you acknowledge and agree that the Company shall be entitled to recover from you half of the JAMS arbitration fees invoiced to the parties (less any amounts you paid to JAMS) in a federal or state court of competent jurisdiction. Each party is responsible for its own attorneys' fees, except as expressly set forth in your Confidentiality Agreement. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. This paragraph shall not apply to an action or claim brought in court pursuant to the California Private Attorneys General Act of 2004, as amended. **Arbitration is not a mandatory condition of your employment. If you wish to opt out of this arbitration agreement, you must notify the Company in writing by sending an email to <u>hr@opendoor.com</u> stating your intent to opt out within 30 days of signing this Agreement.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)**<u>Withholding</u>**. All amounts payable to you will be subject to appropriate payroll deductions and withholdings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)**<u>Electronic Delivery</u>**. The Company may, in its sole discretion, decide to deliver to you by email or any other electronic means any documents or notices related to this letter, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's organizational documents, each as amended from time to time. You hereby consent to receive such documents and notices by such electronic delivery and agree to participate through any online or electronic system that may be established and maintained by the Company, or a third party designated by the Company.

------

To indicate your acceptance of the Company's offer of employment, please sign and date this Agreement and the enclosed Confidentiality Agreement and Participation Agreement where indicated and return them to me no later than September 11, 2024. This offer, if not accepted, will expire at the close of business on such date.

Best regards,

**OPENDOOR LABS INC.**

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Amelia Generalis&nbsp;&nbsp;&nbsp;&nbsp;</u><br> Name: Amelia Generalis

Title: <u>&nbsp;&nbsp;&nbsp;&nbsp;Chief People Officer&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Date:<u>&nbsp;&nbsp;&nbsp;&nbsp;09/11/2024&nbsp;&nbsp;&nbsp;&nbsp;</u>

ACCEPTED AND AGREED:

<u>/s/ Shrisha Radhakrishna&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Shrisha Radhakrishna

Date: <u>&nbsp;&nbsp;&nbsp;&nbsp;09/11/2024&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

------

**ATTACHMENT 1**

**NOTICE OF PARTICIPATION**

Opendoor Technologies Inc.

410 N. Scottsdale Road, Suite 1600

Tempe, AZ 85288

Shrisha Radhakrishna

c/o Opendoor Technologies Inc.

410 N. Scottsdale Road, Suite 1600

Tempe, AZ 85288

Dear Shrisha:

Reference is hereby made to the Opendoor Technologies Inc. Executive Severance Plan (the "Plan"). Any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan.

The purpose of this Notice of Participation is to inform you that effective as of your commencement of employment, subject to the terms of the Plan, you are hereby eligible to participate in the Plan as a Tier 2 Executive.

Sincerely,

OPENDOOR TECHNOLOGIES INC.

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Amelia Generalis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;

Name: <u>&nbsp;&nbsp;&nbsp;&nbsp;Amelia Generalis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Title: <u>&nbsp;&nbsp;&nbsp;&nbsp;Chief People Officer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

ACCEPTED AND AGREED:

<u>/s/ Shrisha Radhakrishna&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Shrisha Radhakrishna

Date: <u>&nbsp;&nbsp;&nbsp;&nbsp;09/11/2024&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

## Exhibit 10.2

**Exhibit 10.2**

**OPENDOOR LABS INC.**<br> 410 N Scottsdale Rd Ste 1000<br>Tempe, AZ, 85288

VIA EMAIL

August 26, 2025

Shrisha Radhakrishna<br>[\*\*\*]

Re: Amended Employment Offer

Dear Shrisha:

You and Opendoor Labs Inc., a Delaware corporation (the "<u>Company</u>"), are parties to an employment offer letter, dated September 10, 2024 (the "<u>Original Agreement</u>"), which sets forth certain terms of your employment with the Company. This letter (this "<u>Amended Agreement</u>") amends and restates the Original Agreement in its entirety, effective as of the date set forth above (the "<u>Amendment Date</u>"), and provides for the terms of your continued employment in the position of President of the Company and Opendoor Technologies Inc. ("<u>Parent</u>"). You will also serve as interim principal executive officer ("<u>Interim PEO</u>") of Parent. All terms herein are contingent on your execution of this Amended Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.<u>Employment</u>**. As President and Interim PEO, you will be responsible for performing such duties as are customarily associated with such position, and such other responsibilities consistent with your title, as may be assigned to you by the Board of Directors of Parent (the "<u>Board</u>"), to whom you will report. You acknowledge and agree that you shall automatically cease to serve as Interim PEO as of the effective date of the Board's appointment of another individual as the principal executive officer or Chief Executive Officer of Parent, and, if so determined by the Board at such time, report to such individual. You further acknowledge and agree that neither of the foregoing events (you ceasing to serve as Interim PEO upon the appointment of another individual as the principal executive officer or Chief Executive Officer of Parent, and you reporting to such individual) shall, by themselves and absent another adverse change in your employment relationship, constitute Good Reason under the Severance Plan or any other written agreement with the Company or Parent.

You will continue to be employed on a full-time basis. During the term of your employment with the Company, you will devote your best efforts and substantially all of your business time and attention to the business of the Company, except for approved vacation periods

------

and reasonable periods of illness or other incapacities permitted by the Company's general employment policies. You will be based in the San Francisco Bay Area, you will work in person from our San Francisco, California office three days per week or otherwise in accordance with the Company's standard policies with respect to in-office expectations for senior employees, and you will travel as reasonably required in connection with your duties when deemed necessary or requested by the Company from time to time. This is an exempt position.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.<u>Salary</u>**. Effective August 15, 2025, you will be paid a base salary at the annual rate of $700,000, to be paid in accordance with the Company's regular payroll practices. As an exempt salaried employee, you will be required to work the Company's normal business hours, and such additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation. The Company may change your base salary from time to time with reasonable advance notice, subject to the terms and conditions set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.<u>Annual Bonus</u>**. In addition to your base salary, you will be eligible to earn, for each fiscal year of the Company ending during the term of your employment with the Company, an annual cash bonus, as approved from time to time by the Board or the Compensation Committee of Parent. Your target annual bonus opportunity will be 50% of your base salary actually paid for the year to which such annual bonus relates. Your actual annual bonus will be determined on the basis of such criteria established by the Board or Compensation Committee of Parent in accordance with the terms and conditions of any bonus plan adopted from time to time. Except as otherwise provided in the Severance Plan (as defined below), you must be employed by the Company on the date of payment of such annual bonus in order to be eligible to receive such annual bonus. You hereby acknowledge and agree that nothing contained herein confers upon you any right to an annual bonus in any year, and that whether the Company pays you an annual bonus and the amount of any such annual bonus will be determined by the Company in its sole discretion. Notwithstanding the foregoing, your annual bonus for 2025 will be guaranteed in an aggregate amount equal to $500,000, subject to your continued employment through December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.<u>Benefits</u>**. You will be eligible to participate in all of the employee benefit plans or programs the Company generally makes available to similarly situated employees, pursuant to the terms and conditions of such plans. You will be eligible for Company-paid holidays and paid time off in accordance with the Company's policies. The Company may, from time to time, change these benefits in its discretion, provided that you shall be treated no less favorably than similarly situated employees. Additional information regarding these benefits is available for your review upon request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.<u>Special Bonus</u>**. In connection with your appointment as President and Interim PEO, you will be entitled to receive a one-time cash bonus in the amount of $250,000, less taxes,

------

deductions, and withholdings, payable on or before the first regularly scheduled payroll date following the Amendment Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.<u>At-Will Employment; Severance</u>**. Employment with the Company is for no specific period of time. Your employment with the Company is "at will," meaning that either you or the Company may terminate your employment at any time and for any reason, with or without Cause (as defined in the Severance Plan) and with or without advance notice. Any contrary representations which may have been made to you are superseded by this offer. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company's personnel policies and procedures, may change from time to time, the "at will" nature of your employment may only be changed in an express written agreement signed by you and the Chief Executive Officer of the Company.

Notwithstanding the foregoing, you may be entitled to severance upon certain qualifying terminations of employment, as outlined in the Opendoor Technologies Inc. Executive Severance Plan (the "<u>Severance Plan</u>"). By signing this Amended Agreement and the Participation Agreement with respect to your participation in the Severance Plan, attached hereto as <u>Attachment 1</u> (the "<u>Participation</u> <u>Agreement</u>"), you acknowledge your designation as a Tier 1 Executive (as defined in the Severance Plan) in the Severance Plan and your understanding that you agree to all the terms and conditions of the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.<u>Expenses</u>**. You will be entitled to reimbursement for all ordinary and reasonable out-of-pocket business expenses which are reasonably incurred by you in furtherance of the Company's business, with appropriate documentation and in accordance with the Company's standard policies. Any reimbursement of expenses or in-kind benefits payable under this Amended Agreement shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid on or before the last day of your taxable year following the taxable year in which you incurred the expenses. The amount of expenses reimbursed or in-kind benefits payable in one year shall not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of yours, and your right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit. The Company shall reimburse you for your reasonable attorneys' fees and expenses incurred in connection with the review of this Amended Agreement, up to a maximum of $5,000, payable promptly upon the Company's receipt of an applicable invoice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.<u>Compliance with Confidentiality Information Agreement and Company Policies</u>**. In connection with your employment with the Company, you will receive and have access to Company confidential information and trade secrets. Accordingly, in connection with your commencement of employment with the Company, you previously executed the Employee

------

Confidential Information and Inventions Assignment Agreement ("<u>Confidentiality Agreement</u>"), a copy of which is attached hereto as <u>Attachment 2</u>, which contains restrictive covenants and prohibits unauthorized use or disclosure of the Company's confidential information and trade secrets, among other obligations. In addition, you are required to abide by the Company's policies and procedures (including but not limited to the Company's employee handbook), as adopted or modified from time to time within the Company's discretion, and acknowledge in writing that you have read and will comply with such policies and procedures (and provide additional such acknowledgements as such policies and procedures may be modified from time to time). The Company may modify, revoke, suspend or terminate any of the policies and/or procedures at any time, with or without notice.

Nothing in this Amended Agreement or the Confidentiality Agreement shall prevent you from (i) communicating directly with, cooperating with, or providing information to, or receiving financial awards from, any federal, state or local government agency, including without limitation the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations Board, without notifying or seeking permission from the Company, (ii) exercising any rights you may have under Section 7 of the U.S. National Labor Relations Act, such as the right to engage in concerted activity, including collective action or discussion concerning wages or working conditions, or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination based on a protected characteristic or any other conduct that Employee has reason to believe is unlawful. In addition, you acknowledge receipt of the following notice of immunity rights under the U.S. Defend Trade Secrets Act, which states: "(1) An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (2) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal, and (B) does not disclose a trade secret, except pursuant to court order."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.<u>Protection of Third-Party Information</u>**. By signing this Amended Agreement, you are representing that you have full authority to accept this position and perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty to or duties for the Company. You specifically warrant that you are not subject to an employment

------

agreement or restrictive covenant preventing full performance of your duties to the Company. You agree not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of your former employers. You also represent that you are not in unauthorized possession of any materials containing a third party's confidential and proprietary information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.<u>Outside Activities</u>**. During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) 1% of any class of securities of any enterprise (but without participating in the activities of such enterprise) and you may passively invest in hedge funds, mutual funds, private equity funds and similar funds. Nothing in this Amended Agreement shall prohibit or restrict you from managing your personal investments in companies that are not competitive with the Company or engaging in civic, charitable, religious or political activities, sitting on a non-profit, professional, or industry boards, or conducting personal speaking or educational engagements, in each case provided such endeavors do not materially interfere with your obligations under this Amended Agreement. In addition, in the event that you wish to undertake any business activity outside the scope of your employment by the Company, which activity you believe entails no conflict with the Company's activities, you agree to inform the Company of your intentions prior to the initiation of such outside business activity, and you furthermore agree to abide by the Company's decision as to whether or not there is no conflict. If, in the Company's sole determination, a conflict exists or is likely to develop, you agree not to undertake such outside business activity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.<u>Miscellaneous</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)**<u>Governing Law</u>**. The validity, interpretation, construction and performance of this Amended Agreement, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of State of California, without giving effect to principles of conflicts of law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)**<u>Entire Agreement</u>**. You acknowledge and agree that as of your execution of this Amended Agreement, your sole entitlement to any compensation or benefits from the Company will be as set forth in this Amended Agreement. This Amended Agreement, together with the Confidentiality Agreement, the Indemnification Agreement (as defined below) and the documents governing any equity awards granted to you, sets forth the entire agreement and

------

understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, understandings and agreements, whether oral or written, between you and the Company relating to the subject matter hereof, including the Original Agreement. No amendment or modification to this Amended Agreement shall be effective unless it is in writing and signed by an authorized officer of the Company and by you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)**<u>Counterparts</u>**. This Amended Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement. Facsimile and electronic image signatures (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) will be deemed an original and valid signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)**<u>Successors and Assigns</u>**. This Amended Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns, except that you may not assign any of your duties hereunder and you may not assign any of your rights hereunder, without the written consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)**<u>Severability</u>**. If any provision of this Amended Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Amended Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)**<u>Waiver</u>**. Any waiver of a breach of this Amended Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)**<u>Electronic Delivery</u>**. The Company may, in its sole discretion, decide to deliver any documents or notices related to this Amended Agreement, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's Certificate of Incorporation or Bylaws by email or any other electronic means. You hereby consent to: (i) conduct business electronically; (ii) receive such documents and notices by such electronic delivery; and (iii) sign documents electronically and agree to participate through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)**<u>Arbitration</u>**. You agree that any and all disputes relating to or regarding your employment, including disputes regarding compensation and any and all other conflicts, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16 ("<u>FAA</u>"), or if inapplicable, the California Arbitration Act, to the fullest extent permitted by law, by final and binding arbitration. You further agree that such disputes shall be resolved on an individual basis only, and not on a class, collective or representative basis on behalf of other employees ("<u>Class Waiver</u>"), to the extent permitted by applicable law. Any claim that all or part of the Class Waiver is invalid, unenforceable, unconscionable, void or voidable may be determined only by a court. In no case may class, collective or representative claims proceed in arbitration. Notwithstanding the foregoing, this paragraph shall not apply to an action or claim brought in court that cannot be subject to mandatory arbitration as a matter of law, including without limitation, claims alleging sexual harassment or a nonconsensual sexual action or sexual contact, to the extent any such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law is not preempted by the FAA or otherwise invalid (the "<u>Excluded Claims</u>"). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You and the Company agree to bring any dispute in arbitration before a single neutral arbitrator with JAMS, Inc. or its successor ("<u>JAMS</u>"), in San Francisco, California or in the county of your residence if it is not in the San Francisco Bay Area at the time of the commencement of an arbitration proceeding, pursuant to the JAMS Employment Rules & Procedures (which can currently be reviewed at <u>http://www.jamsadr.com/rules-employment-arbitration/</u> and will be provided to you upon request). You on the one hand, and the Company on the other, waive any rights to a jury trial or a bench trial in connection with the resolution of any dispute under this Amended Agreement or your employment (although both parties may seek interim emergency relief from a court to prevent irreparable harm pending the conclusion of any arbitration). The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator's essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that you or the Company would be entitled to seek in a court of law. You and the Company shall equally share all JAMS' arbitration fees, or such fees shall be paid in such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company's agreement to arbitrate; provided, however, if you reside in California, the Company shall pay all JAMS' arbitration fees in excess of the amount of court fees that would be required of you if the dispute were filed in Superior Court. To the extent JAMS does not collect or you otherwise do not pay to JAMS an equal share of all JAMS' arbitration fees for any reason, and the Company pays JAMS your share, you acknowledge and agree that the Company shall be entitled to recover from you half of the JAMS arbitration fees invoiced to the parties (less any amounts you paid to JAMS)

------

in a federal or state court of competent jurisdiction. Each party is responsible for its own attorneys' fees, except as expressly set forth in your Confidentiality Agreement. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. This paragraph shall not apply to an action or claim brought in court pursuant to the California Private Attorneys General Act of 2004, as amended. **Arbitration is not a mandatory condition of your employment. If you wish to opt out of this arbitration agreement, you must notify the Company in writing by sending an email to <u>hr@opendoor.com</u> stating your intent to opt out within 30 days of signing this Amended Agreement.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)**<u>Withholding</u>**. All amounts payable to you will be subject to appropriate payroll deductions and withholdings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)**<u>Electronic Delivery</u>**. The Company may, in its sole discretion, decide to deliver to you by email or any other electronic means any documents or notices related to this letter, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's organizational documents, each as amended from time to time. You hereby consent to receive such documents and notices by such electronic delivery and agree to participate through any online or electronic system that may be established and maintained by the Company, or a third party designated by the Company.

------

To indicate your acceptance of this Amended Agreement, please sign and date below and return this Amended Agreement to me.

Best regards,

**OPENDOOR LABS INC.**

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Michelle Oceguera-Garcia&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name:&nbsp;&nbsp;&nbsp;&nbsp;Michelle Oceguera-Garcia

Title:&nbsp;&nbsp;&nbsp;&nbsp;Vice President, Human Resources

Date: &nbsp;&nbsp;&nbsp;&nbsp;August 26, 2025

ACCEPTED AND AGREED:

<u>/s/ Shrisha Radhakrishna&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Shrisha Radhakrishna

Date:&nbsp;&nbsp;&nbsp;&nbsp;August 26, 2025

\|

## Exhibit 10.3

**Exhibit 10.3**

<u>EXECUTION VERSION</u>

**OPENDOOR LABS INC.**<br> 410 N. Scottsdale Road Suite 1000<br>Tempe, AZ 85288

September 10, 2025

Kaz Nejatian<br>VIA EMAIL

Dear Kaz:

Opendoor Labs Inc., a Delaware corporation (the "<u>Employer</u>"), is pleased to offer you employment on the terms described in this letter agreement (this "<u>Agreement</u>"). Your employment will commence as soon as reasonably practicable following the date of this Agreement, but in no event later than October 7, 2025 (the "<u>Start Date</u>").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.<u>Employment; Board Service</u>**. During your employment with the Employer, you will serve as the Chief Executive Officer of the Employer's parent company, Opendoor Technologies Inc. (the "<u>Company</u>"). As Chief Executive Officer of the Company, you will be responsible for performing such duties as are customarily associated with such position, and such other responsibilities consistent with your title, as may be assigned to you by the Board of Directors of the Company (the "<u>Board</u>"), to whom you will report. Upon your Start Date, you will be appointed to serve as a member of the Board. In the event you are no longer Chief Executive Officer of the Company, you shall and hereby do resign your position as a member of the Board, effective as of the date you are no longer Chief Executive Officer of the Company. During your employment with the Employer, you will devote your reasonable best efforts and substantially all of your business time and attention to the business of the Company and its subsidiaries, including the Employer (the "<u>Company Group</u>"), except for approved vacation periods and reasonable periods of illness or other incapacities permitted by the Company Group's general employment policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.<u>Work Location and Residence</u>**. You will primarily work from one or more of the Company Group's offices (which, for twelve (12) months following the Start Date, shall include your home office located in the Bahamas), as selected by you in your reasonable discretion. You agree to obtain all necessary work authorization to permit you to lawfully work in the United States and to relocate your permanent residence to the United States within twelve (12) months following the Start Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.<u>Salary</u>**. Your annual base salary will be one dollar ($1). As an exempt salaried employee, you will be required to work the Company's normal business hours, and such additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.<u>Make-Whole Awards</u>**. Subject to your delivery to the Company of reasonable documentation evidencing the amount of incentive compensation forfeited by you as a result of your termination of employment with your current employer that would have vested prior to December 31, 2025 had you remained employed with your current employer (the "<u>Forfeited Compensation</u>"), the Company will grant you the awards in the amounts set forth below (the "<u>Make-Whole Awards</u>"). If, based on the documentation produced by you, the Forfeited Compensation is less than the aggregate value of the Make-Whole Awards set forth below, then

------

the value of the Make-Whole Awards will instead equal the amount of the Forfeited Compensation and the value of each Make-Whole Award will equal fifty percent (50%) of the Forfeited Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Cash Make-Whole Award</u>. You will be paid a cash lump amount of $15,000,000 (the "<u>Cash Make-Whole Award</u>"), subject to applicable tax withholdings, on the first regularly scheduled payroll date following the date that is nine (9) months after the Start Date, subject to your continued employment with the Employer through such date. Notwithstanding the foregoing, in the event that your employment with the Employer is terminated (i) by you for Good Reason (as defined below), (ii) by the Employer other than for Cause (as defined below), (iii) due to your death, or (iv) due to your Disability (clauses (i)-(iv), a "<u>Qualifying Termination</u>") then the Cash Make-Whole Amount will, subject to your satisfaction of the Release Requirement (as defined below), vest in full on your Qualifying Termination and be paid to you no later than the second regularly scheduled payroll date following the Qualifying Termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>RSU Make-Whole Award</u>. The Company will grant you an award of restricted stock units in respect of shares of Company common stock ("<u>RSUs</u>") with an aggregate grant date fair value equal to $15,000,000 (the "<u>RSU Make-Whole Award</u>") pursuant to the Nasdaq "inducement award" exception under Nasdaq Listing Rule 5635(c)(4), effective as of the Start Date. The number of RSUs will be determined by dividing such grant value by the closing price of the Company's common stock on the date of grant and rounding up to the nearest whole number. The RSU Make-Whole Award will vest in full on the date that is nine months after the Start Date, subject to your continued employment with the Employer through such date. Notwithstanding the foregoing, subject to your satisfaction of the Release Requirement, the RSU Make-Whole Award will vest in full upon your Qualifying Termination after the Grant Date. Except as expressly provided herein, the Make-Whole RSU Award will be subject to the terms of the form of grant notice and award agreement attached hereto as <u>Attachment A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.<u>Benefits</u>**. You will be eligible to participate in the Company's standard benefit programs, subject to the terms and conditions of such plans, to the same extent as other executive officers of the Company. The Company may, from time to time, change these benefits in its discretion. Additional information regarding these benefits is available for your review upon request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.<u>Equity</u>**. The sign-on equity awards described in this paragraph 6, together with the RSU Make-Whole Award, are intended to be your exclusive long-term incentive compensation from the Company Group during the performance and vesting periods covered by such awards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>First Sign-On PSU Award</u>. The Company will grant you an award of performance-based RSUs with a stock price performance gate covering 40,886,344 shares of the Company's common stock (the "<u>First Sign-On PSU Award</u>") pursuant to the Nasdaq "inducement award" exception under Nasdaq Listing Rule 5635(c)(4), effective as of the Start Date. The First Sign-On PSU Award will be granted pursuant to the form of grant notice and award agreement attached to this Agreement as <u>Attachment B</u> (the "<u>First Sign-On PSU Award Agreement</u>") and will be subject to all terms and conditions set forth in the First Sign-On PSU Award Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Second Sign-On PSU Award</u>. The Company will grant you an award of performance-based RSUs covering 40,886,344 shares of the Company's common stock (the

------

"<u>Second Sign-On PSU Award</u>") pursuant to the Nasdaq "inducement award" exception under Nasdaq Listing Rule 5635(c)(4), effective as of the Start Date. The Second Sign-On PRSUs will be granted pursuant to the form of grant notice and award agreement attached to this Agreement as <u>Attachment C</u> (the "<u>Second Sign-On PSU Award Agreement</u>") and will be subject to all terms and conditions set forth in the Second Sign-On PSU Award Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.Certain Defined Terms**. For purposes of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)"<u>Cause</u>" means: (i) your commission of any act that constitutes a felony or any crime involving dishonesty or moral turpitude, (ii) your engaging in any act of fraud or embezzlement, whether or not related to the business of the Company Group, or any other act of material dishonesty against the Company Group, (iii) any material breach by you of this Agreement, the Confidentiality Agreement or similar agreement or of any material written policy of the Company Group and, if curable, your failure to cure such breach within thirty (30) days after receiving written notice thereof from the Board specifying the nature of such breach with reasonable specificity; (iv) your willful and continued failure to substantially perform your duties to the Company Group (other than any such failure resulting from your incapacity due to physical or mental illness), after written demand for substantial performance is delivered by the Board that identifies with reasonable specificity the manner in which the Employer believes that you have not substantially performed your duties, which is not cured within thirty (30) days after notice of such failure has been given to the Participant by the Board; (v) the willful engaging by you in misconduct or gross neglect (including any conduct that is in violation of the written employee workplace policies of the Company Group) that is materially injurious to the Company Group, monetarily, in reputation or otherwise; or (vi) any other intentional act causing material damage to the Company Group's business, property or reputation; provided, however, that any written notice of breach or written demand for performance described in clauses (iii) or (iv) must be delivered to you no later than thirty (30) days after the Board's initial knowledge of the conduct believed to constitute Cause, in order for such conduct to constitute Cause.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)"<u>Disability</u>" shall have the meaning set forth in the Company's long-term disability plan, as in effect from time to time (or, if no such plan is then in effect, as such term was most recently defined therein).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)"<u>Good Reason</u>" means: (i) a material diminution in your positions, responsibilities or authorities imposed by the Employer or the Company; or (ii) a material breach by the Employer or the Company of the terms of this Agreement or any other material agreement between you and any member of the Company Group. Notwithstanding the foregoing, Good Reason shall not exist unless, within thirty (30) days after your initial knowledge of the occurrence of a circumstance that you believe in good faith to constitute Good Reason, you deliver written notice to the Board setting forth with specificity such circumstance that you believe in good faith constitutes Good Reason, the Company or the Employer shall have failed to cure any claimed event of Good Reason (if capable of cure) within thirty (30) days after receipt of such notice, and you must actually terminate your employment no later than 30 days following the expiration of the Company's cure period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)"<u>Release Requirement</u>" means the requirement that you execute and deliver (without revoking) to the Employer or the Company a release of claims in favor of the Company Group on the Company Group's standard form of release of claims for executives (which shall not include additional restrictive covenants and shall not require release of your rights to indemnification and insurance coverage as a director and officer of the Company

------

Group, your rights to vested benefits under any employee benefit plan or equity award or any other vested and non-forfeitable rights under this Agreement or any other written agreement with any member of the Company Group) (the "<u>Release</u>") on or after the date of your Qualifying Termination and on or before the 21st day following the date on which the Company delivers the Release to you, which will be within two (2) days following your Qualifying Termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.<u>Expenses</u>**. You will be entitled to reimbursement for all ordinary and reasonable out-of-pocket business expenses which are reasonably incurred by you in furtherance of the Company Group's business, with appropriate documentation and in accordance with the Company Group's standard policies, provided that your reimbursement for business travel will be limited to $1,000,000 per year. For the avoidance of doubt, you will not be reimbursed for personal travel, including expenses for commuting from your personal residence outside the United States to or from a Company Group office in the United States. The Employer will also reimburse you up to $50,000 for your attorneys' fees incurred in connection with the negotiation and implementation of this Agreement, promptly upon submission of appropriate supporting documentation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.<u>Compliance with Confidentiality Information Agreement and Company Policies</u>**. As a condition of employment, you agree to sign and comply with the Confidential Information and Inventions Assignment Agreement (the "<u>Confidentiality Agreement</u>") attached hereto as <u>Attachment D</u>. In addition, you are required to abide by the Company Group's policies and procedures (including but not limited to the Company Group's employee handbook), as adopted or modified from time to time within the Company Group's discretion, and acknowledge in writing that you have read and will comply with such policies and procedures (and provide additional such acknowledgements as such policies and procedures may be modified from time to time); <u>provided</u>, <u>however</u>, that in the event the terms of this Agreement differ from or are in conflict with the Company Group's general employment policies or practices, this Agreement shall control.

Nothing in this Agreement or the Confidentiality Agreement shall prevent you from (i) communicating directly with, cooperating with, or providing information to, or receiving financial awards from, any federal, state or local government agency, including without limitation the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations Board, without notifying or seeking permission from the Company, (ii) exercising any rights you may have under Section 7 of the U.S. National Labor Relations Act, such as the right to engage in concerted activity, including collective action or discussion concerning wages or working conditions, or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination based on a protected characteristic or any other conduct that Employee has reason to believe is unlawful. In addition, you acknowledge receipt of the following notice of immunity rights under the U.S. Defend Trade Secrets Act, which states: "(1) An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (2) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing

------

the trade secret under seal, and (B) does not disclose a trade secret, except pursuant to court order."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.<u>Protection of Third-Party Information</u>**. By signing this Agreement, you are representing that you have full authority to accept this position and perform the duties of the position commencing on the Start Date without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty to or duties for the Company. You specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company on and after the Start Date. In addition, you agree not to bring to the Company or use in the performance of your responsibilities at the Company any materials or documents of a former employer that are not generally available to the public, unless you have obtained express written authorization from the former employer for their possession and use. You also agree to honor all obligations to former employers during your employment with the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11.<u>Employment Relationship</u>**. Your employment with the Employer is for no specific period of time. Your employment with the Employer is "at will," meaning that either you or the Employer may terminate your employment at any time and for any reason, with or without Cause and with or without advance notice. Any contrary representations which may have been made to you are superseded by this offer. This Agreement, including the Attachments hereto, is the full and complete agreement between you and the Company Group regarding your employment. The "at will" nature of your employment may only be changed in an express written agreement signed by you and the Board. You will not be entitled to any severance or termination benefits from the Company Group, other than as expressly set forth in this Agreement or its Attachments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12.<u>Outside Activities</u>**. During your employment by the Employer, except on behalf of the Company Group, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company Group (or is planning or preparing to compete with the Company Group), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company Group; <u>provided</u>, <u>however</u>, that you may purchase or otherwise acquire up to (but not more than) 1% of any class of securities of any enterprise (but without participating in the activities of such enterprise) and you may passively invest in hedge funds, mutual funds, private equity funds and similar funds. Nothing in this Agreement shall prohibit or restrict you from managing your personal investments in companies (and serving on their boards) that are not competitive with the Company Group or engaging in civic, charitable, religious or political activities, sitting on a non-profit, professional, or industry boards, or conducting personal speaking or educational engagements, in each case provided such endeavors do not materially interfere with your obligations under this Agreement. In addition, in the event that you wish to undertake any substantial business activity outside the scope of your employment by the Employer, which activity you believe entails no conflict with the Company Group's business, you agree to inform the Board of your intentions prior to the initiation of such outside business activity, and you furthermore agree to abide by the Board's decision, which shall be rendered in good faith, as to whether or not there is such a conflict. If, in the Board's sole determination, such a conflict exists or is likely to develop, you agree not to undertake such outside business activity.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**13.<u>Miscellaneous</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)**<u>Governing Law</u>**. The validity, interpretation, construction and performance of this Agreement, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of state of California, without giving effect to principles of conflicts of law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)**<u>Entire Agreement</u>**. You acknowledge and agree that as of your execution of this Agreement, your sole entitlement to any compensation or benefits from the Company Group will be as set forth in this Agreement. This Agreement, including the Attachments hereto, set forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, understandings and agreements, whether oral or written, between you and the Company Group relating to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)**<u>Counterparts</u>**. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement. Facsimile and electronic image signatures (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) will be deemed an original and valid signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)**<u>Successors and Assigns</u>**. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Employer and the Company, and inure to the benefit of both you and the Employer and the Company, their heirs, successors and assigns, except that you may not assign any of your duties hereunder and you may not assign any of your rights hereunder, without the written consent of the Employer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)**<u>Severability</u>**. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)**<u>Amendment or Waiver</u>**. No provision of this Agreement may be amended unless such amendment is expressly set forth in a writing that is signed by you and an authorized representative of the Company and the Employer. Any waiver of a breach of this Agreement, or rights hereunder, shall not be effective unless expressly made in a writing that is signed by the party against whom it is sought to be enforced, and shall not be deemed to be a waiver of any successive breach or rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)**<u>Withholding</u>**. All amounts payable to you will be subject to appropriate payroll deductions and withholdings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)**<u>Electronic Delivery</u>**. The Employer or the Company may, in its sole discretion, decide to deliver any documents or notices related to this Agreement, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's Certificate of Incorporation or Bylaws by email or any other electronic means. You hereby consent to: (i) conduct business electronically; (ii) receive such documents and notices by such electronic delivery; and (iii) sign documents electronically and agree to participate through an

------

on-line or electronic system established and maintained by the Company Group or a third party designated by the Employer or the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(i)<u>Arbitration</u>**. You agree that any and all disputes relating to or regarding your employment, including disputes regarding compensation and any and all other conflicts, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16 ("<u>FAA</u>"), or if inapplicable, the California Arbitration Act, to the fullest extent permitted by law, by final and binding arbitration. You further agree that such disputes shall be resolved on an individual basis only, and not on a class, collective or representative basis on behalf of other employees ("<u>Class Waiver</u>"), to the extent permitted by applicable law. Any claim that all or part of the Class Waiver is invalid, unenforceable, unconscionable, void or voidable may be determined only by a court. In no case may class, collective or representative claims proceed in arbitration. Notwithstanding the foregoing, this paragraph shall not apply to an action or claim brought in court that cannot be subject to mandatory arbitration as a matter of law, including without limitation, claims alleging sexual harassment or a nonconsensual sexual action or sexual contact, to the extent any such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law is not preempted by the FAA or otherwise invalid (the "<u>Excluded Claims</u>"). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You and the Company agree to bring any dispute in arbitration before a single neutral arbitrator with JAMS, Inc. or its successor ("<u>JAMS</u>"), in San Francisco, California or in the county of your residence if it is not in the San Francisco Bay Area at the time of the commencement of an arbitration proceeding, pursuant to the JAMS Employment Rules & Procedures (which can currently be reviewed at http://www.jamsadr.com/rules-employment-arbitration/ and will be provided to you upon request). You on the one hand, and the Company on the other, waive any rights to a jury trial or a bench trial in connection with the resolution of any dispute under this Agreement or your employment (although both parties may seek interim emergency relief from a court to prevent irreparable harm pending the conclusion of any arbitration). The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator's essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that you or the Company would be entitled to seek in a court of law. You and the Company shall equally share all JAMS' arbitration fees, or such fees shall be paid in such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company's agreement to arbitrate; provided, however, if you reside in California, the Company shall pay all JAMS' arbitration fees in excess of the amount of court fees that would be required of you if the dispute were filed in Superior Court. To the extent JAMS does not collect or you otherwise do not pay to JAMS an equal share of all JAMS' arbitration fees for any reason, and the Company pays JAMS your share, you acknowledge and agree that the Company shall be entitled to recover from you half of the JAMS arbitration fees invoiced to the parties (less any amounts you paid to JAMS) in a federal or state court of competent jurisdiction. Each party is responsible for its own attorneys' fees, except as expressly set forth in your Confidentiality Agreement. Nothing in this Agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. This paragraph shall not apply to an action or claim brought in court pursuant to the California Private Attorneys General Act of 2004, as amended. Arbitration is not a mandatory condition of your

------

employment. **If you wish to opt out of this arbitration agreement, you must notify the Company in writing by sending an email to hr@opendoor.com stating your intent to opt out within 30 days of signing this Agreement.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)**<u>Indemnification</u>**. Concurrently with entering into this Agreement, you and the Company are entering into the indemnification agreement attached hereto as <u>Attachment E</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)**<u>Company and Employer Representations</u>**. The Company and Employer each represent and warrant that (i) it is fully authorized by action of the Board to enter into this Agreement and perform its obligations under this Agreement, (ii) the execution, delivery and performance of this Agreement does not violate any applicable law, regulation, order, judgement or decree or any agreement, arrangement, plan or corporate governance document to which it is a party or by which it is bound, and (iii) upon the execution and delivery of this Agreement by the parties, this Agreement shall be its valid and binding obligation, enforceable against it in accordance with its terms, except to the extent that enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors rights generally.

*[Signature Page Follows.]*

------

To indicate your acceptance of the Employer's offer of employment, please sign and date this Agreement, the enclosed Confidentiality Agreement, and the enclosed Indemnification Agreement in the space provided for your signature and return them to me within two business days of the date of this letter.

Very truly yours,

OPENDOOR LABS INC.

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Sydney Schaub&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: Sydney Schaub

Title: Chief Legal Officer

OPENDOOR TECHNOLOGIES INC.

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Eric Feder&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: Eric Feder

Title: Lead Independent Director

**ACCEPTED AND AGREED:**

<u>/s/ Kaz Nejatian&nbsp;&nbsp;&nbsp;&nbsp;</u>

Kaz Nejatian

**Attachment A: Make-Whole RSU Award Agreement** 

**Attachment B: First Sign-On PSU Award Agreement**

**Attachment C: Second Sign-On PSU Award Agreement**

**Attachment D: Confidentiality Agreement**

**Attachment E: Indemnification Agreement**

[*Signature Page to Offer Letter*]

------

<u>EXECUTION VERSION</u>

**Attachment A**

**OPENDOOR TECHNOLOGIES INC.**<br>**RESTRICTED STOCK UNIT GRANT NOTICE**<br>

Opendoor Technologies Inc., a Delaware corporation (the "***Company"***), has granted to the participant listed below ("***Participant***") the Restricted Stock Units (the "***RSUs***") described in this Restricted Stock Unit Grant Notice (this "***Grant Notice***"), subject to the terms and conditions of the Opendoor Technologies Inc. 2022 Inducement Award Plan (as amended from time to time, the "***Plan***") and the Restricted Stock Unit Agreement attached hereto as **Exhibit A** (the "***Agreement***"), both of which are incorporated into this Grant Notice by reference. Capitalized terms not specifically defined in this Grant Notice or the Agreement have the meanings given to them in the Plan.

**Participant:** Kaz Nejatian

**Grant Date:** September 15, 2025

**Number of RSUs:** 1,580,611

**Vesting Commencement Date:** September 15, 2025

**Vesting Schedule:** 100% of the RSUs to vest on [*date that is 9 months following Grant Date*].

By accepting (whether in writing, electronically or otherwise) the RSUs, Participant agrees to be bound by the terms of this Grant Notice, the Plan, and the Agreement. Participant has read and understands that the Plan, this Grant Notice and the Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of the Plan, this Grant Notice and the Agreement.

**NOTE: RSUs will be cancelled and forfeited on your Termination Date except as set forth in the Agreement; you will not be entitled to compensation or damages pursuant to contract, common law or civil law in respect of any such cancellation and forfeiture.**

**OPENDOOR TECHNOLOGIES INC.**&nbsp;&nbsp;&nbsp;&nbsp;**PARTICIPANT**

---

| | | |
|:---|:---|:---|
| By: | /s/ Eric Feder | /s/ Kaz Nejatian |
| Name: | Eric Feder | Kaz Nejatian |
| Title: | Lead Independent Director |  |

---

------

*Exhibit A to Attachment A*

**<br>OPENDOOR TECHNOLOGIES INC.**<br>**RESTRICTED STOCK UNIT AGREEMENT**<br>

Capitalized terms not specifically defined in this Agreement have the meanings specified in the Grant Notice or, if not defined in the Grant Notice, in the Plan.

**Article 1<br>GENERAL**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1<u>Award of RSUs</u>. The Company has granted the RSUs to Participant effective as of the Grant Date set forth in the Grant Notice. Each RSU represents the right to receive one Share as set forth in this Agreement. Participant will have no right to be issued any Shares until the time (if ever) the RSUs have vested.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2<u>Incorporation of Terms of the Plan</u>. The RSUs are subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any conflict between the Plan and this Agreement, the terms of this Agreement will control. Notwithstanding the foregoing, no action by the Administrator or the Company that is permitted under Articles 8.2(e) or 8.2(f) of the Plan shall have an adverse effect on the economic value of the RSUs, as determined by the Administrator in its reasonable discretion, without the express written consent of the Participant. The RSUs are being granted pursuant to the Nasdaq "inducement award" exception under Nasdaq Listing Rule 5635(c)(4) and all terms and conditions of these RSUs shall be interpreted and applied consistently with such rule.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3<u>Unsecured Promise</u>. The RSUs will at all times prior to settlement represent an unsecured Company obligation payable only from the Company's general assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4<u>Definitions</u>. Capitalized terms listed in this Article 1.3 shall have the meanings set forth below. Capitalized terms otherwise used but not defined herein shall have the same meanings as in the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)"***Offer Letter***" shall mean that certain letter agreement between Participant, the Company and Opendoor Labs Inc., dated as of September 10, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)"***Qualifying Termination***" has the meaning set forth in the Offer Letter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)"***Termination Date***" shall mean the date the last day of Participant's employment with the Company or Subsidiary, as determined in accordance with the Offer Letter, provided that in the case of termination of employment by resignation by Participant, such date

------

shall not be earlier than the date notice of resignation was given; or in the event that Participant's death or Disability occurs prior to such date, the date of Participant's death or Disability.

**Article 2<br>VESTING; FORFEITURE AND SETTLEMENT**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1<u>Vesting; Forfeiture</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Subject to the terms and conditions of this Agreement, the RSUs will vest according to the vesting schedule in the Grant Notice except that any fraction of an RSU that would otherwise be vested will be accumulated and will vest only when a whole RSU has accumulated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)In the event Participant experiences a Termination of Service, then all unvested RSUs will immediately and automatically be cancelled and forfeited on the Termination Date (as defined below), except as otherwise set forth below in Article 2.1(d) hereof or as determined by the Administrator or expressly provided in a binding written agreement between Participant and the Company, and Participant will not be entitled to any damages or other amounts in respect of such cancellation and forfeiture of RSUs in connection with Participant's Termination of Service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Notwithstanding the terms of the Plan, Participant's Termination of Service is deemed to occur on the Termination Date for the purposes of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)In the event of Participant's Qualifying Termination, then the RSUs, to the extent unvested, shall immediately vest as of the Termination Date and be settled, subject to Participant's timely execution and nonrevocation of a release of claims in favor of the Company in accordance with the terms of Article 2.2 hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2<u>Settlement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The RSUs will be paid in newly-issued Shares as soon as administratively practicable after the vesting of the applicable RSU, but in no event later than the March 15 of the year following the year in which the RSUs' vesting date occurs. Notwithstanding Article 9.9 of the Plan, no portion of the RSUs will be settled in cash without Participant's consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Notwithstanding the foregoing, the Company may delay any payment under this Agreement that the Company reasonably determines would violate the Applicable Laws until the earliest date the Company reasonably determines the making of the payment will not cause such a violation (in accordance with Treasury Regulation Section 1.409A-2(b)(7)(ii)); <u>provided</u> that the Company reasonably believes the delay will not result in the imposition of excise taxes under Section 409A.

**Article 3<br>TAXATION AND TAX WITHHOLDING**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1<u>Representation</u>. Participant represents to the Company that Participant has reviewed with Participant's own tax advisors the tax consequences of this award of RSUs and the

Ex. A A-2

------

transactions contemplated by the Grant Notice and this Agreement. Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2<u>Tax Withholding</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Participant may pay the Company, or make provision satisfactory to the Administrator for payment of, any taxes required by Applicable Law to be withheld in connection with such Participant's RSUs. If Participant does not pay the Company such taxes, then following consultation between Participant and the Company and subject to any requirements or limitations under Applicable Law, the Company shall and Participant hereby authorizes and consents to the Company, or their respective agents, at their discretion, to satisfy their withholding obligations with regard to the RSUs by one of the following methods, notwithstanding anything to the contrary in Article 9.5 of the Plan:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)by surrendering to the Company for cancellation RSUs with respect to that number of Shares with a Fair Market Value to the applicable tax withholding obligations; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)if there is a public market for Shares at the time the tax obligations are satisfied, delivery by the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to sell shares issued in respect of the RSUs in an amount necessary to satisfy the applicable tax withholding obligations and deliver promptly to the Company funds sufficient to satisfy the tax withholding; provided that such amount is paid to the Company as soon as practicable; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)a combination of the payment forms described in clauses (i)-(ii) of this Article 3.2(a).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Participant acknowledges that Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs, regardless of any action the Company or any Subsidiary takes with respect to any tax withholding obligations that arise in connection with the RSUs. Neither the Company nor any Subsidiary makes any representation regarding the treatment of any tax withholding in connection with the awarding, vesting or payment of the RSUs or the subsequent sale of Shares. The Company and its Subsidiaries do not commit and are under no obligation to structure the RSUs to reduce or eliminate Participant's tax liability.

**Article 4<br>OTHER PROVISIONS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1<u>Adjustments</u>. Participant acknowledges that the RSUs, and the Shares subject to the RSUs, are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2<u>Notices</u>. Any notice to be given under the terms of this Agreement to the Company must be in writing and addressed to the Company in care of the Company's Secretary at the Company's principal office or the Secretary's then-current email address or facsimile number. Any notice to be given under the terms of this Agreement to Participant must be in writing and

Ex. A A-3

------

addressed to Participant (or, if Participant is then deceased, to the Designated Beneficiary) at Participant's last known mailing address, email address or facsimile number in the Company's personnel files. By a notice given pursuant to this Section, either party may designate a different address for notices to be given to that party. Any notice will be deemed duly given when actually received, when sent by email, when sent by certified mail (return receipt requested) and deposited with postage prepaid in a post office or a regularly maintained branch post office, when delivered by a nationally recognized express shipping company or upon receipt of a facsimile transmission confirmation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3<u>Titles</u>. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4<u>Conformity to Securities Laws</u>. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all Applicable Laws and, to the extent Applicable Laws permit, will be deemed amended as necessary to conform to Applicable Laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5<u>Successors and Assigns</u>. The Company may assign any of its rights under this Agreement to single or multiple assignees, provided that any such assignee is the successor to all or substantially all of the business and assets of the Company and expressly assumes the liabilities and obligations of the Company under this Agreement, and this Agreement will inure to the benefit of the successors and permitted assigns of the Company. Subject to the restrictions on transfer set forth in this Agreement or the Plan, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and permitted assigns of the parties hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6<u>Limitations Applicable to Section 16 Persons</u>. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Grant Notice, this Agreement and the RSUs will be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3) that are requirements for the application of such exemptive rule. To the extent Applicable Laws permit, this Agreement will be deemed amended as necessary to conform to such applicable exemptive rule.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7<u>Entire Agreement</u>. The Plan, the Grant Notice and this Agreement (including any exhibit hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof. Participant agrees and acknowledges that Participant has received and read a copy of the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8<u>Agreement Severable</u>. In the event that any provision of the Grant Notice or this Agreement is held illegal or invalid, the provision will be severable from, and the illegality or invalidity of the provision will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.9<u>Limitation on Participant's Rights</u>. The participation of any Participant in the Plan is entirely voluntary and participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and may not be construed as creating a trust. Neither the Plan nor any underlying

Ex. A A-4

------

program, in and of itself, has any assets. Participant will have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the RSUs, and rights no greater than the right to receive the Shares as a general unsecured creditor with respect to the RSUs, as and when settled pursuant to the terms of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10<u>Not a Contract of Employment</u>. Nothing in the Plan, the Grant Notice or this Agreement confers upon Participant any right to continue in the employ or service of the Company or any Subsidiary or interferes with or restricts in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.11<u>Counterparts</u>. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to Applicable Law, each of which will be deemed an original and all of which together will constitute one instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.12<u>Special Provisions for Bahamas</u>. Notwithstanding any other provision of this Agreement or the Plan to the contrary:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Participant acknowledges that the grant, vesting, and settlement of the RSUs may be subject to the securities laws of The Bahamas, including the Securities Industry Act, 2024 and any successor legislation. The Company shall cooperate in good faith to facilitate any required filings, exemptions, or disclosures with the Securities Commission of The Bahamas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Participant understands that, as a resident of The Bahamas, holding or receiving foreign securities or related proceeds may require prior approval under the Exchange Control Regulations Act. Participant agrees to seek any necessary approvals, and the Company shall provide reasonable assistance in connection with such applications, including documentation of the award terms and valuation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Company makes no representations regarding the tax treatment of the RSUs under Bahamian law. Participant is solely responsible for complying with any applicable tax reporting or payment obligations arising from the grant, vesting, or settlement of the RSUs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)To the extent required by the laws of The Bahamas, this Agreement shall be interpreted in a manner consistent with such laws, provided that no provision herein shall be deemed to create an employment relationship under Bahamian law.

*[Signature Page Follows.]*

Ex. A A-5

------

&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have executed this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**OPENDOOR TECHNOLOGIES INC.**

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**By: <u>__ /s/ Eric Feder________________</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Eric Feder

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Lead Independent Director

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Participant**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>___/s/ Kaz Nejatian______________</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Kaz Nejatian

[*Signature Page to RSU Award Agreement*]

## Exhibit 10.7

**Exhibit 10.7**

**OPENDOOR LABS INC.**

410 N Scottsdale Rd Ste 1600

Tempe, AZ, 85288

VIA EMAIL

September 18, 2025

Christy Schwartz

[\*\*\*]

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Re: &nbsp;&nbsp;&nbsp;&nbsp;Employment Offer

Dear Christy:

Opendoor Labs Inc., a Delaware corporation (the "<u>Company</u>"), is pleased to offer you employment as the Company's Interim Chief Financial Officer, on the terms described in this letter agreement (this "<u>Agreement</u>"). Your employment will commence no later than September 30, 2025 (such actual date of your commencement of employment will be referred to herein as the "<u>Start Date</u>") and will conclude on the earlier of (i) May 15, 2026, or (ii) 30 days from the appointment of a Chief Financial Officer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.<u>Employment</u>.** As Interim Chief Financial Officer, you will be responsible for performing such duties as are customarily associated with such position, and such other responsibilities consistent with your title as may be assigned to you by Kaz Nejatian, Chief Executive Officer, to whom you will report, including serving as the Principal Financial Officer of Opendoor Technologies, Inc. ("Parent"). You will be employed on a full-time basis. During the term of your employment with the Company, you will devote your best efforts and substantially all of your business time and attention to the business of Parent, the Company and its and their subsidiaries (collectively, the "Company Group"), except for approved vacation periods and reasonable periods of illness or other incapacities permitted by the Company's general employment policies. You will be based in the San Francisco Bay Area, you will work in person from our San Francisco, California office three days per week or otherwise in accordance with the Company's standard policies with respect to in-office expectations for senior employees, and you will travel as reasonably required in connection with your duties when deemed necessary or requested by the Company from time to time. This is an exempt position.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.<u>Salary</u>.** You will be paid a base salary at the annual rate of $1,200,000, to be paid in accordance with the Company's regular payroll practices. As an exempt salaried employee, you will be required to work the Company's normal business hours, and such additional time as appropriate for your work assignments and position, and you will not be entitled to overtime compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.<u>Benefits</u>.** You will be eligible to participate in all of the employee benefit plans or programs the Company generally makes available to similarly situated employees, pursuant to the terms and conditions of such plans. You will be eligible for Company-paid holidays and paid time off in

------

accordance with the Company's policies. The Company may, from time to time, change these benefits in its discretion, provided that you will be treated no less favorably than similarly situated employees. Additional information regarding these benefits is available for your review upon request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.<u>Equity</u>.** Subject to the approval of the Board of Directors or Compensation Committee of Parent, as soon as practicable following the Start Date, you will be granted 400,641 restricted stock units ("<u>RSUs</u>" and such grant, the "<u>RSU Grant</u>"). Each RSU will represent the right to receive one share of the common stock of Parent. The RSU Grant will vest on the following schedule, except as set forth herein: 133,547 RSUs will vest on November 15, 2025, 133,547 RSUs will vest on February 15, 2026, and 133,547 RSUs will vest on May 15, 2026. The RSU Grant will be subject to the provisions of Parent's current equity incentive plan or inducement award plan, as applicable (the "<u>Plan</u>") and our standard form of RSU award agreement, which will govern and control in all respects, except as otherwise set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.<u>Termination</u>.** Employment with the Company is for no specific period of time. Your employment with the Company is "at will," meaning that either you or the Company may terminate your employment at any time and for any reason, with or without Cause (as defined below) and with or without advance notice. Any contrary representations that may have been made to you are superseded by this offer. This is the full and complete agreement between you and the Company on this term. Although your job duties, title, compensation, and benefits, as well as the Company's personnel policies and procedures, may change from time to time, the "at will" nature of your employment may only be changed in an express written agreement signed by you and the Chief Executive Officer of the Company.

Notwithstanding the foregoing, in the event that the Company terminates your employment other than for Cause prior to May 15, 2026, you resign 30 days after the Company hires a Chief Financial Officer, or you terminate your employment for any reason subsequent to May 15, 2026, you will be entitled to (i) the difference between $1,200,000 and any salary (before taxes, deductions, and withholdings) already paid to you under this Agreement, and (ii) any unpaid amounts that would have been payable under Section 4 of this Agreement. These amounts will be paid within 30 days of your termination date. For avoidance of doubt, you will not be eligible for any executive severance plan made available by the Company Group.

For the purposes of this Agreement, (a)&nbsp;&nbsp;&nbsp;&nbsp;"Cause" means: (i) your commission of any act that constitutes a felony or any crime involving dishonesty or moral turpitude, (ii) your engaging in any act of fraud or embezzlement, whether or not related to the business of the Company Group, or any other act of material dishonesty against the Company Group, (iii) any material breach by you of this Agreement, the Confidentiality Agreement or similar agreement or of any material written policy of the Company Group and, if curable, your failure to cure such breach within thirty (30) days after receiving written notice thereof from the Board specifying the nature of such breach with reasonable specificity; (iv) your willful and continued failure to substantially perform your duties to the Company Group (other than any such failure resulting from your incapacity due to physical or mental illness), after written demand for substantial performance is delivered by the Board that identifies with reasonable specificity the manner in which the Employer believes that you have not substantially performed your duties, which is not cured within thirty (30) days after notice of such failure has been given to you by the Board; (v) the willful engaging by you

------

in misconduct or gross neglect (including any conduct that is in violation of the written employee workplace policies of the Company Group) that is materially injurious to the Company Group, monetarily, in reputation or otherwise; or (vi) any other intentional act causing material damage to the Company Group's business, property or reputation; provided, however, that any written notice of breach or written demand for performance described in clauses (iii) or (iv) must be delivered to you no later than thirty (30) days after the Board's initial knowledge of the conduct believed to constitute Cause, in order for such conduct to constitute Cause.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.<u>Expenses</u>.** You will be entitled to reimbursement for all ordinary and reasonable out-of-pocket business expenses which are reasonably incurred by you in furtherance of the Company's business, with appropriate documentation and in accordance with the Company's standard policies. Any reimbursement of expenses or in-kind benefits payable under this Agreement shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid on or before the last day of your taxable year following the taxable year in which you incurred the expenses. The amount of expenses reimbursed or in-kind benefits payable in one year shall not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of yours, and your right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.<u>Compliance with Confidentiality Information Agreement and Company Policies</u>.** In connection with your employment with the Company, you will receive and have access to Company confidential information and trade secrets. Accordingly, as a condition to your commencement of employment with the Company, you will be required to execute the Employee Confidential Information and Inventions Assignment Agreement ("<u>Confidentiality Agreement</u>") attached hereto as <u>Attachment 2</u>, which contains restrictive covenants and prohibits unauthorized use or disclosure of the Company's confidential information and trade secrets, among other obligations. In addition, you are required to abide by the Company's policies and procedures (including but not limited to the Company's employee handbook), as adopted or modified from time to time within the Company's discretion, and acknowledge in writing that you have read and will comply with such policies and procedures (and provide additional such acknowledgements as such policies and procedures may be modified from time to time). The Company may modify, revoke, suspend or terminate any of the policies and/or procedures at any time, with or without notice.

&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement or the Confidentiality Agreement shall prevent you from (i) communicating directly with, cooperating with, or providing information to, or receiving financial awards from, any federal, state or local government agency, including without limitation the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, the U.S. Department of Justice, the U.S. Equal Employment Opportunity Commission, or the U.S. National Labor Relations Board, without notifying or seeking permission from the Company, (ii) exercising any rights you may have under Section 7 of the U.S. National Labor Relations Act, such as the right to engage in concerted activity, including collective action or discussion concerning wages or working conditions, or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination based on a protected characteristic or any other conduct that Employee has reason to believe is unlawful. In addition, you acknowledge receipt of the following notice of immunity rights under the U.S. Defend Trade Secrets

------

Act, which states: "(1) An individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (2) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal, and (B) does not disclose a trade secret, except pursuant to court order."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.<u>Protection of Third-Party Information</u>.** By signing this Agreement, you are representing that you have full authority to accept this position and perform the duties of the position without conflict with any other obligations and that you are not involved in any situation that might create, or appear to create, a conflict of interest with respect to your loyalty to or duties for the Company. You specifically warrant that you are not subject to an employment agreement or restrictive covenant preventing full performance of your duties to the Company on and after the Start Date. You agree not to make any unauthorized disclosure or use, on behalf of the Company, of any confidential information belonging to any of your former employers. You also represent that you are not in unauthorized possession of any materials containing a third party's confidential and proprietary information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.<u>Outside Activities</u>.** During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) 1% of any class of securities of any enterprise (but without participating in the activities of such enterprise) and you may passively invest in hedge funds, mutual funds, private equity funds and similar funds. Nothing in this Agreement shall prohibit or restrict you from managing your personal investments in companies that are not competitive with the Company or engaging in civic, charitable, religious or political activities, sitting on a non-profit, professional, or industry boards, or conducting personal speaking or educational engagements, in each case provided such endeavors do not materially interfere with your obligations under this Agreement. In addition, in the event that you wish to undertake any business activity outside the scope of your employment by the Company, which activity you believe entails no conflict with the Company's activities, you agree to inform the Company of your intentions prior to the initiation of such outside business activity, and you furthermore agree to abide by the Company's decision as to whether or not there is no conflict. If, in the Company's sole determination, a conflict exists or is likely to develop, you agree not to undertake such outside business activity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**10.<u>Miscellaneous</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)**<u>Background Check and Proof of Right to Work</u>.** This offer is contingent upon a satisfactory reference check and satisfactory proof of your right to work in the United States. If the

------

Company informs you that you are required to complete a background check or drug test, this offer is contingent upon satisfactory clearance of such background check and/or drug test. You agree to assist as needed and to complete any documentation at the Company's request to meet these conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)**<u>Governing Law</u>.** The validity, interpretation, construction and performance of this Agreement, and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of State of California, without giving effect to principles of conflicts of law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)**<u>Entire Agreement</u>.** You acknowledge and agree that as of your execution of this Agreement, your sole entitlement to any compensation or benefits from the Company will be as set forth in this Agreement. This Agreement, together with the Confidentiality Agreement, the Indemnification Agreement (as defined below) and the documents governing any equity awards granted to you, sets forth the entire agreement and understanding of the parties relating to the subject matter herein and supersedes all prior or contemporaneous discussions, understandings and agreements, whether oral or written, between you and the Company relating to the subject matter hereof. No amendment or modification to this Agreement shall be effective unless it is in writing and signed by an authorized officer of the Company and by you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)**<u>Counterparts</u>.** This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same agreement. Facsimile and electronic image signatures (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) will be deemed an original and valid signature.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)**<u>Successors and Assigns</u>.** This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns, except that you may not assign any of your duties hereunder and you may not assign any of your rights hereunder, without the written consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)**<u>Severability</u>.** If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)**<u>Waiver</u>.** Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)**<u>Electronic Delivery</u>.** The Company may, in its sole discretion, decide to deliver any documents or notices related to this Agreement, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's Certificate of Incorporation or Bylaws by email or any other

------

electronic means. You hereby consent to: (i) conduct business electronically; (ii) receive such documents and notices by such electronic delivery; and (iii) sign documents electronically and agree to participate through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)**<u>Arbitration</u>.** You agree that any and all disputes relating to or regarding your employment, including disputes regarding compensation and any and all other conflicts, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16 ("<u>FAA</u>"), or if inapplicable, the California Arbitration Act, to the fullest extent permitted by law, by final and binding arbitration. You further agree that such disputes shall be resolved on an individual basis only, and not on a class, collective or representative basis on behalf of other employees ("<u>Class Waiver</u>"), to the extent permitted by applicable law. Any claim that all or part of the Class Waiver is invalid, unenforceable, unconscionable, void or voidable may be determined only by a court. In no case may class, collective or representative claims proceed in arbitration. Notwithstanding the foregoing, this paragraph shall not apply to an action or claim brought in court that cannot be subject to mandatory arbitration as a matter of law, including without limitation, claims alleging sexual harassment or a nonconsensual sexual action or sexual contact, to the extent any such claims are not permitted by applicable law to be submitted to mandatory arbitration and such applicable law is not preempted by the FAA or otherwise invalid (the "<u>Excluded Claims</u>"). In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration. You and the Company agree to bring any dispute in arbitration before a single neutral arbitrator with JAMS, Inc. or its successor ("<u>JAMS</u>"), in San Francisco, California or in the county of your residence if it is not in the San Francisco Bay Area at the time of the commencement of an arbitration proceeding, pursuant to the JAMS Employment Rules & Procedures (which can currently be reviewed at <u>http://www.jamsadr.com/rules-employment-arbitration/</u> and will be provided to you upon request). You on the one hand, and the Company on the other, waive any rights to a jury trial or a bench trial in connection with the resolution of any dispute under this Agreement or your employment (although both parties may seek interim emergency relief from a court to prevent irreparable harm pending the conclusion of any arbitration). The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator's essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that you or the Company would be entitled to seek in a court of law. You and the Company shall equally share all JAMS' arbitration fees, or such fees shall be paid in such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company's agreement to arbitrate; provided, however, if you reside in California, the Company shall pay all JAMS' arbitration fees in excess of the amount of court fees that would be required of you if the dispute were filed in Superior Court. To the extent JAMS does not collect or you otherwise do not pay to JAMS an equal share of all JAMS' arbitration fees for any reason, and the Company pays JAMS your share, you acknowledge and agree that the Company shall be entitled to recover from you half of the JAMS arbitration fees invoiced to the parties (less any amounts you paid to JAMS) in a federal or state court of competent jurisdiction. Each party is responsible for its own attorneys' fees, except as expressly set forth in your Confidentiality Agreement. Nothing in this letter agreement is intended to prevent either you or the

------

Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. This paragraph shall not apply to an action or claim brought in court pursuant to the California Private Attorneys General Act of 2004, as amended. **Arbitration is not a mandatory condition of your employment. If you wish to opt out of this arbitration agreement, you must notify the Company in writing by sending an email to <u>hr@opendoor.com</u> stating your intent to opt out within 30 days of signing this Agreement.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)**<u>Withholding</u>**. All amounts payable to you will be subject to appropriate payroll deductions and withholdings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)**<u>Electronic Delivery</u>**. The Company may, in its sole discretion, decide to deliver to you by email or any other electronic means any documents or notices related to this letter, securities of the Company or any of its affiliates or any other matter, including documents and/or notices required to be delivered to you by applicable securities law or any other law or the Company's organizational documents, each as amended from time to time. You hereby consent to receive such documents and notices by such electronic delivery and agree to participate through any online or electronic system that may be established and maintained by the Company, or a third party designated by the Company.

------

To indicate your acceptance of the Company's offer of employment, please sign and date this Agreement and the enclosed Confidentiality Agreement where indicated and return them to me no later than September 18, 2025. This offer, if not accepted, will expire at the close of business on such date.

Best regards,

**OPENDOOR LABS INC.**

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Sydney Schaub&nbsp;&nbsp;&nbsp;&nbsp;</u><br> Name: Sydney Schaub

Title: Chief Legal Officer

Date:<u>&nbsp;&nbsp;&nbsp;&nbsp;9/18/25&nbsp;&nbsp;&nbsp;&nbsp;</u>

ACCEPTED AND AGREED:

<u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Christy Schwartz&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Christy Schwartz

Date: <u>&nbsp;&nbsp;&nbsp;&nbsp;9/18/25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

## Exhibit 10.8

**Exhibit 10.8**

**ADVISORY AGREEMENT** 

This Advisory Agreement (this "***Agreement***") is entered into between Carrie Wheeler ("***Advisor***"), and Opendoor Technologies Inc. (the "***Company***"), effective as of August 15, 2025 (the "***Effective Date***").

WHEREAS, the Advisor was employed by a subsidiary of the Company pursuant to that certain employment letter agreement between the Advisor and Opendoor Labs Inc. dated as of September 3, 2020, as amended effective as of December 1, 2022 (the "***Employment Agreement***");

WHEREAS, the Advisor resigned her employment with the Company and its subsidiaries effective August 15, 2025 (the "***Employment End Date***"); and

WHEREAS, the Company desires to continue to engage the Advisor as an independent contractor following her resignation from employment on the terms and conditions set forth in this Agreement.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties agree as follows:

1.<u>Services</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Scope of Services</u>. During the period commencing on the Effective Date and ending on the earlier of December 31, 2025 and the date the Agreement is terminated as provided in Section 2(a) below (the "***Advisory Period***"), the Advisor shall serve as a special advisor to the board of directors (the "***Board***") of the Company and agrees to perform such consulting, advisory and related services as may be reasonably requested by the Board and agreed to by the Advisor from time to time (the "***Services***"). The Advisor agrees to perform the Services in accordance with (i) the terms of this Agreement; (ii) all applicable laws, statutes, rules, regulations, ordinances and other pronouncements having the binding effect of law of any applicable government authority, court, tribunal, arbitrator, agency, legislative body or commission; and (iii) all Company policies, procedures and guidance memoranda provided to the Advisor in writing in connection with the Advisor's performance under this Agreement. During the Advisory Period, the Advisor shall be allowed to continue using the Advisor's Company email address.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Availability</u>. The Advisor agrees to provide the Services on or around such dates and at or around such times as may be reasonably requested by the Board. The Advisor shall provide the Services remotely unless otherwise mutually agreed.

2.<u>Term and Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)This Agreement may be terminated by either the Company or the Advisor at any time for any reason upon no less than fifteen (15) days' prior written notice to the other party. This Agreement shall automatically terminate on December 31, 2025 if not terminated earlier.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)In the event that the Advisor terminates this Agreement prior to December 31, 2025, such termination shall not affect the Company's obligation to pay any amounts owed with respect to months (or partial months) prior to such termination in accordance with, or expenses reasonably incurred by the Advisor for which the Advisor is entitled to reimbursement under, Section 3 of this Agreement.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)In the event that the Company terminates this Agreement other than for Cause (as defined in the Employment Agreement) prior to December 31, 2025, the Advisor shall be entitled to (i) any amounts owed with respect to months (or partial months) prior to such termination in accordance with, or expenses reasonably incurred by the Advisor for which the Advisor is entitled to reimbursement under, Section 3 of this Agreement and (ii) any amounts that would have been payable under Section 3(a) of this Agreement with respect to months (or partial months) following her termination through December 31, 2025, had she continued to provide Services as an Advisor through such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Termination of this Agreement by either the Advisor or the Company shall not affect the Advisor's continuing obligations to the Company under Section 5 of this Agreement.

3.<u>Compensation</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Compensation</u>. During the Advisory Period, the Advisor shall be compensated as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The Company will pay to the Advisor a monthly fee of $62,500 per month during the Advisory Period, payable in arrears on a monthly basis and pro-rated for any partial months of service regardless of whether any Services have been requested or provided.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)During the Advisory Period, the Advisor shall continue to vest in any time-based Company equity awards granted to the Advisor that were outstanding as of immediately prior to the Employment End Date and which, pursuant to their terms, are capable of vesting (in whole or in part) on or prior to December 31, 2025 (together, the "***Eligible Equity Awards***"), subject to continued service with the Company through the applicable vesting date. Any Company equity awards held by the Advisor as of the Employment End Date other than the Eligible Equity Awards shall be forfeited without consideration as of the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)During the Advisory Period, the Advisor shall receive the benefits set forth in Section 8(f)(ii) of the Employment Agreement in accordance with the terms and conditions thereof, assuming that the "Date of Termination" as described therein refers to the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>No Right to Employee Benefits</u>. The Advisor acknowledges that the Advisor shall not be eligible to participate in any plan or program which, as a condition of eligibility for such plan or program, requires the Advisor to be an employee of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Expense Reimbursements</u>. During the Advisory Period, the Company shall reimburse the Advisor for reasonable and pre-approved out-of-pocket business expenses incurred in connection with the performance of her Services hereunder, subject to (i) such policies as the Company may from time to time establish, and (ii) the Advisor furnishing the Company with evidence in the form of receipts substantiating the claimed expenditures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>No Right to Other Payments</u>. Other than the payments to which the Advisor may become entitled under this Agreement, the Advisor acknowledges and agrees that she has received all salary, paid time off, or other compensation she earned that was payable by the Company prior to the Effective Date. Without limiting the foregoing, the Advisor shall not be eligible for an annual cash performance bonus for the 2025 fiscal year, but shall be reimbursed for any business expenses incurred prior to the Effective Date in accordance with applicable Company policies.

------

4.<u>Relationship of the Parties; No Conflicts</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Independent Contractor</u>. Notwithstanding any provision of this Agreement to the contrary, the Advisor is and shall at all times be an independent contractor and not an employee of the Company or any of its affiliates and shall be free to exercise her discretion and judgment as to the methods and means of performing the Services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>No Agency Relationship</u>. Nothing contained in this Agreement shall be construed as creating an agency relationship between the Company or any of its affiliates and the Advisor and, without the Company's prior written consent, the Advisor shall have no authority hereunder to bind the Company or any of its affiliates or make any commitments on behalf of the Company or any of its affiliates. The Advisor shall not take any action in connection with the rendering of Services hereunder which the Advisor reasonably believes would cause any third party to reasonably assume that she has such authority.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Taxes and Withholding</u>. The Advisor shall have no claim under this Agreement or otherwise against the Company or its affiliates for workers' compensation, unemployment compensation, sick leave, vacation pay, group insurance arrangements, or any other employee benefits. The Advisor is solely responsible for providing, at the Advisor's own expense, all taxes, withholdings and other similar statutory obligations including, but not limited to, disability insurance, unemployment insurance, Social Security, FICA, FUTA, SDI and federal, state or any other employee payroll taxes for the Advisor and the Advisor's employees, subcontractors and Advisors. Except as otherwise required under applicable law, the Company shall not withhold on behalf of the Advisor hereunder, any sums for income tax, unemployment insurance, social security or any other withholding pursuant to any law or requirement of any government agency. The Advisor shall comply at the Advisor's expense with all applicable provisions of worker's compensation laws, unemployment compensation laws, federal Social Security laws and all other applicable federal, state, and local laws, regulations and codes relating to terms and conditions of employment required to be fulfilled by employers or independent contractors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>No Violation of Third-Party Obligations</u>. The Advisor represents and warrants that neither this Agreement nor the performance thereof will conflict with or violate any obligation of the Advisor to a third party or right of any third party.

5.<u>Certain Covenants</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Continuing Obligations</u>. The Advisor hereby expressly reaffirms her obligations under the Employee Confidential Information and Invention Assignment Agreement to which she is a party and which is attached hereto as <u>Exhibit A</u> (the "***Confidential Information Agreement***"), which is incorporated herein by reference; provided that, the one-year period contemplated under the restriction set forth in Section 5 of the Confidential Information Agreement (No Solicitation of Employees, Consultants or Contractors) shall begin upon the termination of the Advisory Period, rather than upon the Employment End Date. Subject to the foregoing proviso, the Advisor agrees that her obligations under the Confidential Information Agreement applicable during the Advisor's employment with the Company shall continue to apply during the Advisory Period and shall, to the extent such obligations would survive the termination of the Advisor's employment with the Company, survive any termination of her Services to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Return of Property</u>. To the extent that the Advisor retains or obtains Confidential Information (as defined in the Confidential Information Agreement), other Company information or Company property during the Advisory Period, the Advisor represents and warrants that, upon the termination of the Advisory Period, she shall follow and comply with the procedures for return

------

of such information and property set forth in Section 8 of the Confidential Information Agreement, as if she were terminating her employment relationship, except as otherwise permitted by the last sentence of Section 1(a) of this Agreement. Promptly following the Effective Date, the Company and the Advisor shall cooperate to determine if any existing electronic resources other than her Company email address (e.g., Slack) will be necessary for the Advisor to perform the Services and, if so, the Advisor shall continue to have access thereto subject to applicable Company policies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Mutual Nondisparagement</u>. The Advisor shall not disparage the Company, its subsidiaries, their respective boards of directors, or their products or services. The Company agrees to instruct the members of the Board, the Company's executive officers, and the Company's senior management team not to disparage the Advisor while they are employed by or providing services to the Company, and the Company agrees, and agrees to cause its subsidiaries, not to disparage the Advisor in corporate communications to third parties or to the employees of the Company and its subsidiaries. Nothing contained herein shall preclude either party from enforcing the terms of this Agreement or providing truthful testimony or responses in any judicial or other governmental proceeding when required to do so by legal process. The Company agrees that, unless otherwise required by applicable law, the Company will describe the Advisor's cessation of employment in all internal and external communications in a manner consistent with Schedule A hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Whistleblower Provision</u>. Nothing herein shall be construed to prohibit the Advisor from communicating directly with, cooperating with, or providing information to, any government regulator, including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, or the U.S. Department of Justice. The Advisor acknowledges that the Company has provided the Advisor with the following notice of immunity rights in compliance with the requirements of the Defend Trade Secrets Act: (i) the Advisor shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of proprietary information that is made in confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, (ii) the Advisor shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of proprietary information that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and (iii) if the Advisor files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Advisor may disclose the proprietary information to the Advisor's attorney and use the proprietary information in the court proceeding, if the Advisor files any document containing the proprietary information under seal, and does not disclose the proprietary information, except pursuant to court order.

6.<u>Rights and Remedies Upon Breach</u>. If either party breaches or threatens to commit a breach of any of the provisions of Section 5 of this Agreement, the non-breaching party shall have the right and remedy to have such provisions specifically enforced by any court of competent jurisdiction, it being agreed that any breach or threatened breach of such provisions would cause irreparable injury to the non-breaching party and that money damages would not provide an adequate remedy to the non-breaching party. The nonbreaching party shall also have any other rights and remedies available to such party under law or in equity.

7.<u>Arbitration</u>. The parties agree that any and all controversies, claims, or disputes arising out of, relating to, or resulting from the Advisor's employment or service to the Company or any subsidiary, shall be subject to arbitration in accordance with Section 11 of the Employment Agreement.

------

8.<u>Release of Known and Unknown Claims By the Advisor</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)In exchange for the compensation set forth in Section 3(a) above, and in consideration of the further agreements and promises set forth herein, the Advisor, on behalf of herself and her executors, heirs, administrators, representatives and assigns, hereby agrees to release and forever discharge the Company and all predecessors, successors and their respective parent corporations, affiliates, related, and/or subsidiary entities, and all of their past and present investors, directors, stockholders, officers, general or limited partners, employees, attorneys, agents and representatives, and the employee benefit plans (including plan sponsors, plan fiduciaries, and insurers) in which the Advisor is or has been a participant by virtue of her employment with or service to the Company (collectively, the "***Company Releasees***"), from any and all claims, debts, demands, accounts, judgments, rights, causes of action, equitable relief, damages, costs, charges, complaints, obligations, promises, agreements, controversies, suits, expenses, compensation, responsibility and liability of every kind and character whatsoever (including attorneys' fees and costs), whether in law or equity, known or unknown, asserted or unasserted, suspected or unsuspected, direct or derivative (collectively, "***Claims***"), which the Advisor has or may have had against such entities based on any events or circumstances arising or occurring on or prior to the date hereof, arising directly or indirectly out of, relating to, or in any other way involving in any manner whatsoever Executive's employment by or service to the Company or her resignation therefrom, Executive's ownership of Company securities or otherwise, including any and all claims arising under federal, state, or local laws, including without limitation claims of wrongful discharge, breach of express or implied contract, fraud, misrepresentation, defamation, or liability in tort, and claims of any kind that may be brought in any court or administrative agency including, without limitation, claims under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. Section 2000, <u>et</u> <u>seq</u>.; the Americans with Disabilities Act, as amended, 42 U.S.C. § 12101 <u>et</u> <u>seq</u>.; the Rehabilitation Act of 1973, as amended, 29 U.S.C. § 701 <u>et</u> <u>seq</u>.; the Civil Rights Act of 1866, and the Civil Rights Act of 1991; 42 U.S.C. § 1981, <u>et</u> <u>seq</u>.; the Equal Pay Act, as amended, 29 U.S.C. Section 206(d); regulations of the Office of Federal Contract Compliance, 41 C.F.R. Section 60, <u>et</u> <u>seq</u>.; the Family and Medical Leave Act, as amended, 29 U.S.C. § 2601 <u>et</u> <u>seq</u>.; the Fair Labor Standards Act of 1938, as amended, 29 U.S.C. § 201 <u>et</u> <u>seq</u>.; the Employee Retirement Income Security Act, as amended, 29 U.S.C. § 1001 <u>et seq</u>.; the Worker Adjustment and Retraining Notification Act, as amended, 29 U.S.C. § 2101 <u>et</u> <u>seq</u>.; the California Fair Employment and Housing Act, as amended, Cal. Gov. Code § 12940 et seq.; the California Equal Pay Law, as amended, Cal. Lab. Code §§ 1197.5(a),1199.5; the Moore-Brown-Roberti Family Rights Act of 1991, as amended, Cal. Gov't Code §§12945.2, 19702.3; the California WARN Act, Cal. Lab. Code § 1400 et seq.; the California False Claims Act, Cal. Gov't Code § 12650 et seq.; or under the California Labor Code, or any other local ordinance or federal or state statute, regulation or constitution, whether known or unknown arising from any action or inaction whatsoever prior to the date of execution of this Agreement.

Notwithstanding the generality of the foregoing, the Advisor does not release any claim which, by law, may not be released, including the following claims (the "***Retained Claims***"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Claims for workers' compensation insurance benefits under the terms of any worker's compensation insurance policy or fund of the Company or its affiliates and/or pursuant to the terms of applicable state law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)Claims pursuant to the terms and conditions of the federal law known as COBRA or the comparable California law known as Cal-COBRA;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)Claims for indemnity under the bylaws of the Company or its affiliates, as provided for by applicable law, or Claims under any applicable insurance policy with respect to the Advisor's liability as an employee, officer or director of the Company or its affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)Claims for the Advisor's right to bring to the attention of the Equal Employment Opportunity Commission or any other federal, state or local government agency claims of discrimination, or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission or any other federal, state or local government agency; provided, however, that the Advisor does release her right to secure any damages for alleged discriminatory treatment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)Claims based on any right the Advisor may have to enforce the Company's or its affiliates' executory obligations under this Agreement or any agreement referenced herein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)Claims the Advisor may have to vested or earned compensation and benefits; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)Executive's right to communicate or cooperate with any government agency.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)THE ADVISOR ACKNOWLEDGES THAT THE ADVISOR HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS:

**"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY."** 

BEING AWARE OF SAID CODE SECTION, THE ADVISOR HEREBY EXPRESSLY WAIVES ANY RIGHTS THE ADVISOR MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.

The Advisor represents and warrants to the Company Releasees that there has been no assignment or other transfer of any interest in any Claim that the Advisor may have against the Company Releasees. The Advisor agrees to indemnify and hold harmless the Company Releasees from any liability, claims, demands, damages, costs, expenses and attorneys' fees incurred as a result of any such assignment or transfer from the Advisor.

9.<u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Entire Agreement; Modification</u>. This Agreement, the Employment Agreement, the Confidential Information Agreement and the other agreements referenced herein and therein set forth the entire understanding of the parties with respect to the subject matter hereof, supersedes all existing agreements between them concerning such subject matter. This Agreement may be amended or modified only with the written consent of the Advisor and an authorized representative of the Company. No oral waiver, amendment or modification will be effective under any circumstances whatsoever.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Assignment; Assumption by Successor</u>. The rights of the Company under this

------

Agreement may, without the consent of the Advisor, be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company and assumes and agrees to perform this Agreement by operation of law or otherwise. Unless expressly provided otherwise, "***Company***" as used herein shall mean the Company as defined in this Agreement and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Survival</u>. The covenants, agreements, representations and warranties contained in or made in the last sentence of Section 1(a) and in Sections 2(b), 2(c), 4, 5, 6, 7, 8 and 9 of this Agreement shall survive any termination of the Advisor's Services or any termination of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Third-Party Beneficiaries</u>. This Agreement does not create, and shall not be construed as creating, any rights enforceable by any person not a party to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Notices</u>. Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice deemed given as indicated: (i) by personal delivery when delivered personally; (ii) by overnight courier upon written verification of receipt; (iii) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission; or (iv) by certified or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to the Advisor at the address set forth on the Company's personnel records and to the Company at its principal place of business, or such other address as either party may specify in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Severability</u>. In the event any provision of this Agreement is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law. If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)<u>Non-transferability of Interest</u>. None of the rights of the Advisor to receive any form of compensation payable pursuant to this Agreement shall be assignable or transferable except through a testamentary disposition or by the laws of descent and distribution upon the death of the Advisor. Any attempted assignment, transfer, conveyance, or other disposition (other than as aforesaid) of any interest in the rights of the Advisor to receive any form of compensation to be made by the Company pursuant to this Agreement shall be void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)<u>Governing Law and Venue</u>. This Agreement will be governed by and construed in accordance with the laws of the United States and the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)<u>Counterparts</u>. This Agreement may be executed in multiple counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)<u>Interpretation; Construction</u>. The headings set forth in this Agreement are for convenience only and shall not be used in interpreting this Agreement. This Agreement has been

------

drafted by legal counsel representing the Company, but the Advisor has participated in the negotiation of its terms. Furthermore, the Advisor acknowledges that the Advisor has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. Either party's failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision or prevent that party thereafter from enforcing each and every other provision of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)<u>Waiver</u>. The failure of either party hereto at any time to enforce performance by the other party of any provision of this Agreement shall in no way affect such party's rights thereafter to enforce the same, nor shall the waiver by either party of any breach of any provision hereof be deemed to be a waiver by such party of any other breach of the same or any other provision hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)<u>Section 409A</u>. The compensation and benefits payable under this Agreement are not intended to constitute "nonqualified deferred compensation" within the meaning of Section 409A of the Code. To the extent applicable, this Agreement shall be interpreted in accordance with Code Section 409A and Department of Treasury regulations and other interpretive guidance issued thereunder. The amount of expenses reimbursed or in-kind benefits payable during any taxable year of the Advisor's will not affect the amount eligible for reimbursement or in-kind benefits payable in any other taxable year of the Advisor's, and the Advisor's right to reimbursement for such amounts shall not be subject to liquidation or exchange for any other benefit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)<u>Knowing and Voluntary; Right to Seek Independent Advice</u>. The Advisor represents and agrees that she is entering into this Agreement knowingly and voluntarily. The Advisor affirms that no promise was made to cause the Advisor to enter into this Agreement, other than what is promised in this Agreement. The Advisor further confirms that she has not relied upon any other statement or representation by anyone other than what is in this Agreement as a basis for her agreement. The Advisor acknowledges and agrees that neither the Company nor the Company's counsel has provided any legal or tax advice to the Advisor and that the Advisor is free to, and is hereby advised to, consult with a legal or tax advisor of the Advisor's choosing. The Company shall reimburse the Advisor for the reasonable legal fees and expenses of her counsel in connection with the preparation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)<u>RIGHT</u> <u>TO</u> <u>ADVICE</u> <u>OF</u> <u>COUNSEL</u>. THE ADVISOR ACKNOWLEDGES THAT SHE HAS THE RIGHT, AND IS ENCOURAGED, TO CONSULT WITH HER LAWYER; BY HER SIGNATURE BELOW, THE ADVISOR ACKNOWLEDGES THAT SHE HAS CONSULTED, OR HAS ELECTED NOT TO CONSULT, WITH HER LAWYER CONCERNING THIS AGREEMENT.

(Signature Page Follows)

------

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date(s) set forth below.

---

| | | |
|:---|:---|:---|
| **OPENDOOR TECHNOLOGIES INC.** | **OPENDOOR TECHNOLOGIES INC.** | **OPENDOOR TECHNOLOGIES INC.** |
| By: | &nbsp;&nbsp;&nbsp;&nbsp;/s/ Glenn Solomon | &nbsp;&nbsp;&nbsp;&nbsp;/s/ Glenn Solomon |
| Print Name: | Print Name: | Glenn Solomon |
| Title: |  | Chair, Compensation Committee |
| Date: |  | August 15, 2025 |
| **CARRIE WHEELER** | **CARRIE WHEELER** | **CARRIE WHEELER** |
| /s/ Carrie Wheeler | /s/ Carrie Wheeler | /s/ Carrie Wheeler |
| Date: |  | August 15, 2025 |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)**

**AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Kaz Nejatian, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Opendoor Technologies Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 06, 2025 | By: | /s/ Kaz Nejatian |
|  |  |  | Kaz Nejatian |
|  |  |  | Chief Executive Officer |
|  |  |  | *(Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF INTERIM CHIEF FINANCIAL OFFICER**

**PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)**

**AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Christy Schwartz, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Opendoor Technologies Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 06, 2025 | By: | /s/ Christy Schwartz |
|  |  |  | Christy Schwartz |
|  |  |  | Interim Chief Financial Officer |
|  |  |  | *(Principal Financial and Accounting Officer)* |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND INTERIM CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Opendoor Technologies Inc. (the "Company") for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Kaz Nejatian, Chief Executive Officer of the Company, and Christy Schwartz, Interim Chief Financial Officer of the Company, each certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | | |
|:---|:---|:---|:---|
| Date: | November 06, 2025 | By: | /s/ Kaz Nejatian |
|  |  |  | Kaz Nejatian |
|  |  |  | Chief Executive Officer |
|  |  |  | *(Principal Executive Officer)* |
| Date: | November 06, 2025 | By: | /s/ Christy Schwartz |
|  |  |  | Christy Schwartz |
|  |  |  | Interim Chief Financial Officer |
|  |  |  | *(Principal Financial and Accounting Officer)* |

---

<br>